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Introduction 
 
Medici obbligati a “parlare facile”. Stop allo sfoggio di tecnicismi.  
«Dottore, parla come mangi». Ѐ la rivoluzione nell’informazione al paziente dell’azienda 
ospedaliera. La decisione è contenuta in una disposizione al personale per porre fine alla 
situazione tragicomica che si ripete da anni al letto del malato. 
 Il medico che dice: «Parliamo del fastidio postprandiale che avverte in sede epigastrica». 
Ed il paziente che risponde: «Oddio, ma io ero venuto qui solo perché ho mal di pancia 
dopo aver mangiato». Ed il camice bianco che ribatte: «Ѐ quello che ho appena detto».                           
(Fabiana Pesci, Il Mattino di Padova, 8 Luglio 2010, p.3) 
 
These are the title and the first lines of the newspaper article published in Il Mattino 
di  Padova,  which  focuses  on  the  language  used  by  doctors  and  on  the  patients’ 
inability to understand it. When I read this article I thought ‘finally someone is aware 
that, at times, doctors’ language is incomprehensible’, and I remembered when, few 
years before, my family doctor told me that I had a hiatus hernia. At first, I thought 
he would explain to me what he was talking about; he only talked about treatments 
instead. Therefore, I had to ask him what the meaning of hiatus hernia was and, 
then, he explained it to me through an anatomical sketch. That was the first time I 
thought about the language used by doctors in everyday medical encounters. 
As  is  well  known,  medicine  has  always  occupied  a  prominent  place  in  all 
cultures and times, because it is a common concern of all human beings: their health 
and healthcare are at the top of the political agenda in most parts of the world. 
However,  the  language  through  which  medical  knowledge  and  concepts  are 
conveyed  has  often  been  criticized  for  being  difficult  to  understand.  In  order  to 
provide an historical overview, the present study, in Chapter one, shows how medical 
language  and its  terminology evolved over time,  and how much the language of 
medicine  has  been  criticized  over  the  centuries.  Moreover,  in  Chapter  two,  the 
linguistic and syntactic features which characterize the language used by physicians 
are presented, thus providing a way to become closer to the language of the medical 
community. 
Since the language of medicine generally causes problems of understanding to 
laypeople, in Chapter three and four, two different situations in which patients may 
come  in  contact  with  medical  terms  have  been  investigated:  doctor-patient 
interactions and patient information leaflets. 4 
 
In  Chapter  three,  the  attention  focuses  on  medical  practice  and  on  the 
communication  between  health  professionals  and  non-expert  people.  Central  to 
medical practice are doctor-patient relationships and interactions which have recently 
been identified as the key factors for successful treatment. Physicians need to adapt 
the  language  they  use  according  to  their  patients’  age,  educational  level  and 
comprehension skills in order to communicate in an effective way with their patients, 
thus avoiding misunderstandings.  
Another  relevant  aspect  of  modern  medical  practice  is  patients’  need  to  be 
informed about their health conditions and to be involved in shared decision-making 
about treatments and medications. In this respect, in the last decade, there has been 
a major change in the amount of information made available to people other than 
the  traditional  experts  in  the  medical  field  –  the  doctors,  pharmacists  and  other 
medical  practioners.  Many  countries  have  adopted  policies  which  mandate  that 
adequate information be made available about treatments, medications and surgical 
procedures,  thus  allowing  people  to  participate  in  an  informed  way  in  the 
management of their own health. However, in more recent times, a technological 
innovation, the Internet, has assumed considerable importance among the sources 
which  provide  health-related  information,  thus  challenging  doctors’  essential  role. 
The technological revolution which is underway reshapes the way that health care is 
organized  and  delivered,  and  traditional  resources  -  such  as  consultations  with 
physicians - are being supplemented and replaced in increasing numbers. In order to 
see whether doctors succeed in maintaining their central role in small towns – where 
doctors have always been seen as an important guide for the social community – in 
section 3.3, the results of a survey in the town of Lusiana are presented. 
In Chapter four the attention shifts to another kind of communicative context: 
patient information leaflets. Though in our society, there is an enormous amount of 
information  about  health  and  medications  which  is  available  from  many  different 
sources, it is not always easy for patients to access medical information. For many 
people, the primary source of information about drugs remains the statutory patient 
information leaflet (PIL) which has to provide all the essential information patients 
need  to  use  medications  safely.  Since  patient  information  leaflets  should  be 
‘informative texts’ for all types of patients, the present study aims at verifying to 5 
 
what extent patient information leaflets of over-the-counter drugs are informative 
texts  for  laypeople.  In  this  respect,  a  corpus-based  quantitative  analysis  into  the 
complexity of these texts (Italian and English PILs) was carried out by investigating 
the  phenomena  of  lexical  density,  lexical  variation,  readability  and  keyness.  In 
addition, a linguistic analysis of lexis, specialized terms and LSP collocations found in 
the corpora under investigation is provided. 
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Chapter one: medical language throughout history 
The importance that has always been attached to the suffering of body and 
soul suggests that medical texts, together with religious writings, are amongst the 
most ancient domains of translation. Due to the development of medical sciences 
and the need to term new concepts, medical language evolved over the centuries 
and  medical  vocabulary  has  continuously  been  expanded.  To  understand  how 
medical language has changed and how new terms have been coined, the following 
paragraphs will try to sketch a time line that will highlight what have been the most 
significant facts in the evolution of medical language. 
 
1.1  Historical overview  
 
The scientific methods that characterize modern western medicine are traceable 
to  Classic  and  Hellenistic  Greece,  when  the  Greek  physician  Hippocrates  first 
attributed illness to physical causes. The importance of Hippocrates’ thought derives 
from the fact that he distinguished medical practice from priestly ministrations and 
pioneered the belief that poor health should be examined through logical reasoning 
and actual observation. Hippocrates and his successors produced a large body of 
medical texts in Greek and many of the anatomic, pathologic and therapeutic terms 
found in those texts remain in use today – some of them with little or no change in 
meaning (Dirckx 2005:9). During the classical era, Greek medical writing was the 
most important medium for medical scholars to communicate their ideas. At the time 
of  the  Roman  Empire  and  later  in  medieval  Europe  medical  language  changed 
considerably.  
At the time Greece was absorbed by the Roman Empire, the centres of learning 
moved from Greece to Egypt. Despite of this change, Greek physicians succeeded in 
maintaining their importance: Greek medical texts began to be translated into Arabic 
and only marginally into Latin.  
 8 
 
After the demise of the Roman Empire in the 5
th century, most works of the 
Greek  physicians  remained  unknown  in  Western  Europe  until  the  11
th  and  13
th 
centuries. At the time, Western society began to rediscover ancient Greek scientific 
texts thanks to the discovery of Arab repositories of learning in Spain and elsewhere 
during  the  Crusades,  and  ancient  works  were  translated  from  Arabic  into  Latin 
(Berghammer 2006:40). Although the translation of texts had been made from their 
Arabic  versions,  Arabic  had  contributed  relatively  little  to  western  medical 
terminology. Therefore, it can be said that Arabic represented a bridge that provided 
access to the Hellenic system of science.
1 
 Later on, after the Ottoman conquest of Constantinople in the 15
th century, 
Greek scholars migrated to Italy bringing with them their ancient works. During the 
Renaissance, when Greek was no longer so widely understood, Greek texts were 
directly translated into Latin, which absorbed Greek and Arabic medical terminology 
through  transliteration  or  overlay  with  Latin  prefixes  and  suffixes  (Berghammer 
2006:40). 
Between  1000-1800AD,  Latin  served  as  a  universal  language  for  scholarly 
communication and, being the language of the Roman Empire, which included most 
of  Europe,  part  of  Asia  and  Africa,  Latin  assumed  the  role  of  lingua  franca  of 
medicine. Until the early modern era, the language of medicine consisted largely of 
Latin terms and still today it remains the official language of anatomic terminology 
and taxonomic nomenclature (Dirckx 2005:9). However, because of the increasing 
need to communicate with non-university-trained physicians, students and patients, 
Latin as the language of medicine was almost entirely replaced by local languages – 
even though all of them retained the Greco-Latin terminological core (Berghammer 
2006:40).  
Undoubtedly,  throughout  history,  dominance  in  knowledge  has  implied 
repercussions on the language used in medical discourse, as is the case with the 
                                                           
1 A basic change in European medicine occurred following the translation into Latin of Arabic scientific 
treatises. Through their Latin versions, three of the early Arabic medical encyclopedias soon came to 
dominate European medical theory. Two of them were massive attempts at synthesizing all available 
medical  knowledge  and  the  first  Arabic  medical  treatise  to  be  translated  into  Latin  was  the 
comprehensive medical compendium Pantegni (Loudon 1997:15). 
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English language. From the second half of the 20
th century, English has become the 
shared medium of the medical community and English terms have been imported 
into  many  other  national  languages.  This  may  be  clearly  seen  as  a  direct 
consequence of United States leadership in many fields. 
The  advantages  of  a  common,  shared  language  for  scientific  research  are 
obvious.  However,  the  predominance  of  English  gives  English  native  speakers  a 
competitive edge over those who first have to acquire the necessary linguistic skills 
in order to be able to read English materials and to communicate their ideas and 
findings in a foreign language. 
 
1.1.1  Greek-Latin terminological core 
 
As has been said above, much of the medical terminology of western European 
languages consists of roots and affixes drawn from Greek and Latin. The advantages 
of this terminological core are the following: it serves as an artificial language; it no 
longer changes because Latin and Greek are dead languages; and it is precise and 
internationally comprehensible and accepted (Berghammer 2006:40). 
The oldest written sources of western medicine are the Hippocratic texts from 
the 5
th and 4
th century BC, which cover all aspects of medicine known at that time; in 
fact, many medical terms had been coined in that period. Then, Romans, who had 
no similar medical tradition, imported Greek medicine as well as Greek terminology, 
for instance, the words catarrh (downflow), diarrhoea (throughflow), dyspnoea (bad 
breathing) (Wulff 2004:187-188). 
At the beginning of the first century AD, when Greek was still the language of 
medicine in the Roman world, a relevant development took place. A Roman aristocrat 
from  Narbonne,  Aulus  Cornelius  Celsus,  wrote  De  Medicina,  an  encyclopaedic 
overview of medical knowledge based on Greek sources. Celsus was very important 
for  western  medical  language  because  he  was  the  first  to  face  a  testing 
terminological problem: the majority of Greek medical terms had no Latin equivalents 
(Wulff 2004:187-188). 
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As Wulff (2004:187-188) states, from a linguistic point of view, the manner in 
which Celsus succeeded to solving this problem is of considerable interest. Firstly, he 
imported  a  few  Greek  terms  directly,  even  preserving  their  Greek  grammatical 
endings, and wrote them with Greek letters; he included, for instance, the Greek 
word pyloros (now pylorus). Secondly, he transliterated Greek words, writing them 
with  Latin  letters  and  replacing  Greek  inflectional  endings  with  Latin  ones,  for 
example  the  word  stomachus.  Thirdly,  he  retained  the  imagery  of  the  Greek 
anatomical terminology by translating Greek terms into Latin, such as dentes canini 
from the Greek Kynodontes (dog teeth). It is for the same reason that we can still 
enjoy  the  old  Greek  tradition  of  likening  the  shape  of  anatomical  structures  to 
musical instruments, as in the words tuba-trumpet, tibia-flute. 
Celsus’ De Medicina appeared in print in 1478 and, in the following centuries, 
almost  all  important  medical  works  were  published  into  Latin.  Therefore,  medical 
vocabulary expanded but, basically, the language did not change: it was a compound 
of  ordinary  Latin  and  numerous  Greek  and  Latin  medical  terms (Wulff  2004:187-
188). The era of Latin gradually came to an end during the 19
th century. In Britain, 
William Heberden’s Commentarii was probably the last notable medical text to be 
written in Latin. It appeared in 1802 and it is also referred to as ultimus Romanorum 
(the  last  text  of  the  Romans).  In  other  countries  medical  Latin  survived  a  little 
longer. 
1.1.2  National medical languages 
 
Though national medical languages had much in common, since most of the 
medical  terms  derived  from  medical  Latin,  there  were  some  differences  in  the 
translation process that still persist. Germanic languages often adopt anatomic terms 
and disease names with their correct Latin endings, whereas Romance languages 
tend to adapt the terms according to the norms of each particular language while 
Slavic languages tend to translate the terms (Wulff 2004:187-188). 
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For example
2, the Latin terms nervus musculocutaneus and ulcus ventriculi are 
considered below: 
-   Germanic languages: nervus musculocutaneus / ulcus ventriculi 
-  Romance languages: 
French: le nerf musculo-cutané / ulcère gastrique 
Italian: il nervo musculocutaneo / ulcera gastrica 
English: the musculocutaneous nerve / gastric ulcer 
-  Slav languages:  
Russian : kozhno-myzhechny nerv (‘skin-muscle nerve’) / jasva zheludka (‘ulcer 
of stomach’). 
Furthermore, national medical languages did not limit themselves to importing 
terms already found in medical Latin. Scientists continued to develop new concepts 
that  needed  to  be  named,  coining  for  this  reason  a  multitude  of  new  terms. 
However, since Latin does not permit the formation of composite words to the same 
extent as Greek, these neologisms were usually composed of Greek rather than Latin 
roots (Wulff 2004:187-188), as it can be seen in the following examples:  
Erythrocyte-Etymology: Gk, erythros + kytos, cell; 
Nephrectomy-Etymology: Gk, nephros, kidney + ektomē, excision. (M’sMM 2009) 
 
The huge neoclassical wordstock with Greek roots, which is still being used, 
presents other characteristics of linguistic importance, such as:  
  the special meaning attached to certain Greek suffixes (-itis,  -oma), 
 
Arthritis [ärthrī′tis]  
Etymology: Gk, arthron, joint + Gk, itis, inflammtion  
any inflammatory condition of the joints, characterized by pain, swelling, heat, redness, 
and limitation of movement. (M’sMM 2009) 
 
Lymphoma [limfō′mə] pl. lymphomas, lymphomata  
Etymology: L, lympha + Gk, oma, tumor 
a  type  of  neoplasm  of  lymphoid  tissue  that  originates  in  the  reticuloendothelial  and 
lymphatic systems. It is usually malignant but in rare cases may be benign. It usually 
responds to treatment. Two main kinds of lymphomas are Hodgkin's disease and non-
Hodgkin's lymphoma (NHL). (M’sMM 2009) 
                                                           
2 The examples are taken from the article “The language of medicine” by Wulff, 2004. 
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  and the fact that some prefixes and suffixes are more productive than others. 
For instance, focusing on the coining process of a new word within medical 
discourse, it is clear that the Greek prefix hyper- is more productive than its Latin 
equivalent super- (Wulff 2012:187-188). Therefore, we say hypertension rather than 
supertension. The productiveness of the Greek prefix hyper- can be demonstrated by 
the  analysis  of  the  online  corpus  WebCorp  LSE  and  focusing  on  the  sub-corpus 
“health”. In fact, the results show that the number of words with the prefix hyper- is 
much higher than the one presenting the prefix super-. Some of the occurrences 
taken from WebCorp are reported in Table 1.1 below: 
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Hyper*[N*] 1490 occurrences  Hyper*[Adj*] 238 occurrences 
Hypertension 
Hypersensitivity 
Hypercalcemia 
 Hyperphosphatemia 
 Hypervitaminosis 
Hyperkalemia 
Hyperactivity 
Hyperplasia 
Hyperclycemia 
Hypertriglyceridemia 
Hyperthyroidism 
Hyperparathyroidism 
Hypeuricemia 
Hypertrophy 
Hyperlipidemia 
Hypercholesterolemia 
Hyperthermia 
Hyperventilation 
Hyperaldosteronism 
hyper-reninism 
hyperalgesia 
hyperreflexia 
hyperammonemia 
hypercalciuria 
hypernatremia 
hyperpigmentation 
 
Hyperplastic 
Hypertensive 
Hyperactive 
Hypersensitive 
Hypercapnic 
Hyperkalemic 
Hypermetabolic 
Hypertrophic 
Hyperendemic 
Hyperchloremic 
Hypertonic 
Hyperbaric 
Hyperechoic 
Hyperglycemic 
Hyperacute 
Hypercoagulable 
Hypercellular 
Hyperextended 
Hyperfractionated 
Hyperinsulinemic 
Hyperintense 
Hyperthermic 
Hypercalcemic 
Hyperserotonergic 
hyperpigmented 
Super*[N*]  Super*[Adj*] 
Supervision 
Supervisor 
Superoxide 
Superoxol 
Superbug 
Supernatant 
superinfection 
Superior 
Supervised 
Superficial 
Supernatant 
Super-oxidized 
superacid 
Table 1.1. Occurrences of nouns and adjectives with the prefixes hyper- and super- taken from the 
online corpus WebCorp LSE- health. 
Focusing  now  on  recent  times,  all  the  most  influential  medical  journals  are 
written in English and English has become the language for international medical 
communication. However, while in the past new medical terminology consisted of 
classical roots, today words are often borrowed from general English. As an example, 
we can consider the following definitions of the word bypass (Oxford 2013):  
1. (general En.) A road that passes around a town or city rather than through the centre. 
2. (med.) A medical operation in which blood is directed along a different route. 14 
 
As  can  be  seen,  both  definitions  refer  to  a  different  direction  that  is  being 
taken. Therefore, the meaning of the ordinary noun is assigned to the medical term. 
For what concerns other national languages, doctors from non-English-speaking 
countries can choose between importing these English neologisms directly into their 
mother language as loan words, translating them into their own language or coining 
new terms. The term bypass, for instance, is accepted in Italian, whereas in French it 
is  translated  into  pontage  (Wulff  2004:187-188).  The  different  attitude  towards 
borrowing can probably be explained by the resistance of French language towards 
English loan words that can be seen not only in the medical field, but also in the 
language of technology, as is the case with computer science: 
Computer -  ordinateur   
mouse – souris 
mailing list - liste de distribution 
home page – page d’accueil 
browser – navigateur 
Web – Toile/ réseau 
1.1.2.1  English influence on Italian medical language 
 
The  increasing  and  rapid  expansion  of  English  in  medical  journals  is 
demonstrated in a recent article “Le lingue della comunicazione scientifica” (Carli and 
Calaresu  2003:27-74),  where  the  authors  analysed  the  editorial  policies  of  five 
medical Italian journals from 1990 to 2000. The research shows that two of the five 
medical journals started to publish articles in English already in 1990. From 2001, 
they only accept contributions in English and they even translated the name of the 
journals - Italian Health Journal (since 2000) and Italian Journal of Pediatrics (since 
2001). However, the Italian Health Journal continues to publish articles in Italian, but 
it  attaches  different  functions  to  the  two  languages:  while  Italian  is  seen  as  the 
medium to broaden international scientific knowledge and its implications in clinical 
practice,  English  is  seen  as  the  language  for  experimental  researches,  shared  by 
scientists from all over the world.  15 
 
Despite this difference of purpose of the two languages in the journals, it can 
be seen that loan words from English are used even in journal articles that have 
been written in Italian and that are intended for Italian doctors. According to Serianni 
(2005:186), in Italian medical discourse we can distinguish five different types of 
loans from English: 
a.  general loan words, that are terms which can also be found outside medical 
discourse  and  can  be  substituted  by  Italian  words,  such  as  ‘ipertensione 
borderline (ai limiti della norma)’; ‘core lipidico (nucleo)’; ‘l’inserzione di un 
patch  (innesto)’;  ‘sensazione  di  handicap  (disagio)’;  ‘turnover  cellulare 
(ricambio)’. 
b.  Loan words which refer to the pathology, some of them well consolidated in 
their  use,  such  as  ‘shock  emorragico  (sindrome  a  insorgenza  acuta 
caratterizzata  da  complessi  disturbi  della  dinamica  circolatoria)’;  ‘bulky-
disease (massa tumorale rilevante)’. 
c.  Loan words which refer to surgery, introduced in recent times but generally 
used, such as ‘posizionamento di uno stent coronarico (tipo di protesi)’. 
d.  Loans that refer to diagnosis, such as ‘breath-test (test del respiro)’, ‘follow-
up (controllo periodico)’. 
e.  Loans  that  belong  to  the  biological  field,  such  as  ‘incremento  degli  spike 
(picchi)’,  ‘teoria  dell’underfilling  and  teoria  dell’overfilling’  (respectively 
‘scarso ed eccessivo riempimento’). 
In order to see how frequently these loans from English are used in articles 
addressed  to  the  Italian  audience,  seven  on-line  articles  (Appendix  1)  have  been 
taken into account. In a corpus of almost 2.700 words, 13 English loan words have 
been found. Most of them are general loans (step, test, database, checklist, team, 
target, counselling, borderline, handicap) while the others are loan words that refer 
to  diagnosis  (follow-up,  Framingham  risk  score,  Cac  score).  Only  one  loan  word 
(reuptake) belongs to the biological field. The word reuptake is part of the complex 
medical term selective serotonin reuptake inhibitors, and in Italian the complex term 
can be found in two variants: inibitori selettivi della ricaptazione delle serotonina or 
inibitori selettivi del reuptake della serotonina. 16 
 
As shown above, the presence of English terms in journal articles addressed to 
Italian  general  practioners  is  limited  to  words  that  are  widely  recognized  by  the 
medical community and to those that can also be found outside the medical field. 
To this end, the success in maintaining the use of Italian in journals for general 
practioners can be explained by the fact that Italian is the language through which 
Italian doctors express themselves better and through which they can have a better 
understanding (Serianni 2005:184). 
In addition to loans from English, the influence of English language can also be 
observed in the coining process of  Italian  medical terms. Coining models derived 
from the Anglophone society - which are unusual in Italian - are recently expanding 
in their use. For instance, we can observe Italian adjectives formed of a subordinate 
sequence Noun + Adj., as in the term calcio-antagonista, or the form that follows the 
English  suffix  –like,  as  in  the  terms  aspirino-simile,  antibiotico-simile.  This  last 
sequence can also occurs in the inverse sequence Adj. + Noun, as in simil-virale, 
simil-neoplastico.  Moreover,  we  can  find  the  juxtaposition  of  two  nouns  in  the 
sequence Determiner + determined, as in the following examples coronavirus and 
papillomavirus (Bellina 2011:2). 
Another relevant aspect that is worth considering is that English language is 
influencing not only Italian medical lexis but also the word order within the sentence 
(Serianni,  2005:185).  As  is  recognized,  the  topological  rule  of  Italian  language 
imposes the postposition of the rhematic subject to the predicate, as in the examples 
that follow: 
 ___= predicate 
 […]= rhematic subject 
Chi vuol giocare? Gioco [io] .  
Come con gli altri FANS, sono stati riportati [rari casi d’insufficienza renale]. (Borocilina) 
In caso di sovradosaggio, possono essere utili [la lavanda gastrica e l’impiego di carbone 
attivo]. (Peridon) 17 
 
Despite this accepted rule, in medical Italian, some sequences rheme-theme 
patterned after the English structure can be found. Some examples taken from over-
the-counter drug leaflets are reported below: 
[Una  stretta  sorveglianza  medica  e  una  terapia  di  supporto]  sono  raccomandate… 
(Peridon) 
[Eritema e moderata secchezza e desquamazione della pelle] sono stati osservati in una 
piccola percentuale di casi. (Zovirax) 
[Gravi reazioni cutanee alcune delle quali fatali, includenti dermatite esfoliativa, sindrome 
di  Stevens-Johnson  e  necrolisi  tossica  epidermica,]  sono  state  riportate  molto 
rarammente in associazione con l’uso dei Fans. (Moment) 
At this point, one question comes to mind. If medical language causes many 
problems of understanding when medical concepts are expressed in people’s mother 
tongue, how can the presence of English words facilitate comprehension?  
1.2 “Remedia curant morbum non verba”
3 
The criticism against medical language is not unusual and neither recent. The 
language  used  by  physicians  has  always  caused  problems  of  understanding  and 
literary  traditions  give  us  various,  intense  satirical  statements  against  doctors.  At 
times,  the  criticism  hits  just  one  particular  aspect,  that  is  the  doctors’  lack  of 
technical  preparation:  paradoxically,  doctors  that  are  supposed  to  nurse  patients 
cause the death of sick people because of their inability in health care. Other times, 
critics focalize on the intangible linguistic code exhibited by clinicians. Indeed, the 
favourite  target  is  represented  by  specialized  terms  which  are  apparently 
unfathomable in their meaning. In the following text, several examples of satire will 
help us to understand how prolific the criticism against doctors has been over the 
centuries. 
At the very beginning, we find Petrarch’s Invective contra medicum. Through 
this piece of writing against a doctor of the Papal Court at the time of Clemente VI, 
Petrarch  blames  doctors  to  provide  only  useless  words  to  their  patients, 
                                                           
3 Alexander Knipps Macoppe (1662-1748), he practiced and taught medicine in Padua. He built up a 
great  reputation  for  treating  venereal  disease  and  for  spa  therapy  applied  to  various  conditions. 
Aphorism :“sono le medicine, non le parole, a curare le malattie” (Macoppe 1984:26). 
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“intempestivos flosculos inutilium verborum” (Serianni 2005:14). Later on, Petrarch’s 
criticism  becomes  more  intense  in  the  work  Seniles.  Some  parts  of  the  letter  to 
Giovanni Boccaccio are quoted below: 
 
[…]nulla aver potuto fare ne fatto il medico, da quello in fuori di cui ￨ capace un 
ciarliero dialettico fecondo di noie, e sterile di rimedi. Ora mi scrivi che ricaduto 
nella malattia non chiamasti alcun medico: onde io non mi meraviglio che tu sia 
presto guarito. Non v' è strada più corta a risanare del tenersi lontano il medico. 
[…]per l' uso delle continue menzogne artificiosamente adoperate.[…] 
In questo si convengono gli uni cogli altri, che come fra i guerrieri quegli è stimato 
più grande che più numerose e più larghe mena le stragi; cosi fra i medici chi a 
furia di esperimenti e di prove mette più vite in pericolo , questi mostrato a dito è 
più celebrato, e dagli altri tenuto a 
duce e maestro. Gran pratica , dicono , grande esperienza è la sua: il che significa 
aver egli contratta l'abitudine di ammazzare con securtà.[…] 
Ma qualunque sproposito a que'dottoroni esca di bocca intorno alle cose naturali , 
dal volgo non solo come dogma sicuro, ma come divino oracolo è ricevuto or ti so 
dire che tutti sono uomini dotti, cortesi , egregi parlatori , acuti nel disputare , 
efficaci  nel  persuadere,  tali  in  somma  che  dolcissimamente,  e  quasi  a  ragion 
veduta ammazzano altrui , e sanno sempre abbastanza scusare e difendere il fatto 
loro. 
[…]  disprezzo  ed  abborro  que'  ciurmatori,  che  sotto  una  vernice  di  superficiale 
dialettica cianciano a vuoto invece di medicare, e non solamente immensa noia a 
chi ￨ sano, ma a chi ￨ malato procaccian la morte[…] 
[…] Pure a tornare in pace anche con essi, e per non avere più a parlare 
contro questa genìa, vorrei, che come credono di farsi grandi con nomi di malattie 
e  di  rimedi  presi  dal  greco,  come  alla  greca  si  ammalano  ,  così  alla  greca  si 
lasciassero curare.[…] 
Greca la improntitudine di quegl' impostori, e  la nomenclatura dell' erbe , delle 
piante , delle radici , balausto , rabarbaro , calaminto, tutta è dal greco, anzi pur 
dall'arabico,  perchè  quanto  più  estranio,  tanto  piùcostoso  sia  il  bugiardo 
medicamento.Non aprono la bocca a dichiarare la malattia che non lo facciano con 
greca voce : e se non 1' hanno già pronta , se la compongono: e questa dicono 
apoplessìa, quella epilessia, questa risipola. Bei nomi invero, bei paroloni che a chi 
li ascolta danno diletto , e invogliano di sapere come in greco si chiami quello per 
cui  soffre  un  latino  ,  quantunque  poi  non  si  trovin  rimedii  ne  latini,  né  greci. 
(Fracassetti 1892:285-300) 
 
As can be seen, Petrarch thinks that doctors are unable to cure illnesses and that 
they  display  their  linguistic  knowledge  without  providing  any  real  medical  care. 
Physicians are conceived as skillful orators who use dialectic and unknown terms only 
to exhibit their linguistic eloquence. They use terms that come from Greek and Latin, 
terms that only men of learning can understand, and if they do not know any word 
to express a concept, they coin a new term without the interference of an educated 19 
 
audience that could criticize them. Similarly, criticism is found in the letter to Donato 
Albanzani, where doctors’ inability and ignorance in medical care are emphasized: 
 
[…]molti ne conobbi ed ebbi amicissimi, eloquenti, letterati, in molte scienze dottissimi, 
ma solo nella medicina dappoco. Cosa veramente mirabile: saper di tutto da quello in 
fuori che si vuole e che si deve. 
[…]noi la Dio merc￩ pieni di buona salute ridiamoci della credulità degl' infermi e dell' 
ignoranza de' medici.  (Fracassetti 1982:301-305) 
 
In  France  as  well,  criticism  against  doctors  was  widespread.  Montaigne,  for 
instance,  is  ironical  about  the  obscure  way  in  which  doctors  express  themselves. 
Doctors’ linguistic skills are seen as a source of prestige to be displayed in front of a 
naïve audience. Similarly, in Moli￨re’s work  Le malade imaginaire (The Imaginary 
Invalid, 1673), we find both criticism of the patients’ confidence on healthcare and of 
the  physicians’  inexperience.  Doctors  are  grotesque  figures  with  ridiculous  names 
and  strange  behaviour,  like  Mr.  Purgon,  Mr.  Diafoirus,  and  in  the  comedy  every 
physician is portrayed as selfish and hypocrite. Moreover, Mr. Diafoirus’ son is exactly 
the type of physician that Molière wants to criticize sharply: a young doctor who has 
just finished his studies, who talks about things learnt by heart and who is unable to 
understand what he is supposed to do in real situations. Every doctor in the comedy 
displays his knowledge of ancient languages, and the author’s criticism is clear in 
what follows: 
Béralde : Ils  savent  la  plupart  de  fort  belles  humanités;  savent  parler  en  beau  latin, 
savent nommer en grec toutes les maladies, les définir, et les diviser; mais pour ce qui 
est de les guérir, c'est ce qu'ils ne savent point du tout.  
Argan: Mais toujours faut-il demeurer d'accord, que sur cette matière les médecins en 
savent plus que les autres. 
Béralde: Ils savent, mon frère, ce que je vous ai dit, qui ne guérit pas de grand-chose ; 
et toute l'excellence de leur art consiste en un pompeux galimatias, en un spécieux babil, 
qui vous donne des mots pour des raisons, et des promesses pour des effets. (Marcou 
1995 : 131-134) 
 
Affirming that physicians speak Latin and Greek very well and stating that they are 
able  to  use  these  languages  to  name  and  define  every  kind  of  illness,  Molière 
highlights the fact that their linguistic ability consists just of a sublime set of words 
and promises instead of concrete answers and real medical treatments. 20 
 
In another part of the text, the author shows the doctors’ superiority compared to 
their patients: doctors are educated people who use sophisticated words, which have 
Greek and Latin origins, while patients are ignorant and unable to understand what 
doctors say. Therefore, doctors can even insult their patients, as is the case in the 
following lines: 
Et je veux qu’avant qu’il soit quatre jours vous deveniez dans un ￩tat incurable, que vous 
tombiez dans la bradypepsie, de la bradypepsie dans la dyspepsie, de la dyspepsie dans 
l’apepsie, de l’apepsie dans la lientérie […]  (Marcou 1995: 139). 
 
Following the same common theme, in the 20
th century, in Italy, we find Totò 
and his satire against medical language in the comedy of Tramonti (1993):  
Sig.ra: Io ho un dolore qui ed al mattino viene piano piano, al pomeriggio diventa forte 
forte, la sera ritorna piano, e la notte ridiventa forte forte. Che sarà dottore? 
Mardocheo: Un piano forte 
Sig.ra: Ma come? Ho un pianoforte in petto? 
Mardocheo:  Noialtri  medici  sintetiziamo  i  termini.  La  vostra  malattia  la  chiamiamo 
malattia del piano forte. 
Sig.ra: E cosa sarebbe? 
Mardocheo:  E’  il  cuore  che  trovandosi  a  contatto  col  velopendolo  asciatico,  gonfia  i 
variosceli e la moscia. 
Sig.ra: Ma io non capisco nulla. 
Maedocheo: Nemmeno io. 
Nik: Vede, Signora, è la vera scienza. Non bisogna mai capire nulla. 
Mardocheo: Guai se l’ammalato capisse qualche cosa! Allora i medici che ci starebbero a 
fare? (Serianni 2005:20) 
 
As in Moli￨re’s criticism, the comedy quoted above shows that the patients’ inability 
to understand the language of medicine allows doctors to load their talk with any 
kind  of  technicalities.  Physicians  can  use  invented  terms,  such  as  moscia    and 
asciatico and they can even talk about pathologies that cannot affect certain types of 
patients, as is demonstrated in the explanation of the “piano forte” disease. In this 
case,  the  doctor  says  that  the  heart  stretches  the  varicoceles.  However,  being 
varicocele an abnormal distension of the veins of the spermatic cord in the scrotum
4, 
it is obvious that this pathology only affects male human bodies. Therefore, it cannot 
be a proper diagnosis for a female patient, as is the case in the comedy above. 
Moreover, when doctor Mardocheo finally says that without their patients’ ignorance 
                                                           
4 Definition taken from: http://medical-dictionary.thefreedictionary.com/varicocele 
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doctors would be useless, we find a strong criticism against medicine as a profession 
which emphasizes doctors’ need of having naïve patients. 
Again, in Spain, the playwright Enrique Jardiel Poncela defines medicine as « el 
arte  de  acompañar  con  parablas  griegas  al  sepulcro »  (the  art  that,  using  Greek 
words, lead ill people to their grave) (Serianni 2005:21). 
Over and above its criticism by men of letters, medical language was a relevant 
theme  among  doctors  themselves.  In  the  5
th  century,  very  well  known  were  the 
positions taken by the Italian physician Francesco Redi. In the letter to a sick lady, 
Redi uses a language that is very different from that of his colleagues: 
 
non  aspetti  da  me  che  io  voglia  farle,  come  sogliono  i  medici,  un  lungo  discorso  nel 
produrre  in  campo  quelle  abstruse  cagioni  produttrici  delle  sue  indisposizioni  perchè, 
siccome non le indenderei forse io, che pur le scrivo, così parimente mi do a credere che 
per  avventura  non  le  sprei  fare  intendere  a  V.S.  Illustrissima  e  particolarmente  se  io 
volessi servirmi de’ termini reconditi e misteriosi che usa l’arte medicinale e ancora de’ 
suoi greci e arabici e barbari nomi da far spirare i cani. (Serianni 2005:22) 
 
Redi criticizes the use of ancient words while explaining to patients the diagnosis and 
treatment  for  their  illnesses.  He  highlights  the  fact  that  physicians  usually  use 
complex terms even though they may not know the real meaning of the words they 
use. Therefore, they just display their rhetorical skills without allowing patients to 
understand  the  content  of  the  speech.  As  can  be  seen,  the  main  problem  is 
represented by the use of specialized terms which have Greek and Latin origins, and 
by the fact that patients are unable to understand the meaning of such terms.  
In  the  20
th  century,  we  can  remember  the  severe  judgment  of  Whitehead 
(1956:390),  who  affirms  that  the  medical  curriculum  is  a  “long  and  systematic 
exercise to verbosity”, and in the same period, we find the irony of Crichton who 
states  that  medical  writing  is  a  “highly  skilled  attempt  to  confuse  the  reader” 
(Williams 1990:10). 
However, as any other specialized language, medical language is characterized 
by the presence of highly informative terms the use of which cannot be avoided. 
Certainly, the use of highly specialized terms should be adapted according to the 
interlocutors (experts or non-experts) engaged in the communicative act. According 22 
 
to Baldini (1989:94), this is exactly what doctors are unable to understand: doctors 
use  complex  specialized  terms  even  though  the  communicative  context  does  not 
require them. 
Beyond  doctors’  misuse  of  specialized  terms,  another  aspect  has  to  be 
considered. According to Vitali (1983:196), the language of medicine is characterized 
by a high number of abbreviations, acronyms and synonyms which refer to the same 
medical concept. For instance, if we consider the Salk vaccine, we can see that it has 
been abbreviated in many different ways (Baldini 1989:94): Salk V., Salk vacc., Salk 
vac., Polio v., Polio vac., Salk Polio vac., S. Polio vac., and Polio Vac. The tendency to 
use  different  denominations  to  refer  to  the  same  medical  concept  can  lead  to 
misunderstandings  and  confusion  even  in  expert-to-expert  communication. 
Therefore, Vitali (1983:196) suggests that medical language needs a terminological 
standardization in order to increase its degree of clarity and reduce confusion. In 
Vitali’s words (1983:196):  
Il linguaggio medico ha bisogno di una rigida serie di norme di standardizzazione della 
terminologia al fine di eliminare quella torre di Babele di abbreviazioni, sigle e sinonimi 
che affollano le opere e le produzioni verbali dei medici. 
 
Undoubtedly, criticism evolved over time. Differently from the past, when it was 
thought  that  doctors’  use  of  abstruse  and  incomprehensible  words  would  have 
increased their social prestige
5, in more recent times, it seems necessary to consider 
transparency and patients’ awareness about diagnoses and medical treatments as 
the fundamental pillars over which the doctor-patient relationship should be created. 
Therefore,  nowadays,  the  need  to  communicate  in  an  effective  way,  using 
‘comprehensible’ terms or explaining complex terms through the use of plain words, 
seems to acquire more and more importance. 
 
 
                                                           
5 This idea derives from Galeotto Marzio da Narni (a physician of the 15th century) who stated that 
doctors should vary their language depending on the patient’s cultural level: “con gli uomini dotti, a 
quali è nota la verità, [il medico] dee usare parole comuni e chiare, ma col volgo ignorante e con le 
vecchierelle e cotali persone, anche quelle cose si potranno dire comodamente in latino […] o con 
parlare più oscuro e con parole o greche o arabesche: perciocché gli uomini plebei e volgari alcune 
fiate stimano quello essere ottimo e salutifero che non intendono” (Serdonati, in Serianni 2005:24). 
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Chapter two: linguistic features of English for Medical 
Purposes (EMP) 
Since a highly specialized language, as is medical language, is often criticized 
for its cryptic and obscure nature, the following section will focus on the linguistic 
characteristics of medical English in order to provide a way to became closer to the 
language of the medical community.  
2.1 Lexical Features 
According to Romich (2001:23), “studying medical terminology is like learning a 
new language”. In fact, at first sight, words look different and complicated. However, 
by understanding some important guidelines that govern medical language, people 
may become interested in and aware of how medical terminology works. 
Beyond  the  origins  of  its  terms,  medical  terminology  shows  some  relevant 
characteristics that distinguish it from ordinary English: 
a.  Monoreferentiality 
Medical  English  vocabulary  is  characterized  by  what  Maglie  (2009:24)  calls 
semantic univocity. This feature implies that, in medical language, there is only one 
term  that  designs  a  specific  meaning  or  concept.  Consequently,  medical  terms 
cannot  be  appropriately  replaced  by  synonyms  but,  rather,  by  periphrasis.  As  an 
example, the term hepatits can be explained through the periphrasis an inflammation 
of the liver, caused by infectious or toxic agents. Although monoreferentiality is the 
ideal characteristic for specialized languages, occurrences of synonyms can always 
be found. For instance, several technical expressions refer to megacolon, which is 
known as Hirschprung’s disease
6 by the Danes, whereas by the Dutch it is called  
Ruysch’s disease (Maglie, 2009:24). Another example of synonymy among technical 
terms  can  be  seen  in  the  three specialized  terms  which  refer  to  a  tumor  that  is 
                                                           
6 Descriptions of children with Hirschsprung’s Disease date back to the 17th century, when Ruysch 
(1691), a Dutch anatomist, described a 5-year-old girl who died of intestinal obstruction (O’Neil et al. 
2003:46). 24 
 
malignant  and  tends  to  spread  to  other  parts  of  the  body
7:  malignant  tumor, 
malignant neoplasm and metastatic tumor.  
A  different  example  of  synonymy  is  shown  by  the  terms  varicella  and 
chickenpox.  In  this  case,  varicella  is  the  technical  name  for  chickenpox,  thus 
synonymy is obtained by relating two terms which belong to different registers. 
b.  Denotation 
The medical term denotes one precise meaning. To provide an example, when 
the word brain is used in the medical domain, it refers to the part of the central 
nervous system contained within the cranium
8 (her sister died of a brain tumour/ Her 
brain was damaged in the accident ), whereas in standard English it can acquire a 
connotative value (e.g. use your brain to find a solution!). 
Despite the presence of technical terms , medical language  contains a wide 
range of words and phrases that belong to  general English. Below, some figures of 
speech are taken as an example (Maglie, 2009:25):  
 Catachresis: it expands a word beyond the limits of its own meaning. The 
medical term neck of uterus means the corpus/body of uterus: the meaning of the 
general English word neck has been expanded. 
 Eponym:  it  is  a  person,  whether  real  or  fictitious,  after  whom  a  particular 
place, era, discovery, disease, or other item is named, for instance, the expressions 
Parkinson’s disease and Alzheimer’s disease. 
 Toponym: it is a name of a physical or mental disorder derived from a place or 
a region, e.g. Rio Bravo fever. 
c.  Conciseness 
In medical language, several concepts are expressed in the most concise lexical 
and syntactic form.  To provide an example, we can consider the term urinalysis - 
                                                           
7  Definition taken from http://medical-dictionary.thefreedictionary.com/malignant+tumor. 
8 Definition taken from http://medical-dictionary.thefreedictionary.com/brain 
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the physical, chemical, and microscopic examination of urine
9 - which derives from 
the fusion of the two words urino and analysis; and the term contraception, which is 
the result of the union of the two words  contra and conception (Etymology: Latin, 
contra + concipere, to take in).  
Another  linguistic  device  physicians use to express a concept in a concise 
manner is represented by acronyms, such as  HIV (human immunodeficiency virus), 
AIDS  (acquired immunodeficiency syndrome),  HCV  (hepatitis C virus), and many 
others. In addition, other concepts are expressed through abbreviations, such as CV 
(cardiovascular), Fld (fluid), and stacked noun phrases, such as  body mass index 
(BMI) (Maglie 2009:29).  
Physicians use a variety of abbreviated forms and acronyms in order to quickly 
record  and  refer  to  patient s’  information.  Moreover,  these  expressions  are 
comprehensible,  ‘economical’  and  accepted  within  the  medical  community,  thus 
allowing  physicians  to  communicate  effectively.  However,  since  these  shortened 
forms are also used for prescriptions, understanding these terms may help patients 
to decipher their medical records. 
d.  Precision  
Since  each  term  can  be  directly  referred  to  its  meaning,  monoreferentiality 
leads to the phenomena of precision and transparency of medial language. Words 
can be structurally analyzed dividing them into their basic components: prefix, root 
and  suffix.  For  instance,  the  term  hyperglycaemia  can  be  divided  as  follows:  the 
prefix hyper-, the root –glyc- and the suffix –aemia. After dividing the word into its 
components, the meaning can be gleaned by examining the suffix, followed by the 
prefix  and  then  the  root.  In  hyperclycaemia,  the  suffix  –aemia  means  blood 
condition, the prefix hyper- means excessive and the root –glyc- means sugar. By 
assembling  the  components’  meanings,  we  obtain  the  final  meaning:  a  blood 
condition of excessive sugar (Maglie 2009:28). The same process can be showed 
using the term choledocholithotomy which is a surgical operation to remove (-otomy) 
                                                           
9 Definition taken from http://www.nlm.nih.gov/medlineplus/ency/article/003579.htm 
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a stone (-litho-) that originated in the gall bladder (chole-) but is currently located in 
the common bile duct (-docho-) (Fallon 2002:1). 
However,  even  in  medical  language  there  are  cases  of  imprecision,  as  is 
demonstrated by the suffix –oma in the terms carcinoma, lymphoma and glaucoma. 
In  fact,  while  in  the  formers,  the  suffix  –oma  designates  a  very  life-threatening 
tumor (Etymology: Gk, karkinos + oma, tumor
10 and L, lympha + Gk, oma, tumor
11), 
in the term  glaucoma, the suffix  –oma  does  not  denotes  an  eye  cancer  but  “an 
abnormal condition of elevated pressure within the eye because of obstruction of the 
outflow of aqueous humor”
12. 
2.1.1 Metaphors 
Throughout the history of rhetoric, metaphors have always been understood as 
a matter of language, a sort of creative linguistic ornament that is mainly used in 
poetry  and  rhetoric.  In  this  view,  metaphors  have  always  been  considered  as 
paraphrasable  in  terms  of  literal  language  without  the  loss  of  cognitive  content 
(Richards 1936:49).  
The important claim that metaphor is not just a linguistic embellishment was 
firstly  made  by  Richards  in  1936.  According  to  Richards  (1936:51),  metaphor  is 
pervasive  in  everyday  life,  not  just  in  language  but  also  in  thought  and  action. 
Thought  is  in  itself  metaphoric  and  proceeds  by  comparison;  thus,  metaphor  of 
language  can  be  defined  as  the  explicit  medium  through  which  the  metaphoric 
nature of our conceptual system is expressed. In Richards’ words: 
In asking how language works, we ask about how thought and feeling and all the other 
modes of the mind’s activity proceed. (Richards 1936:52) 
Following this idea, Richards states that when we use a metaphor, two thoughts 
simultaneously  interact  in  our  minds.  By  comparing  the  different  relations  which 
these  two  thoughts  hold  to  one  another,  we  can  understand  the  meaning  of  a 
metaphor (Richards 1936:52). He calls these two thoughts tenor, that is the principal 
subject, and vehicle, that is the thought connected with the principal subject - in the 
                                                           
10 http://medical-dictionary.thefreedictionary.com/carcinoma 
11 http://medical-dictionary.thefreedictionary.com/lymphoma 
12 http://medical-dictionary.thefreedictionary.com/glaucoma 27 
 
example John is a lion, John is the tenor and lion is the vehicle. The meaning of a 
metaphor results from the interactions between tenor and vehicle; such interactions 
may  work  through  resemblances  as  well  as  through  disparities  between  the  two 
thoughts (Richards 1936:60). Following Richards’ reasoning, the linguistic metaphors 
are just mere representations of the way in which we see the world. Therefore, since 
language reflects our thinking, by looking at language, we may understand how our 
concepts are formed and how our conceptual system works. 
Largely influenced by Richards’ view and on the basis of linguistic evidence, in 
the book Metaphors we live by (1980), Lakoff and Johnson state that our conceptual 
system is fundamentally metaphorical in nature and, although we are not aware of 
the fact that our everyday thoughts and actions are structured by metaphors, we 
constantly understand one thing in terms of another (Lakoff and Johnson 1980:3). In 
addition, they claim that our conceptual system is grounded in our experience and 
that  it  is  culturally  conditioned  by  the  constant  interactions  we  hold  with  our 
environments. Therefore, our knowledge and our understanding are based on such 
interactions (Ortony 1993:209). In line with Richards, they suggest that metaphorical 
expressions  should  be  seen  as  the  superficial  representations  of  an  underlying 
metaphorical conceptual system:  
metaphors as linguistic expressions are possible precisely because there are metaphors in 
a person’s conceptual system. (Lakoff and Johnson 1980:6) 
Metaphors are defined as metaphorical concepts that structure our everyday activity 
and, by using several examples of conceptual metaphors, the authors show that they 
are reflected in our everyday language by a variety of metaphorical expressions. A 
conceptual metaphor consists of two conceptual domains, in which one domain is 
understood in terms of another. Therefore, there is a source domain, from which we 
draw  metaphorical  expressions  to  understand  another  conceptual  domain,  and  a 
target  domain,  that  is  the  domain  we  try  to  understand  through  the  use  of  the 
source  domain.  Between  source  and  target  domains  there  is  a  set  of  systematic 
correspondences, in the sense that the constituent conceptual elements of the target 
domain  correspond  to  the  constituent  conceptual  elements  of  the  source  domain 
(Kövecses 2010:5-13).  28 
 
These conceptual correspondences are usually referred to as mapping and according 
to Lakoff (1993:202): 
everyday  metaphor  is  characterized  by  a  huge  system  of  thousands  of  cross-domain 
mappings […] between source and target  conceptual elements the mapping is tightly 
structured. 
After this brief account on the evolution of the definition of metaphor, in what 
follows  we  shall  see  how  metaphors  work  in  the  field  of  medicine.  According  to 
Periyakoil  (2008:842-843),  medical  language  is  built  around  sets  of  conceptual 
metaphors including: 
  sports metaphors, which project the idea that a patient and his/her illness 
are playing on opposite teams. Every competitor has to play until the end 
as quitting the game would be associated with loss of ‘face’ (humiliation); 
  machine metaphors, which are derived from Descartes’ theory by which 
the human body is seen as a machine with defective parts which can be 
removed and replaced; 
  war  metaphors,  which  encourage  the  fight  against  illnesses.  The 
patient/soldier has to fight to the end to avoid a retreat that could be 
perceived as a shameful and coward act. 
As regards metaphors created upon the concept of war, it can be seen that 
military metaphorical expressions appear in every aspect of medical language and 
jargon. Phrases such as “She’s got an infiltrating carcinoma”, “the body defences”, 
“he’s having a heart attack”, “killer T cells”, “the war on cancer”, “we must treat him 
aggressively  and  use  everything  in  therapeutic  armamentarium”  (Hodgkin 
1985:1820) show that the language used, while coping with an illness, is cast almost 
entirely  by  the  metaphor  ‘medicine  is  a  war’.  The  reason  for  the  introduction  of 
military images in the language of medicine lies in the full institutionalization of the 
germ theory of disease by Pasteur (Montgomery 1996:142). This does not mean that 
the association between war and disease was not present before. However, military 29 
 
expressions did not enter medical discourse before the XVIII century because of the 
predominance of other images for referring to disease
13. 
The medical use of war metaphors is not limited to physicians and patients; 
also pharmaceutical companies use them in marketing their products, as can be seen 
in  the  following  slogan  through  which  Novartis  Pharmaceuticals  promoted  the 
aromatase inhibitor Fermara-letrozole:  “Fight  hard  and  fight  back  in  your  battle 
against advanced breast cancer” (Reisfield and Wilson 2004:4024-4027). However, 
since the conceptual metaphor ‘medicine is a war’ is predominant in oncology, what 
follows  presents  the  strengths  and  limitations  of  military  language  in  this  area, 
considering the patient-physician relationship and the patient’s experience of his/her 
illness. 
According to Reisfield and Wilson (2004: 4024-4025), the use of war metaphors 
in oncology has several reasons: 
  this  metaphor  is  highly  present  in  our  society:  it  is  applied  to  express 
several different concepts, like the ‘wars’ on drugs, on poverty, on teen 
pregnancy; 
 
 
 
 
 
 
                                                           
13 In the Middle Age, disease was seen as a punishment for sin and disobedience. In the Seventeenth 
and in Eighteenth centuries, disease became “a vision of discord and anarchy, these being the central 
aspects of deviance from nature” (Montgomery 1996:157). In the Nineteenth century, disease was 
seen as the result of the contact with the external environment or some external forces.  At this time, 
ideas  of  struggle  and  conflict  had  a  central  importance.  In  particular,  as  Montgomery  (1996:158) 
shows, the military metaphor was strictly connected with the concept of organicism of the century, 
when the nation-state was considered as a living body. 
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  it  is  easily  adaptable  to  cancer  because  there  is  a  perfect  set  of 
correspondences among its elements:  
‘Medicine is a war’ 
 
 
 
 
 
 
 
 
Figure 2.1.  Set of correspondences between the source and target domain in the conceptual 
metaphor ‘Medicine is a war’. 
  it has a serious purpose that matches perfectly the aim to cope with the 
illness; 
  war,  its  images  of  power  and  aggression,  serve  as  strong  ideas  in 
patients’ mind which limit the feelings of powerless and passivity often 
associated to patients affected by serious illness. 
Although  the  conceptual  metaphor  ‘medicine  is  a  war’  could  be  thought  to  fit 
perfectly  the  concept  of  cancer  disease,  there  are  some  relevant  limitations.  The 
‘war’ metaphor is inherently masculine, power-based and violent; it emphasises that 
taking action is in itself a virtue; and it suggests that the defeat of cancer is only a 
matter  of  fighting  hard  enough  (Reisfield  and  Wilson  2004:4026-4027).  However, 
patients often cannot find the strength to fight this battle and, for some patients, 
conflict, fighting and war are not the preferred modes of coping with their illness. 
Moreover, the vast majority of malignant diseases cannot be eradicated because of 
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limited  knowledge  of  the  illness  in  medicine,  which  leads  to  inevitable  treatment 
failures.  Undoubtedly,  keep  fighting  and  be  courageous  -  as  concepts  conveyed 
through the metaphor of war - may encourage physicians and patients to resist as 
much  as  possible,  embarking  on  additional  therapies  with  little  or  no  expected 
medical benefit. However, the underlying idea that opting out of therapy would mean 
to lose the fight could affect patients’ decisions about their lives. Patients might feel 
guilty or inadequate because of their inability to keep combating, accepting for this 
reason other treatments that would not provide any benefit. The rest of patient’s life 
is often disregarded because all resources must be used in the battle. 
According  to  Creaturo  (2004:4025),  the  metaphor  of  war  in  oncology  has 
conceptual weaknesses too. The battle against cancer is paradoxical: there are no 
real enemy invaders because the enemy consists of affected cells which are part of 
the patient’s body. Therefore, therapeutic treatments indiscriminately destroy cancer 
cells (the enemy) and the immune system (the defender). Hence, the patient’s battle 
could be described as a fight against him/herself. In Creaturo’s words, “the weapons 
being brought to bear are real and powerful, and they can turn quite treacherously 
against the very individual they are intended to protect” (Creaturo 2004:4025). 
In  Lakoff  and  Johnson’s  view  (1980:156),  metaphors  can  emphasize  some 
aspects  and  hide  some  others.  Thus,  different  set  of  correspondences  generate 
different  metaphorical  entailments.  If  we  consider  contemporary  uses  of  the 
‘medicine is a war’ metaphor, we can notice that the disease is always treated as the 
enemy, but two subtypes of fights should be distinguished: one in which there is a 
correspondence  between  the  patient  and  the  fighter,  and  the  other  in  which  the 
patient comes to be the battlefield and the role of soldiers is conferred to physicians 
(Fuks 2012:4). The latter seems to be the more common of the two and brings in 
itself relevant implications: the disease becomes the focus of physician’s attention 
supplanting the patient’s interlocutor role in the doctor-patient relationship. This shift 
of attention may lead patients to feel abandoned, as they may think that physicians 
are  not  able  to  understand  and  listen  to  their  needs,  concerns  and  feelings  any 
longer.  In  Fuks’s  opinion  (2012:2),  the  dialogic  construction  of  the  narrative  of 
illness, created through the patient’s voice and the doctor’s talk, is supplanted by the 32 
 
physician’s desire for diagnostic clarity which overlooks the patient’s need for relief of 
suffering. 
In medical communication, the emotional sphere is very important and has a 
relevant influence on  the patients’ decision-making processes. However, at  times, 
people’s thoughts and feelings cannot be expressed by literal language. Therefore, 
people use metaphorical expressions. 
Metaphor  is  one  of  the  most  important  tools  for  trying  to  comprehend  partially  what 
cannot  be  comprehended  totally:  our  feelings,  aesthetic  experiences,  moral  practices, 
and spiritual awareness. (Lakoff and Johnson 1980:193) 
Metaphorical  language  may  also  be  used  by  physicians  to  explain  unknown 
medical concepts. On the one hand, by drawing on patients’ past experiences
14 and 
present knowledge to introduce unfamiliar concepts, physicians can help patients to 
understand and connect new information - about an illness and its treatment - with 
something they already know. On the other hand, using metaphorical langua ge, 
clinicians can help patients to break down pre-existing ideas and mind-sets in order 
to  discover  something  new  about  the  illness.  Moreover,  in  medical  setting s, 
metaphors are often used euphemistically to discuss and relate to complex and risky 
situations in a non-threatening and indirect manner. Metaphors may facilitate crucial 
conversations and difficult decisions: it is much simpler, for instance, to talk about 
fatal  illnesses  in  terms  of  something  else.  In  addition,  in  scientific  discourse, 
metaphors may also be considered as a preferred method to coin new terms which, 
once they become part of the specialized language of the scientific community, could 
eventually be accepted as standard terms.  
Nevertheless, metaphorical language has to be used carefully because it could 
lead to misperceptions and misunderstandings. For instance, when patients use 
metaphors that do not fit the illness concept, clinicians have to identify and explain 
the possible discrepancies, correcting in this way misperceptions and redirecting the 
patient to the real situation. Certainly, for physicians, metaphors can be time-efficient 
                                                           
14 The primary function of a metaphor is to provide a partial understanding of one kind of experience 
in terms of another kind of experience. This may involve preexisting isolated similarities, the creation 
of new similarities, and more. The only similarities relevant to metaphor are similarities as experienced 
by people. Experiences may differ from culture to culture, and may depend on our understanding. 
(Lakoff and Johnson 1980:154) 33 
 
tools  to  help  the  patient  understand  complex  biological  processes;  for  patients, 
metaphors can facilitate the understanding process, helping them to be aware of 
their illness and allowing them to achieve an efficient communication. 
To sum up, patients devise their own metaphors based on things they know 
and value, and are thus able to arrange their experiences in personally meaningful 
ways. Metaphors facilitate communication, serving as powerful tools to establish a 
consensual  understanding  of  the  therapeutic  treatment;  they  allow  patients  to 
comprehend distinctive moments of the illness and can have profound effects on the 
illness experience. However, metaphorical language does not have to be used in an 
inappropriate way. Physicians have to be aware of the use of metaphors in clinical 
discourse;  they  should  consider  the  fact  that  some  patients  may  find  the  use  of 
certain  metaphors  inappropriate;  and  they  should  pay  attention  to  patients’ 
metaphorical expressions. By listening to the language used by sick people, physician 
may understand how patients are living their illness experience, how they feel and 
which their attitude is towards further treatments (Reisfield and Wilson 2004:4024-
4027). 
As has been explained above, metaphorical expressions are used to facilitate 
patients’  understanding.  However,  metaphors,  metonymy,  and  similar  kinds  of 
transferred meanings always pose potential problems for non-specialists and non-
native-language people (Salager-Meyer 1990:146). 
Although metaphorical expressions do not hamper overall comprehension, they 
limit comprehension and can foster misunderstandings. While native speakers, by 
living  in  a  given  society,  can  easily  understand  metaphorical  terms,  simply  by 
widening the application of known semantic concepts, terms based on metaphors are 
difficult to understand by foreign people for two principal reasons (Salager-Meyer 
1990:147): 
  foreign  people  may  not  know  the  concept’s  meaning  in  their  mother 
tongue, thus they are unable to make the appropriate transfer; 34 
 
  non-native speakers may know the concepts in their mother tongue but 
their  knowledge  of  the  target  language  is  not  sufficient  to  allow  this 
transfer of meaning from one term to another. 
An  interesting  comparative  study  was  carried  on  by  Salager-Meyer  in  1990. 
Aiming at identifying and analysing metaphorical medical terms, she constituted a 
corpus of 30 texts in medical English, 30 texts in medical French and 30 in medical 
Spanish.  Though  the  percentage  of  metaphorical  expressions  that  was  found  is 
rather low, her analysis shows that scientific writers make use of a variety of source 
domains to express a concept or idea through metaphorical language. For example, 
considering the architectural domain, in medicine we find terms such as ‘aortic arch’, 
‘fibrillation threshold’; while within the phytomorphical domain, we have ‘coronary 
three’ and ‘nerve roots’ (Salager-Meyer 1990:151).  
 According to Salager-Meyer (1990:150), medical metaphors have a precise and 
definite terminological meaning and the semantic transfer of meaning takes place, in 
the  three  languages,  within  the  same  grammatical  categories:  the  majority  of 
metaphorical  words  belong  to  the  nominal  group  and  to  a  lesser  extent  to  the 
adjectival and verbal groups: 
 
Figure 2.2 Grammatical classes of metaphorical terms in the three corpora. (Salager-Meyer 1990:152) 
Furthermore,  according  to  Salager-Meyer,  the  analogical  way  in  which  the 
transfer of meaning takes place in the three languages considered, could suggest 35 
 
that  medical  metaphorical  expressions  are  not  linked  to  culture-specific 
idiosyncrasies.  A  number  of  other  previous  contrastive  analyses  confirm  that 
similarities exist in the type, amount and manner in which information is conveyed in 
scientific  discourse,  thus  supporting  the  hypothesis  that  scientific  discourse  is 
universal (Salager-Meyer 1990:153).  
In order to see how metaphorical language is used in English and in Italian 
articles which talk about medicine, I have analysed seven articles taken from the 
section ‘health’ in the magazines Scientific American and Le Scienze (Appendix 2). 
The analysis shows that both Italian and English articles present several linguistic 
metaphorical expressions which are originated from the same conceptual metaphor, 
thus  referring  to  the  same  source  domain.  Four  frequent  conceptual  metaphors, 
which structure the way of talking in medical discourse, have been identified: 
Conceptual metaphors 
 
Italian  English 
Medicine is a war 
 
-  Tumori aggressivi 
-  La medicina sembra 
avere poche armi 
-  La battaglia quotidiana 
con la malattia 
-  Proteggere 
-  catturare 
-  Attacco di cuore 
-  Funzione difensiva 
-  Bersaglio 
-  Armati e all’erta 
-  The ancient war 
-  Aggressive tumors 
-  Heart attack 
-  Invasion 
-  Virus that killed 
-  Protect 
-  capture 
-  Body’s defences 
-  Counterattack 
-  A fusilade of antibodies 
-  Target 
-  Armed and vigilant 
-  L’antica lotta 
The human body is a 
machine 
 
-  Meccanismo 
-  Riparare 
-  Danno/danneggiato 
-  Funzione di pompa 
-  Mechanism 
-  restore/repair 
-  Damage/damaged 
-  To pump blood 
The genome is a text 
 
-  RNA messaggero 
-  Elaborare l’informazione 
-  Decodificare 
-  Risposta 
-  Messenger RNA 
-  Elaborate 
-  decoding 
-  answer/ response 
Cells are human beings 
 
-  vita e morte delle cellule 
-  ciclo di vita: generare-
proliferare-degenerare-
rigenerare/replicare- 
coltivare- alimentare 
-  Popolazione 
-  The birth and fate of 
heart muscle cells 
-  Life cycle: generate-
proliferate-degenerate- 
regenerate/renew/mak
e copies- culture- 
nourish 
-  population 
Table  2.3.  Linguistic  metaphorical  expressions  created  upon  the  concepts  of  war,  machine, 
communication and biology. The examples above are taken from articles in Le Scienze and Scientific 
American (Appendix 2). 36 
 
By comparing the English articles with their Italian versions, it can be observed 
that metaphorical expressions do not change in the two languages. The ‘war’ and 
‘machine’ metaphors are widely recognized by the scientific community and they are 
also  widely  understood  by  both  Italian  and  English  speakers.  The  metaphors 
referring to the domain of ‘communication’ are quite widespread in genetics, where 
people  talk  about  information  written  in  the  DNA,  messages  that  are  sent,  and 
signals which have to be decoded. In this case, the underlying idea is that the flow of 
information  from  DNA  to  RNA  is  called  ‘transcription’.    According  to  Rijn-van 
Tongeren (1997:73), this conceptual metaphor could be formulated as “A genome is 
a text”. Similarly to the metaphoric expressions which refer to war and machines, the 
metaphor of ‘text’ can be understood without any difficulties by both the Italian and 
the  English  community.  The  same  reasoning  can  be  applied  to  the  biological 
metaphors which depict cells as living bodies having a life cycle and living within a 
population of cells. 
Yet, every time we discuss about science, considering text type is essential. The 
use of metaphorical language may largely differ depending on the type of text and 
on  the  level  of  assumed  shared  information  between  the  target  reader  and  the 
writer. For example, in articles found in Scientific American and Le Scienze (medium-
level interspecialist popular science magazines), a familiarity with some of the basic 
concepts of medicine is taken for granted, whereas in articles published by popular 
science  magazines,  such  as  National  Geographic,  the  writer  needs  to  explain  the 
scientific concept in a more direct and thus comprehensible way. Therefore, in Italian 
and  English  popular-level-science  articles,  concepts  may  be  expressed  through 
different semantic structures, such as culture-specific metaphors, and they may also 
be influenced by the author’s writing style.  
In order to see the differences that may exist between the English source text 
and its Italian translation, some metaphorical expressions taken from two articles 
published in National Geographic and National Geographic Italia (Appendix 3) are 
considered in the following table. 
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Italian  version 
 
English version 
 
“Influenza, la caccia ai nuovi vaccini” 
 
(computer metaphor) 
-  Occorre aggiornare il vaccino 
 
(war metaphor) 
Virus- nemico:  
-  Contrastare le proteine del virus 
-  un vaccino che combatta il virus 
-  un vaccino universale che protegga 
dall'influenza stagionale 
-  combattere ceppi particolarmente 
aggressivi del virus 
 
 
Natura “sfuggente” del virus dell’influenza 
-  Geneticamente flessibile 
-  “E come dover mettere un capotto nuovo 
ogni inverno” 
 
“Avremmo anche noi l’udito di superman?” 
 
-  Udito di Superman 
 
Suono a 20 Hz: 
-   ciò che sentiremmo “a un concerto rock 
se ci trovassimo vicino al bassista” 
 
 
Coclea: 
-  A forma di chiocciola  
 
 
“How far off is a better flu shot?” 
 
(computer metaphor) 
-  The vaccine has to be updated 
 
(war metaphor) 
Virus-enemy: 
-  Target proteins in the influenza virus 
-  A vaccine against the virus 
-  a universal vaccine that protects against 
seasonal flu 
-  fend off a major new flu virus 
-  A dangerous threat 
 
 
Influenza virus is a slippery character 
-  “genetically plastic” 
-  “It’s like putting on a new sport coat 
every winter” 
 
“Superhuman hearing possible, 
experiments suggest” 
-  Superhuman hearing 
 
20Hz sound: 
-  what you'd hear if "you were at an R&B 
concert and you just stood next to the 
bass" 
 
Cochlea: 
-  Resembling a tiny snail 
Table 2.4. Figurative expressions in two English articles and their Italian versions (taken from National 
Geographic and National Geographic Italia). 
In the articles, we see the underlying presence of two conceptual metaphors (the 
one which refers to war and the other which refers to communication in computer 
science
15). The metaphorical expressions which are created  on these two concepts 
are used in the same way in English and in Italian. However, by o bserving other 
examples quoted above, we see that in the two languag es, metaphorical concepts 
may be expressed by different linguistic forms.  
                                                           
15 Information theory entered medical discourse only in the last five decades, precisely in 1953, when 
Watson and Crick discovered the structure of DNA. The language introduced with the information 
theory is called by Montgomery (1996:150) bioinformationism, and it is more likely to be found when 
talking about genes or about how viruses and cells work. 
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For  example,  if  we  consider  the  English  metaphor  ‘Influenza  virus  is  a  slippery 
character’,  we  can  see  that,  throughout  the  paragraph,  there  is  a  sort  of 
‘development’ in the explanation of this metaphor: 
-  the idea of ‘Influence is a slippery character’ is firstly simply outlined as a 
metaphor; 
-  later  in  the  paragraph,  the  explanation  of  its  slippery  nature  is  slightly 
extended  with  the  sentence  stating  that  the  influence  virus  is  ‘genetically 
plastic’; 
-  finally, the meaning of ‘genetically plastic’ is depicted through the simile ‘It’s 
like putting on a new sport coat every winter’. 
The Italian translation follows the same ‘development’, yet the initial metaphor has 
been changed: the Italian version presents the ‘slippery character’ as an attribute of 
the influenza virus. 
Furthermore, we can observe that, in National Geographic articles, concepts are 
expressed in a more direct manner that is easily comprehensible by a wider variety 
of non-specialist readers. Therefore, the writer may also choose to explain a concept 
through  the  use  of  suggestive  images,  as  can  be  seen  in  the  example  where 
‘Superman’  is  used  in  the  Italian  text  to  express  the  idea  of  a  super  hearing. 
Similarly, according to the purpose of clarity and accessibility of the content, the 
writer may also refer to popular-culture, which provides - in this case - the necessary 
background knowledge for understanding such images. For instance, if we consider 
the image of the concert, we can see that the idea of the bass sound during an R&B 
concert is conveyed in Italian with the idea of a bass sound in a rock concert. In this 
case, since Rhythm and Blues music is a popular African-American genre, which has 
no corresponding consolidated tradition in Italy, the Italian author refers to the idea 
of rock music because it is more effective for the target readers. Therefore, we can 
notice that concepts may be expressed in different ways depending on the cultural 
and social backgrounds of the readers. 
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2.2   Syntactic Features  
Medical English shows not only morphological peculiarities but also particular 
syntactic characteristics. The main phenomena are introduced and explained in the 
following  text  through  several  examples  taken  from  medical  journal  articles  and 
patient information leaflets.  
a.   Noun phrases (NPs) 
Scientific  medical  writing  is  characterized  by  a  high  presence  of  long  and 
complex noun phrases.  This phenomenon can be explained by the fact that medical 
formal  writing  needs  a  syntactic  device
16  which allows the expert to convey the 
meaning of a complex medical concept in a highly precise and con cise manner. 
Medical concepts are usually complicated to express and the expert need to include a 
various number of information in the explanation. Additional elements which define a 
given concept could seem unnecessary for non-experts, but in medical contexts, the 
specialist  has  to  be  as  precise  as  possible  to  avoid  ambiguities  and 
misunderstandings. Therefore, the use of compound noun phrases helps the writer 
to  avoid  long  and  detailed  descriptions  which  would  create  difficult  syntactical 
constructions.  In  fact,  according  to  Varantola  (1984 :209),  noun  phrases  are  a 
powerful  syntactical  tool  which  allows  users  to  incorporate  a  great  deal  of 
information in a compact and synthesized form. Obviously, their structure can vary 
from very simple form s  to extremely  complicated constructions according to the 
genre of the text, its assumed addressees and the author’s communicative aims. 
Considering  two  different  genres  of  written  medical  discourse,  patient 
information leaflets and specialized journal articles
17, it has been observed that noun 
phrases  are  usually  created  through  the  elimination  of  post -modifier  clauses.         
                                                           
16 According to Beneventiste (1971, in De Mauro 1994:9), the expert creates an utterance which is impersonal 
and extemporal. The meaning of the utterance is conveyed through terms which are reduced to their semantic 
content. 
17  “Aortic  pulse  wave  velocity  measurement  in  systemic  sclerosis  patients”  (Colaci  et  al.  2012:360-367). 
“Rheumatoid  arthritis,  anti-tumour  necrosis  factor  therapy,  and  risk  of  malignant  melanoma:  nationwide 
population based prospective cohort study from Sweden” (Raaschou et al. 2013:1939). 
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For instance, prepositional phrases with  of, in, for are generally replaced by pre-
modifier elements of the head noun. Some examples are quoted below: 
Root nodule bacteria (bacteria to be found in root nodules) 
The operating room (the room for carrying out operation) 
Fibroblasts activation (activation of fibroblasts) 
Aortic pulse wave velocity measurement (measurement of the velocity of the wave of the 
aortic pulse) 
In  this  way,  different  elements  are  put  together  without  the  use  of  grammatical 
words  which  would  just  complicate  the  syntax  and  increase  the  length  of  the 
sentence.  In  specialized  discourse,  the  omission  of  all  those  words  which  do  not 
carry  any  lexical  meaning  allow  experts  to  communicate  most  rapidly.  Therefore, 
highly specialized texts are generally lexically dense: the number of content words is 
higher  than  that  of  grammatical  words.  The  so-called  function  words,  such  as 
articles, prepositions, conjunctions, auxiliary verbs and pronouns, do not convey the 
meaning of an utterance; they just show the syntactic and grammatical relationships 
which  link  the  different  elements  of  a  sentence.  In  fact,  according  to  Maglie 
(2009:35), the omission of phrasal elements does not prejudice the understanding of 
the text, because they do not convey any lexical meaning and their grammatical 
value can be easily re-established by the specialist. 
Nevertheless,  in  my  opinion,  complex  noun  phrases  expressing  detailed  and 
precise information about the head noun may cause some problems of decoding for 
non-specialist  people,  who  may  not  be  able  to  establish  the  exact  semantic 
relationship which links all the lexical elements of the nominal group. To provide an 
example  of  this  problem,  we  can  consider  the  nominal  clause  “a  cumarinic 
anticoagulant-based therapy (warfarin, dicumarol,…) (Moment medication’s leaflet)”. 
In this nominal clause, we can immediately understand that the therapy is based on 
treatment with anticoagulants. However, if the reader does not know what cumarinic 
is,  s/he  would  find  it  difficult  to  understand  the  connection  between  the  word 
cumarinic  and  the  other  elements  in  the  nominal  group.  One  may  think  that 
cumarine is a kind of anticoagulant drugs, instead of understanding that cumarine is 
actually  an  enzyme  that  is  present  in  anticoagulant  drugs.  Therefore,  the  reader 
would  not  be  able  to  decode  the  exact  meaning  which  is  being  conveyed.              41 
 
To  support  this  statement,  we  can  notice  that  the  patient  information  leaflet  of 
Moment tends to clarify and give an idea of what cumarinic anticoagulants are, by 
providing some examples within parenthesis, i.e. warfarin, dicumarol. 
Similarly to prepositional phrases, in specialized medical texts relative clauses 
are often avoided for the sake of economy and simplicity. They are often replaced by 
other elements within the nominal clause or shortened by omitting some elements. 
We find, for instance: 
-  relative clauses replaced by nouns 
Patients who are affected by scleroderma -> scleroderma patients 
Patients who have systemic sclerosis -> systemic sclerosis patients -> SSc patients 
 
-  relative clauses replaced by adjectives 
Non-invasive tools (tools which are not invasive) 
Abnormal pulmonary function (pulmonary function which is abnormal) 
 
-  relative clauses replaced by gerunds 
May cause allergic reactions, including asthma (Strepsils) 
There  have  been  rare  reports  of  blood  disorders  in  people  taking  products  containing 
paracetamol,..(Benylin) 
 
Moreover, when the verb in the relative clauses is in the passive form and does not 
take a complement, it may become a past participle used in adjectival position, as in 
the following examples: 
The registered waves (the waves which have been registered); 
All recruited female patients (all female patients who have been recruited). 
Or, if it takes a complement, subject and auxiliary are often omitted: 
Thirty-five patients  […] followed at the Rheumatology centre and […] affected by SSc… 
                     [that have been]                                          [who were]   42 
 
For the same reason of concision and shortness, negative relative clauses are 
usually expressed by the prefix un- before a past participle in adjectival position, as 
in the following examples: 
Unwanted/ unespected/ undesirable effects; 
Unselected SSc patients. 
 
To sum up, there are several ways to simplify the syntax of a text and several 
functional  elements  can  be  omitted  without  prejudice  the  sentence’s  meaning. 
However, syntactic simplification does not make a text easier to understand; on the 
contrary, at times, it may be a source of ambiguities and incomprehension. 
a.  Sentence complexity 
 
Despite this search for concision in medical terminology and in the structure of 
clauses, medical texts present a high degree of sentence complexity. In fact, both 
kinds of text - patient information leaflets and specialized journal articles - show that 
medical sentences are longer than those of everyday language. Although the length 
of the sentence is another factor which complicates the comprehension of medical 
texts, it is very difficult to reduce sentences’ length because the omission of certain 
necessary  elements  could  create  information  gaps  or  ambiguities.  In  addition, 
according to Maglie (2009:36), the complexity of medical sentences derives from the 
use  of  a  great  number  of  non-finite  verb  forms,  which  occur  with  double  the 
frequency in medical specialized texts in comparison with standard English.  
Considering an example taken from the patient information leaflet of Moment 
medication,  we  can  observe  how  and  why  medical  sentences  are  long  and 
complicated: 
 
“In some patients with impaired renal function (such as dehydrated patients or elderly 
patients  with  impaired  renal  function),  the  co-administration  of  an  ACE-inibitor  or  an 
Angiotensin II Antagonist and agents inhibiting the cyclo-oxigenenase system can lead to 
further impairment of the renal function, including a possible, usually reversible, acute 
kidney insufficiency.” (Moment) 
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Patients: dehydrated patients, elderly patients with impaired renal function 
Kinds of inhibitors: ACE-inhibitors, Angiotensin II Antagonist, inhibitors of the process 
cyclo-oxigenease 
Effects: further impairment of the renal function, possible acute kidney insufficiency. 
 
In the sentence quoted above, it can be seen that the writer has to explain within 
parenthesis which are the types of patients he/she is referring to. He/she has to list 
all kinds of inhibitors which should not be co-administrated with Moment in patients 
with impaired renal function; and he/she has to specify that further impairment of 
the  renal  function  may  also  means  a  possible  kidney  insufficiency.  Therefore, 
although  specialist  writers  tend  to  be  as  concise  as  possible,  we  may  state  that 
exhaustiveness and precision are the key terms of medical English and assume a 
more relevant role in comparison with concision. 
 
b.  Impersonal structures  
As many other specialized languages, medical English shows the tendency to 
give more importance to nouns instead of verbs. This tendency can be demonstrated 
by three different devices: the creation of long nominal phrases without the presence 
of a verb in the finite form (as has been explained in the previous paragraph); the 
use of nouns - which express lexical meanings - while verbs are conceived as mere 
syntactical connectors (Serianni 2005:255); the reduction of inflected forms of verbs, 
the use of which is usually limited to the 3
rd and 6
th person of the indicative form. All 
these phenomena provide not only a formal tone to the text, but also an impersonal 
style.  
Another characteristic that is worth highlighting is the use of passive voice. The 
frequent  use  of  passive  forms  satisfies  the  need  for  depersonalization  of  medical 
discourse: specialists are more interested in focusing on the effects, conditions and 
results  of  an  action  than  in  stressing  who  the  author  of  an  action  is.  In  fact,  in 
medical writing the agent is seldom expressed. The elimination of the agent can be 
explained  by  the  fact  that,  usually,  medical  articles  are  not  written  by  doctors 
themselves or because the articles are co-authored; the writer’s primary aim is to 
describe something that has been done, focusing in methods and results. In addition, 44 
 
it is quite obvious that implicit agents are physicians and researchers; therefore, it 
would be useless and redundant to explicit the agent. 
Authors, editors, and publishers have a choice about the role of the passive 
voice in their publications, and there is considerable debate about what that role 
should  be.  On  the  one  hand,  there  is  the  argument  that  medical  writers  should 
minimize the use of passive voice because it is less clear, less forceful, and more 
verbose  than  active  voice  alternatives.  Of  this  opinion  is  Sheen  (2010:98),  who 
defines passive voice as:  
the bane of medical writing; it pervades medical literature with the haze and heaviness of 
stagnant  air.  Writers  sometimes  use  passive  voice  in  an  attempt  to  make  their  work 
sound scholarly and scientific, when actually they are perpetuating a writing tradition that 
is fraught with ponderous and obscure language.  
 The  opposing  argument  asserts  that  passive  structure  should  be  the 
predominant style of most types of medical writing because it reflects the objectivity 
of the scientific method, it avoids using a first-person pronoun in a way that would 
be impolite, and it conforms to the style with which medical peers are most familiar. 
This idea is supported by Scarpa (2008:46), who states that the major function of 
passivization is to “spersonalizzare e oggettivizzare ciò che viene scritto”. Therefore, 
the use of passive voice confers not only an impersonal style to the text but also a 
higher degree of formality, which, together with objectiveness, is one of the major 
aims of medical texts.  
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Chapter three: patients and the language of medicine 
 
Considering several theories through which language has been analysed, the 
contextualised  approach  appears  to  be  the  most  effective.  A  large  number  of 
linguists define discourse as a process of social interaction, considering the linguistic 
act  just  a  part  of  it  (Graddol  et  al.1994:16).  According  to  Hyland  (2009:20), 
“discourse analysis is a way of studying language in action, looking at spoken and 
written interactions in relation to the social context in which they are used”. 
An  understanding  of  how  language  functions  in  context  is  central  to 
comprehend the relationship between what is said and what is understood in spoken 
and written discourse. The context of situation (Halliday 2006:53) of what someone 
says  is,  therefore,  crucial  to  interpret  and  decode  the  meaning  that  is  being 
conveyed. The context of situation includes the physical context, the social context 
and the roles of people involved in the interaction. As Thomas (1995:22) puts it: 
meaning is not something that is inherent in the words alone, nor is it produced by the 
speaker alone or the hearer alone. Making meaning is a dynamic process, involving the 
negotiation of meaning between speaker and hearer, the context of utterance (physical, 
social and linguistic), and the meaning potential of an utterance. 
Therefore, meaning is produced during interactions: it is jointly accomplished by both 
the  speaker/writer  and  the  hearer/reader  who  collaborate  in  the  production  of 
meanings as they communicate with each other. 
Following  this  approach,  medical  language  cannot  simply  be  defined  as  the 
medium  through  which  physicians,  nurses  and  doctors  communicate  among 
themselves  within  the  specialized  medical  community.  Since  health  care  is  a 
fundamental  aspect  of  everybody’s  life,  we  need  to  be  aware  of  the  fact  that 
knowledge  of  various  medical  concepts  and  terms  is  quite  common  even  among 
ordinary  people.  Medical  language  is  used  in  a  variety  of  contexts  in  which 
participants are non-expert health professionals. By watching, for instance, television 
programmes which talk about particular diseases, advertisements of pharmaceutical 
products, information leaflets for patients, and promotions of prevention campaigns 
against  particular  diseases,  we  can  see  that  this  specialized  information  are 46 
 
addressed  to  a  non-specialized  audience.  Therefore,  even  though  people  do  not 
come into direct contact with an expert in the field, the doctor, they may collect a 
number  of  specific  concepts  and  specialist  medical  notions  in  various  alternative 
ways.  
For  this  reason,  what  follows  will  focus  on  two  different  situations  in  which 
common people may come in contact with the language of medicine: doctor-patient 
interactions and patient information leaflets. The former (spoken interaction) implies 
a contact with a health professional, while the latter (written discourse) does not 
necessarily need the mediation of an expert, such as a doctor or a pharmacist. 
3.1 Doctor-patient interactions 
 
The fundamental interaction in health care is the one which occurs between 
patient and physician. Its importance in medical practice is well established and it 
has become the focus of increasing interest through several different routes. Doctor-
patient relationships are fundamental to providing and receiving excellent care, to 
the  healing  process  and  to  improved  outcomes.  Therefore,  it  is  important  to 
understand  their  underlying  elements  and  to  identify  which  elements  allow  us  to 
define it a good relationship. 
The  doctor-patient  relationship  is  a  socially  sanctioned,  institutionalized  encounter 
governed by mini-rituals of opening and closing, by a logic of information exchange, by 
time,  place  and  task  constraints,  and  by  setting  specific  diagnostic  aims.  (Manning 
1987:20) 
Clinical  practice  is  centered  on  the  patient
18;  its  main  active  agent  is  the 
physician or the therapeutic team; their main activities deal with patient history, 
diagnosis, prognosis, therapy and prevention. The relationship between doctor and 
patient is usually created through the clinical encounter: by expecting the physician 
to be an expert, the patient decides to consult a doctor to have medical care and 
advice. The clinical encounter serves many purposes and among the most important 
                                                           
18 A widespread misconception about medicine is that medicine is just  concerned with illness and 
disease. However, the subject of medicine is the patient and all the activities have to be directed 
towards the prevention and relief of human suffering (Sadegh-Zadeh, 2012:110). 
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of them, we can find the task of establishing a relationship of mutual trust between 
the physician and the patient.  
The clinical interview of the patient, the so-called history taking or anamnesis 
(Sadegh-Zadeh, 2012:275), is the verbal component of the inquiry through which the 
physician elicits information to understand what affects the patient and what should 
be done for him/her. Diagnoses are usually made from the medical history, and a 
good history almost always means that communication between doctor and patient 
has to be effective. Therefore, patient-doctor communication
19 is the building block 
upon which the physician’s relationship with the patient is made. 
a.  The physician’s role 
Generally,  from  the  very  beginning  of  the  clinical  interview,  the  physician 
generates and tests diagnostic hypotheses. Starting only from a few elements, such 
as  the  patient’s  initial  problem,  gender,  age,  voice  and  appearance,  the  doctor 
automatically forms an initial idea of what the patient might have. However, since 
the  data  initially  provided  by  the  patient  are  not  sufficient  to  form  a  clinical 
judgment, throughout the interaction, the doctor asks specific questions to  acquire 
more  data  which  would  be  useful  to  evaluate  and  test  his/her  initial  hypothesis. 
During the interview, the physician continues to adapt the dialogue, asking questions 
which are considered relevant to obtain a final and unique diagnosis. As Sadegh-
Zadeh (2012:278) suggests, the entire interview, including the physical examination 
which follows, can be defined as a cyclical process of hypothesis-testing actions. The 
clinical reasoning of doctors is schematized below:  
 
 
 
 
 
                                                           
19 Doctor-patient communication consists of both the verbal and non-verbal processes through which 
doctors obtain and share information with patients (Sadegh-Zadeh 2012:285). 
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Clinical reasoning is generally referred to as differential diagnostics (Sadegh-Zadeh, 
2012:277).  This  term  reflects  the  common  belief  that  in  clinical  practice,  the 
physician  initially  considers  all  diseases  that  may  be  apt  to  explain  the  current 
problem the patient presents; secondly, the physician selects the potential diseases 
according to their probability and plausibility; and finally, the doctor differentiates 
between  true  and  false  diagnoses  by  testing  them.  Nevertheless,  according  to 
several claims this logical process does not occur in real medical practice because no 
method of clinical reasoning is taught to medical students (Sadegh-Zadeh 2012:278). 
As a result, physicians usually lack methodological knowledge about how to generate 
meaningful diagnostic hypotheses, how to use patient data correctly and effectively, 
and  how  to  evaluate  the  hypotheses  during  the  medical  encounter.  Moreover, 
despite  the  recent  development  of  high-technology  diagnostic  procedures,  it  is 
claimed that the majority of patients’ problems could still be solved during the first 
few minutes of the patient interview (Cutler in Sadegh-Zadeh, 2012:278). 
As regards all the activities that a physician is supposed to do during a medical 
encounter, we recognize that it is quite a hard job. Doctors not only have to establish 
a  good  and  purposeful  relationship  with  the  patient,  organize  and  adapt  the 
conversation, and make hypotheses about diseases and treatments, but they also 
Ask questions and generates hypotheses 
Test hypotheses by asking questions and by        
examining the patient body 
Did any hypothesis survive? 
Selection of a course of action/ treatment 49 
 
have to listen carefully to the patient, to give him/her the attention needed, to solicit 
the patient to present his/her concerns and to interpret all the information – whether 
useful or not - the patient provides. Physicians have to “ask a variety of detailed 
questions, evaluate patients’ accounts, comment on their general state of health, and 
suggest reasons for their problem and possible courses of action” (Mishler 1984:5).  
 
Figure  3.1.  Physicians’  activities  during  medical  encounters.  This  image  was  taken  from  Welsby 
(2003:3). 
In  May  1999,  at  a  conference  sponsored  by  the  Bayer  Institute  for  Health 
Communication  and  the  Fetzer  Institute,  seven  components  were  identified  as 
fundamental  to  all  encounters  between  clinician  and  patient.  These  points  could 
enhance efficiency in doctor-patient communication, improve quality of care and time 
management (Nelson in Bakić 2008:75):  
  Build the relationship 
  Open the discussion 
  Gather information 
  Understand the patient's perspective 50 
 
  Share information 
  Reach agreement on problems and plans 
  Provide closure 
However, despite the application of these guidelines, the situation of the medical 
interview is complex, dynamic and often unpredictable: all doctor-patient interactions 
are usually influenced by the expectations of both parties (Haftel, 2008:1); there are 
no standard doctors and patients; and what may be useful or accepted by a patient 
may not be suitable for another.    
According to Simpson et al. (1991:1385), most complaints about physicians do 
not deal with clinical competency problems, but with communication problems; and 
the majority of malpractice allegations arise from communication errors. Among the 
deficiencies in doctor-patient communication, a substantial problem seems to be the 
high number of patients who do not understand or remember what their doctors tell 
them about diagnoses and treatments. Moreover, patients’ dissatisfaction has been 
shown to be mainly related to uncertainty and lack of information, explanation, and 
feedback  from  the  doctor.  Doctors  are  often  blamed  for  not  listening  to  their 
patients’ concerns and they are often criticized for not having enough time for their 
patients. As a result, many patients leave the consultation without asking questions 
concerning doubts that are troubling them and feel unsatisfied for the health service 
provided (Simpson et al. 1991:1387). 
 Another important element which contributes to the patients’ dissatisfaction is 
the language used by doctors. It is often unclear and contains medical jargon that is 
not  fully  comprehensible  by  patients  who  do  not  possess  the  same  medical 
knowledge  as  their  physicians.  The  use  of  medical  jargon  may  cause 
misunderstandings  and  it  can  also  encourage  patients  to  use  medical  terms 
improperly. As highlighted by Welsby (2003:7), words may have different meanings 
in different contexts and this is exactly the case when general words are used in 
medical discourse. Patients may think they understood the terms. Instead, they may 
have attributed non-medical meanings to them.  
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The  examples  in  Table  3.2  below  show  different  meanings  which  may  be 
attached to different terms by medical professionals and by patients: 
TERMS  MEDICAL MEANING  NON-MEDICAL MEANING 
acute  Rapid onset  severe 
numb  Lack of cutaneous sensation  Any abnormal sensation 
chronic  Long term, long-lasting  severe 
migraine  A specific headache syndrome  Any severe headache 
cancer  Histologically malignant  Universally fatal 
Table 3.2. How terms can be differently perceived from patients and physicians. The examples are 
taken from Welsby (2003:7). 
Therefore, while passing from doctors’ mouths to patients’ ears, terms may take on 
different  connotations,  because  they  may  be  understood  in  inappropriate  ways. 
Therefore,  physicians’  explanations  and  check  about  what  patients  understand  is 
fundamental in order to avoid misinterpretations. Doctors should monitor the level of 
jargon  they  use,  they  should  provide  explanation  in  a  totally  comprehensible 
language, and they should avoid the use of potentially frightening words - such as 
cancer - because they could result in patients’ negative reactions (Welsby 2003:8). 
b.  The patient  
A living human body is not a mere assemblage of things such as arms, legs, 
stomach, brain, cells, and other elements. A patient is a living being consisting of 
body  and  mind,  a  member  of  a  family,  of  a  community  and  of  a  larger  cultural 
society.  When  patients  seek  the  advice  and  care  of  a  doctor,  they  go  to  the 
physician’s clinic and, with the help of questions doctors ask to gather information, 
they start describing their symptoms. During their explanations, patients may load 
their narratives with unnecessary information and personal concerns, which are, for 
patients, of primary interest. The importance that patients give to some additional 
information may not be appropriate for doctors, who have the ‘power’ to shift the 
conversation  towards  the  most  medically-relevant  aspects.  However,  a  great 
influence  on  the  success  of  medical  treatments  has  to  be  attributed  to  patients’ 
illness  framework  in  terms  of  their  subjective  experience  and  meaning  of  illness, 52 
 
psychological  impacts  on  the  patient’s  self  concept  and  everyday  life,  patients’ 
beliefs,  priorities  and  preferences  for  treatment  (Myfanwy  2008:55).  According  to 
Waitzkin  (1991:3),  illness  affects  the  whole  of  people’  lives  and  a  patient’s 
experience of physical problems is inseparable from the wider social context in which 
these problems occur. Effective diagnoses depend not only on the identification of 
physical symptoms, but also on the identification of those symptoms that may have 
psychological or social origins, thus requiring different treatment plans (Bird et al. 
1993:1).  Therefore,  doctors  who  attentively  listen  to  their  patients  facilitate  and 
encourage the patient’s active involvement during the healing process.  
In  Mishler’s  opinion  (1984:95-96),  physicians  always  control  the  contents  of 
their consultations. The relevance and appropriateness of information can be defined 
in terms of what physicians choose to attend to and to ask about. Occasionally, the 
flow of the interview can be interrupted by the voice of patients (Mishler 1984:95) 
when they refer to the personal and social contexts of their problems. But, generally, 
such  disruptions  are always  reasserted  by  physicians.  Despite  the  leading  role  of 
physicians during the consultations, patients can always assume a more participative 
attitude by interrupting the doctor with questions or requests for explanations.  
In this respect, according to Myfanwy (2008:56), younger people seem more 
likely  to  expect  a  relationship  of  mutual  participation  than  elderly  people  do. 
Similarly, patients with higher educational level tend to participate more during the 
consultation compared with patients from lower socio-cultural background. However, 
despite  these  differences  of  attitudes,  patients’  participative  approach  during  the 
communicative exchange generally increases over the course of an illness as patients 
gain  more  knowledge  and  understanding  of  their  health  condition  (Myfanwy 
2008:57). It can also be pointed out that because in general practice there is the 
opportunity  for  continuity  of  care,  with  doctors  and  patients  often  knowing  each 
other  over  a  long  period,  patients  may  feel  more  at  ease  to  express  their  own 
concerns,  doubts  and  worries  than  in  other  settings,  such  as  hospitals  (Myfanwy 
2008:58). 
The  asymmetry  which  characterizes  doctor-patient  relationships  may  also  be 
explained by looking at participants’ different priorities. On the one hand, doctors 53 
 
need information to establish the right diagnosis and treatment plan; whereas, on 
the other hand, patients need to know and understand what is going on and they 
need to feel listened to and understood. According to the European Task Force on 
Patient  Evaluations  of  General  Practice  (1998:175-186),  the  most  highly  rated 
priorities  of  patients are:  humanness,  competency,  patients’  involvement,  doctors’ 
listening skills and provision of information.  
Another fundamental element which has to be considered while talking about 
medical consultations is the underlying concept of informed consent. The patients’ 
right to make decisions about medical treatments has been enshrined in legal and 
ethical statements throughout the world. The Declaration of Lisbon on the Rights of 
the Patient (WMA 2005, Art.7) reads: 
The  patient  has  the  right  to  self-determination,  to  make  free  decisions  regarding 
himself/herself.  The  physician  will  inform  the  patient  of  the  consequences  of  his/her 
decisions.  The  patient  has  the  right  to  the  information  necessary  to  make  his/her 
decisions.  The  patient  should  understand  clearly  what  is  the  purpose  of  any  test  or 
treatment,  what  the  results  would  imply,  and  what  would  be  the  implications  of 
withholding consent. Information should be given in a way appropriate to the patient’s 
culture and in such a way that the patient can understand. 
 
Therefore,  a  necessary  condition  for  informed  consent  is effective  communication 
between physicians and patients. Physicians have to provide patients with all the 
information they need to make their decisions. They have to explain complex medical 
diagnoses,  prognoses  and  treatment  regimes  in  simple  language,  ensuring  that 
patients  understand  what  they  say.  They  should  present  all  treatment  options, 
advantages  and  disadvantages  of  each  treatment.  Physicians’  successful 
communication will provide all necessary information to patients, thus allowing them 
to make an informed decision about how to proceed. 
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Similarly, the European Charter of Patients’ Rights (2002) reads: 
Art.3.  Right  to  Information:  Every  individual  has  the  right  to  access  to  all  kind  of 
information regarding their state of health, the health services and how to use them, and 
all that scientific research and technological innovation makes available. 
Art 4. Right to consent: Every individual has the right of access to all information that 
might  enable  him  or  her  to  actively  participate  in  the  decisions  regarding  his  or  her 
health; this information is a prerequisite for any procedure and treatment, including the 
participation in scientific research. Health care providers and professionals must use a 
language known to the patient and communicate in a way that is comprehensible to 
persons without a technical background. 
Art.5. Right to free choice: Each individual has the right to freely choose from among 
different treatment procedures and providers on the basis of adequate information. 
 
As can be seen, both documents emphasize the need to use a language that patients 
know and they highlight the fact that medical information should be provided in a 
way  that  is  coherent  with  the  linguistic  and  technical  background  knowledge  of 
patients.  
However,  despite  all  misunderstandings  which  may  occur  during  medical 
encounters, spoken discourse can be regarded as taking place in real time and being 
generally interactive: people speak in turns and have a direct feedback from the real 
audience they are addressed to. Therefore, during consultations, both doctors and 
patients have a direct feedback. On the one hand, doctors may always modify their 
talk when they realize that their message is not passing and they can always check 
whether the message is clear enough for their patients or not. On the other hand, 
patients  always  have  a  chance  to  interrupt  their  doctors  to  ask  for  further 
explanations.  
To sum up, according to doctor Shmerling (Appendix 4): 
 […] the main difficulty is that physicians spend so much time immersed in the language 
doctors  use  that  they  forget  that  patients  cannot  understand  them.  And  patients  are 
often hesitant to ask for clarification. Much like translating a foreign language, doctors 
have  to  remember  to  slow  down  and  communicate  in  terms  their  patients  will 
understand. Conversely, patients need to understand that it is okay to ask their doctors 
to explain things more clearly. 
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2.3  Changing dynamics in doctor-patient relationship 
 
Before  the  information  era,  knowledge  of  medicine  belonged  only  to  the 
physician.  In  early  1980s,  doctors  were  seen  as  “intractable  holders  of  power, 
collectors  and  analyzers  of  technical  information  elicited  from  patients”  (Mishler 
1984:10). Patients were perceived as passive objects whose only task was to answer 
physicians’ queries, listen to doctors’ indications and comply. Because of widespread 
ignorance and illiteracy among people, and the consequent difficulties in accessing 
medical information, patients could not form their personal opinions. Therefore, for 
any health problem, patients used to go visit the doctor, who was the only channel 
for them to acquire information on their health status.  
Parson (1951), who was one of the earliest sociologists to examine the role of 
doctors  and  patients,  portrayed  doctor-patient  relationship  as  an  asymmetrical 
relationship: by virtue of his or her specialist knowledge, the doctor occupied the 
dominant  position  and  the  patient  merely  cooperated  (Myfanwy  2008:54).  This 
paternalistic  view  about  the  role  of  doctors  traditionally  characterized  medical 
consultations.  Patients  relied  on  the  doctor  and  were  relieved  of  worries  and 
responsibilities of decision-making, while doctors directed care and made decisions 
about treatments on their own, thus maintaining an authoritarian behavior and a 
high  control  over  their  uninformed  patients.  However,  this  asymmetry  of  power 
resulted  in  inevitable  inequalities  between  doctor  and  patient  in  terms  of  status, 
knowledge and access to other health related services (Todd and Fisher 1993:ix). 
In more recent years, medical consultations began to change. Patients became 
increasingly involved during the consultation, thus creating a relationship of mutual 
exchange  of  ideas  and  opinions  between  doctors  and  patients.  In  this  way,  the 
doctor brings his/her clinical skills and knowledge to the consultation in terms  of 
diagnostic  techniques,  knowledge  of  the  diseases’  causes,  prognoses,  treatment 
options  and  preventive  strategies,  while  patients  bring  their  own  experiences, 
explanations  of  their  illnesses,  their  social  circumstances  and  their  treatment 
preferences (Myfanwy 2008:54). Consequently, in the communicative act, patients 
are seen as partners whose knowledge gaps should be filled by educating them.  56 
 
But still, according to Andersons et al. (2003:75), the doctor plays the role of the 
active interlocutor and medical information is provided at the physician’s discretion. 
The doctor-patient relationship continued to evolve and nowadays it is rather 
complex to explain. People’s educational level and health awareness have increased. 
In the past 30 years, medical care in the Western world has increasingly emphasized 
patient  autonomy  in  decision  making  (Gotti  and  Salager-Meyer  2006:11)  and  the 
trend toward preventive medicine contributed to the patients’ desire to acquire as 
much  medical  knowledge  as  possible.  As  a  result,  patients  assume  more 
responsibility  for  their  own  health  and  they  actively  participate  in  health-related 
decisions that affect them.  
Health information has become more accessible: the doctor is no longer the 
only  channel  to  acquire  medical  information  and  physicians  are  increasingly 
confronted  with  patients  who  empower  and  educate  themselves  using  different 
sources. In recent time, the media, such as the television, the radio, newspapers and 
magazines,  provide  a  constant  and  readily  accessible  supply  of  health  care 
information and advice. The media cover advances in medical treatments and new 
drugs; they alert their audiences to health risks; they promote the value of taking 
care of the self; and they may also provide detailed insights on socio-political issues 
like medical funding and health service delivery. The provision of health information 
is  widely  distributed  across  the  media  occurring,  for  instance,  in  news  stories, 
documentaries, medical and science programs, and health promotion campaigns
20 
(McKay 2006:311). In this way, the information gap between doctors and patients is 
reversed and physicians feel threatened by the fact that many patients seem to have 
more information than doctors (Anderson et al. 2003:77). 
However,  nothing  has  influenced  doctor -patient  relationship  more 
fundamentally than one technological innovation: the Internet.  
 
                                                           
20 Nowadays, health and illness are major themes in entertainment media forms too, like television 
dramas and TV series, lifestyle shows and soap operas (McKay 2006:311). 
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In  the  article  La  rivoluzione  del  paziente  informato  nel  “villaggio  globale”, 
Miglino (2012:14) states:  
Sono lontani i tempi in cui il medico era un vero e proprio oracolo e il sapere discendeva 
da lui verso un paziente in forte soggezione e timore reverenziale. Oggi chiunque abbia 
un problema di salute accende un computer, digita una parola chiave su Google, entra in 
un sito, legge, stampa e corre dal medico con la frase che lo indispone più di ogni altra 
cosa: Dottore ho letto su Internet… . 
According to Akerkar and Bichile (2004:120), we are now assisting to the e-
patient revolution: 
they are arriving at your clinic armed with information they have found on the web, with 
a  preconceived  idea  about  their  diagnosis  and  treatment  options,  more  demanding 
regarding  convenience  and  ease  of  access.  They  want  to  actively  participate  in 
therapeutic decisions and want all the decisions to be informed and intelligent. Meet the 
new empowered patient!-empowered by the information technology and its benefits. 
 The Web has upended the past scenario. It has become a source of health 
information  and  it  offers  virtually  unlimited  amounts  of  information:  health  and 
medical websites provide an enormous range of health-related material, while chat 
rooms  and  newsgroups  facilitate  patient-to-patient  interactions  and  discussions 
(McKay 2006:312). Generally, greater access to high-quality medical information on 
the Internet increases the number of informed patients who bring detailed and often 
complex questions to their doctors and desire to participate in decisions concerning 
their care (Myfanwy 2008:63). The Internet changed the exclusive focus of health 
care  from  curing  diseases  to  preventing  diseases  and  enhancing  health  status 
(Anderson et al. 2003:68). The first health contact traditionally represented by the 
family physician is slowly being replaced by the Internet in many cases. Everyone 
can now visit many of the sites that inform and educate doctors. Besides, popular 
search engines, such as Google and Yahoo, provide portals with several kinds of data 
(primary data, criticism and different opinions). As a result, patients surf the Net and 
consult their physician armed with information or, after the medical visit, they may 
check the efficiency of treatments suggested by their doctor (Akerkar and Bichille 
2004:120).  
A driving force behind the demand for online health information seems to be 
patients’  dissatisfaction  with  traditional  health-related  services  (Anderson  et  al. 
2003:72). Nowadays, doctors have less and less time to spend with their patients; 58 
 
the health systems of industrialized countries are coming under increased cost-saving 
pressure; the cost of medical care has risen and patients increasingly have to pay out 
of  their  own  pockets  for  medications  and  other  health  products  and  services; 
insurance companies and government agencies often demand a share in decision-
making  power,  thus  reducing  the  freedom of  choice  of  both  the  patient  and  the 
doctor in many ways (Gotti and Salager-Meyer 2006:11). Therefore, patients have to 
think more about the quality and costs of their medical treatment choices. 
Particularly  via  the  Internet,  patients  can  find  accessible  and  inexpensive 
sources  of  information  about  health  and  medicine,  heath  insurance,  physicians, 
hospitals,  and  other  health-related  topics.  By  surfing  the  Net,  patients  may  even 
obtain information about the rarest health conditions and experimental or alternative 
treatments, which often physicians do not know anything about. The Internet offers 
the possibility to communicate with health experts, even anonymously, thus avoiding 
the  embarrassment  that  may  occur  in  face-to-face  communication.  Moreover, 
because of the immediacy of feedback and information availability 24 hours a day, it 
simply appears more convenient to look for information online rather than getting an 
appointment with a doctor (Anderson et al. 2003:73). 
The  widespread  use  of  the  Net  for  health  information  has  been  proved  by 
various  research  projects  in  America  and  in  Italy.  According  to  the  study  Health 
Online  2013  carried  out  by  the  Pew  Research  Center’s  Internet  &  American  Life 
Project (2013:3-18), seventy-two percent of internet users say they looked online for 
health  information  in  2012.  On  the  one  hand,  for  one-third  of  U.S.  adults,  the 
Internet  is  a  diagnostic  tool.  Therefore,  they  use  it  in  order  to  figure  out  what 
medical  condition  they  or  someone  else  have  and  to  look  for  specific  medical 
problems. On the other hand, one in four U.S. adults sees the Internet as a useful 
tool  to  have  peer-to  peer  healthcare  information.  Women,  younger  people,  white 
people and those with higher educational level were found to be the most active 
among online health information seekers. 
 In Italy, in 2012, the Censis and the Forum per la Ricerca Biomedica carried 
out  a  similar  research:  Quale  futuro  per  il  rapporto  medico-paziente  nella  nuova 
sanità. According to the study (2012:18-20), thirty-two percent of the interviewees 59 
 
said they use the Internet to look for health information. Although the use of the 
Web  as  a  health-informative  tool  greatly  varies  according  to  people’s  age  and 
education, the data show that the use of the Web among people aged between 40 
and 60-years-old is increasing. As regards information type, the majority of online 
health information seekers (90.4 %) look for information about particular medical 
conditions and about physicians and health services (58.6%), whereas only 13.9% of 
Internet users look for peer-to peer health information. 
As shown above by a summary of the most relevant data, the Internet has a 
relevant position among the channels which offer information about health and its 
use  is  quite  widespread  among  the  American  and  Italian  people.  According  to 
Anderson  et  al.  (2003:68),  this  technological  innovation  is  reshaping  the  way  in 
which health care is organized and delivered and, since ‘it is here to stay’, in few 
years more and more people will use it. 
However, despite noteworthy effects of the Internet as a valuable informative 
tool, some physicians remain skeptical about the advantages of using the Internet 
more actively in their practices, while, some others worry that patients who consult 
web sites for information (e-patients) may not consult actual doctors when serious 
problems  arise  (Anderson  et  al.  2003:68). Other  relevant  factors  determining  the 
resistance  from  health  care  professionals  is  the  variable  and  unreliable  nature  of 
medical information on the Net, the loss of human touch and also the perception of 
the informed patient as the ‘problematic patient’ (Akerkar and Bachile 2004:121). 
 As  shown  by  the  Censis  and  Pew  Project  researches,  only  one-third  of  e-
patients later talked to doctors or other health professionals about the information 
they found online, whereas two-thirds did not (Pew Internet & American Life Project 
2006:6; Censis 2012:24). The problem is that the Internet is a double-edged sword. 
On  the  one  hand,  it  offers  an  enormous  quantity  of  information  about  almost 
anything,  even  giving  the  possibility  to  enter  into  contact  with  highly  specialist 
notions.  On  the  other  hand,  specialist  information  for  non-experts  can  lead  to 
potentially  dangerous  misperceptions  and  misunderstandings  (Censis  2012:16). 
Therefore,  e-patients  should  discuss  with  their  doctor  the  information  they  found 
online in order to relate these information to their personal health condition. In this 60 
 
way, they could effectively understand such information. However, the majority of e-
patients do not consistently check the source and date of the information they find 
online (Pew Internet & American Life Project 2006:11), and when they bring the 
printed  information  to  the  doctor,  the  latter  cannot  verify  their  reliability. 
Furthermore, it has been shown that most e-patients began their search at a search 
engine such as Google, Bing, or Yahoo; while the percentage of those who began at 
a site that specializes in health information is rather low (Pew Internet & American 
Life Project 2013:8). The central role of search engines is undoubtedly due to the 
fact that they allow people to find various kinds of information in a limited amount of 
time. However, the risk to find inappropriate and imprecise  information (at times 
related to business interests) increases when starting at a search engine. Generally, 
the first results provided by search engines consist of links to Wikipedia’s pages or 
other websites that are not specialized in health information. Links to institutional 
web  sites,  such  as  the  NIH  (National  Institute  of  Health)  and  the  NHS  (National 
Health Service), usually appears later on the following pages (Laurent and Vickers 
2009:471-479). 
Certainly, patients need to be informed about their health, but they also need 
to  pay  attention  to  the  quality  and  reliability  of  information  they  find.  It  is  just 
through  the  use  of  reliable  information  that  patients  can  create  a  relationship  of 
mutual exchange of information, thus an effective communication with their doctors.  
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Figure 3.3. Evolution of the patient-physician relationship in terms of ‘information gap’ (Anderson et 
al. 2003:76-78). 63 
 
3.3    Survey: doctor-patient relationship in Lusiana 
 
In  small  towns,  the  role  of  doctors  has  always  had  a  great  importance. 
Together with mayors and priests, doctors have always been an important guide for 
the social community. In small contexts, doctors usually know all inhabitants and, 
generally, they create close relationships with their patients. Physicians meet their 
patients not only in their clinics, but also outside the medical context. Therefore, they 
know almost everything about their patients’ everyday activities and lives. Similarly, 
patients know everything about their physicians. Hence, doctors need to act in the 
most appropriate way in order to maintain their good reputation. 
Within this social context, physicians often succeed in creating a relationship of 
mutual trust with their patients, and patients show a confident attitude towards their 
medical  practioners.  The  family  doctor  is  seen  as  a  fundamental  figure:  once  a 
patient has a health problem, he/she just goes to the doctor asking for advices and 
cures.  
Another  aspect  that  seems  worth  highlighting  is  the  fact  that  these  close 
relationships between doctors and patients often result in activities doctors are not 
paid for. For instance, doctors often go visit elderly people at home just to see if they 
feel well (even though patients did not call them), or, if they know that one of their 
patients has been sent to the hospital, they go there to visit him/her. Differently from 
a city context, doctors in small towns have more time to spend with their patients 
and they know them better. Moreover, this social context allows patients to have a 
greater degree of confidentiality with their doctors, thus patients assume an active 
attitude. 
As has been previously shown in section 3.2, the relationship between doctor 
and patient has changed considerably over time. Especially with the information era, 
new technological devices, in particular the Internet, seem to acquire more and more 
importance even within the context of health.  
In order to see whether the Internet affects doctor-patient relationships even in 
small towns, patients were asked to answer some questions. All of the considered 
patients  live  in  the  town  of  Lusiana,  where  four  male  doctors  provide  healthcare 64 
 
services.  The  questionnaire  was  addressed  to  patients  aged  between  twenty  and 
forty years old (henceforth referred to as younger patients), and to patients aged 
between fifty and sixty-five years old (henceforth referred to as older patients). The 
same questions (Appendix 5) where asked to both groups of people. People who 
answered the questionnaire were 21 in each group. 
According to their answers, doctors still succeed in maintaining a relevant role 
within the community under investigation. Both younger patients and older patients 
still see their doctor as a fundamental figure to obtain health-related information. 
Certainly,  since  younger  people  make  use  of  the  Internet  to  a  higher  extent 
compared to older people, they also look for health-related information on the Web 
(18  younger  people  out  of  21  look  for  health-related  information  online). 
Nevertheless,  even  among  those  people,  the  doctor  maintains  an  important  role. 
Differently  from  what  I  expected,  just  2  out  of  21  younger  patients  see  their 
physician as ‘one of the various sources which provide health-related information’ 
and only 7 out of 18 younger patients, who uses the Internet to find information 
about  their  health  conditions,  do  not  discuss  with  their  physician  about  the 
information they found on the Web. Moreover, 13 out of 21 younger patients always 
search for doctor’s advice before starting a new treatment; 7 of them often or at 
times look for medical advice; just one does not search for physician’s advice. 
As far as older patients are concerned, just 8 out of 21 patients, at least once, 
looked for health-related information online. Among them, just two patients did not 
discuss with their doctor about the information they found, and just two patients see 
the doctor as one of the available sources to obtain medical information. Moreover, 
17 out of 21 younger patients always search for doctor’s advice before starting a new 
treatment; 3 of them often look for medical advice; just one does not search for 
physician’s advice. 
As regards physicians’ attitude towards information found online, the answers 
show that physicians are always keen to provide further explanations, though, at 
times, they criticize the kind of information patients found. Moreover, the answers of 
both groups of patients highlight the fact that physicians never recommended useful 
websites  which  provide  reliable  and  useful  information  about  health.  This  datum 65 
 
shows that physicians in Lusiana are reluctant to suggest the use of the Internet for 
health information researches. According to doctors, it is much better to talk directly 
with patients about health problems because highly specialized medical information 
written  on  the  Internet  may  be  difficult  to  understand  for  lay  people.  Moreover, 
doctors state that even though patients can find reliable information on the Web, 
they  may  not  be  able  to  elicit  information  that  is  useful  for  their  own  health 
conditions. According to doctor Rasotto (Appendix 6): 
sul Web [i pazienti] acquisiscono varie conoscenze non sempre corrette e, comunque, 
anche quando sono corrette [i pazienti] non sanno contestualizzarle. La conoscenza che 
spesso le persone acquisiscono per tale via è magari abbondante, ma frequentemente 
fuorviante e talora non incentrata sull’essenza del problema. 
As regards the quality of online information, one out of 18 younger patients 
thinks that the information found on the Web is exhaustive and just 5 of them think 
that online information is totally comprehensible. Moreover, the majority of younger 
patients think that at times, or often, online information creates confusion. On the 
other  hand,  among  the  8  older  patients  who  look  online  for  health-related 
information, just four patients think that online information is exhaustive, and only 
one  patient  thinks  that  online  information  is  totally  comprehensible.  In  addition, 
except for one patient, all the others think that the Web creates confusion.  
Considering  now  the  language  used  by  doctors,  25  out  of  42  patients  who 
answered the questionnaire said that at times they find doctors’ language difficult to 
understand and 38 out of 42 patients said that they  at times ask the doctor  for 
further explanations about terms’ meanings. 
Below, Figure 3.1 shows the comparison between younger and older patients’ 
answers concerning four different topics. 66 
 
 
Figure 3.4. Comparison between younger and older patients’ answers to four different questions. 
 
In order to understand the doctors’ point of view, a different questionnaire was 
prepared (Appendix 6). The physicians’ answers show that every time doctors speak, 
they adjust their talk according to their patients. The language changes according to 
several aspects, such as patients’ age, patients’ educational level and comprehension 
skills. For instance, since the majority of people in Lusiana are elderly people, who 
only know dialect, physicians often need to recur to the use of dialect during medical 
visits.   
In  addition,  doctors  highlight  the  fact  that  they  always  try  to  use  simple 
language to convey medical concepts: they tend to use simple words that belong to 
general language. Moreover, some doctors often synthesize at the end what they 
have said throughout the visit, and all doctors under investigation continuously check 
patients’ feedback in order to see whether the patient understands him or not. 
All physicians state that they use a language that is very different from the so-
called ‘language of medicine’ with all kinds of patients. However, tree out of four 
doctors still make use of medical terms providing all the explanations patients need 
in order to comprehend the terms’ meaning. When patients ask for clarifications, 
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doctors make use of different kinds of devices. Those indicated by physicians are 
listed below:  
  common language or dialect, 
  examples taken from everyday life, 
  similes and metaphors, 
  anatomical  sketches  or  figures  taken  from  journals  or  other  written 
papers, 
  sketches or diagrams downloaded in real time from the Internet, 
  scholarly citations (when patients are able to understand them). 
As far as mass media are concerned, doctors think that the Web does not have 
a relevant role for patients living in Lusiana. Most patients are elderly people who do 
not use the Internet. Instead, some patients may watch TV health-related programs. 
Therefore, all data show that doctors in Lusiana still succeed in maintaining their 
central role and are not replaced by technological innovations yet. 
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Chapter four: analysis of Patient Information Leaflets (PILs) 
 
Patients increasingly expect to access information which enables them to make 
informed decisions about their health. Good information helps patients to participate 
in  shared  decision-making  with  their  healthcare  professionals.  Similarly,  patients 
need to have sufficient and high-quality information about drugs, in particular over-
the counter drugs which are not prescribed by physicians.  
As regards prescription medications, a significant part of information, in terms 
of  usage  and  effects,  derives  from  the  consultation  with  a  healthcare  provider. 
However, even in this case, the physician’s advice cannot be relied on as the only 
source of information for all patients. For medications purchased over the counter, 
the  interactions  between  the  patient  and  a  healthcare  expert  may  be  limited  or 
unavailable. As a result, written information has a great importance for safe use of 
medicinal products.  
In our society, there is an enormous amount of information about health and 
drugs which is available from many different sources. However, it is not always easy 
for patients to access information. For many people, the primary or only source of 
information about their medicinal treatment remains the statutory patient information 
leaflet  (PIL),  which  has  had  to  be  supplied  with  all  drugs  since  1999.  This  text 
provides the essential information patients need to use medications safely and gain 
the most benefit. Unlike other sources of information, the patient information leaflet 
is a highly regulated text. All PILs are required to be reviewed and approved by the 
Medicines and Healthcare products Regulatory Agency before being supplied with the 
medicinal product. 
 
4.1       Legal framework 
 
All medicinal products placed on the European market are required by European 
Community law to be accompanied by labelling and package leaflets which provide a 
set of comprehensible information which enables patients to use drugs appropriately. 70 
 
In 1992, the European Commission issued Directive 92/27/EEC on the labelling 
of medicinal products for human use and on package leaflets. The Directive brought 
together requirements for detailed information that must accompany medicines to 
ensure  their  safe  and  effective  use.  The  directive  was  fully  implemented  into  UK 
legislation  with  the  Medicines  Labelling  and  Medicines  Leaflets  Amendment 
Regulations which enter into force in January 1993. UK legislation on labeling and 
patient information leaflets had to comply with European law by the 31
st December 
1998. As a result, since the 1
st January 1999, it has been a legal requirement that all 
licensed medicinal products in the UK would be supplied with a patient information 
leaflet  (PIL).  Similarly,  Italian  law  implemented  the  European  Directive  with  the 
D.L.vo  540:  Attuazione  della  direttiva  92/27/CEE  concernente  l'etichettatura  ed  il 
foglietto illustrativo dei medicinali per uso umano (30 December 1992).  
 
According  to  the  law,  the  PIL  must  provide  comprehensive  information  that 
reflects  information  detailed  in  the  Summary  of  Product  Characteristics  (SmPC). 
Information has to be accessible to and understandable by patients who receive it, 
thus allowing them to properly and safely use medicinal products. Article 8 of the 
European Directive 92/27/EEC reads: 
the package leaflet must be written in clear and understandable terms for the patient and 
be clearly legible in the official language or languages of the Member State where the 
medicinal product is placed on the market. 
Subsequently, other European Directives (2001/83/EC; 2004/27/EC) have come 
into force in order to amend the previous legislation.  
Finally,  in  January  2009,  aiming  at  providing  guidance  on  how  to  ensure 
accessibility of the information contained in the labeling and package leaflets, the 
European Commission issued the Guideline on the Readability of the Labeling and 
Package Leaflet of Medical Products for Human Use
21. In the document, attention is 
focused not only on the quality of information provided, but also on the quantity and 
type of information that is necessarily required by the law. As a result, the guidance 
gives advice on the presentation of the content, on the design and on the layout  of 
                                                           
21 This guideline is published in accordance with Article 65(c) of Directive 2001/83/EC, which provides 
for the development of guidelines concerning the legibility of particulars on the labelling and package 
leaflet. 71 
 
the labelling and package leaflet in order to optimize their usability. According to the 
guideline, the package leaflet, that is primarily intended for patients, has to be well 
designed  and  clearly  worded,  thus  allowing  a  wider  range  of  people  to  use  that 
information.  In  what  follows,  I  will  try  to  summarize  the  most  relevant 
recommendations provided by the guideline in section A: Readability of the package 
leaflet and the labeling (ENTR/F/2/SF/jr(2009)D/869:7-11): 
1.  Type size and font 
An easily readable font should be chosen and the type size should be as large 
as possible to aid readers. Different text sizes could be appropriate to enable 
key information to stand out and to facilitate navigation in the text, as is the 
case with headings. 
 
2.  Design and layout of the information 
As the space between lines is an important factor influencing the clarity of the 
text,  line  spaces  should  be  kept  clear.  Contrast  between  the  text  and  the 
background is important in order to avoid interferences with the written text 
which would make it harder to read. When a multilingual leaflet is proposed 
there should be a clear demarcation between the different languages used. 
 
3.  Headings 
Headings are an important navigation tool and can help patients to find the 
information looked for. Where complex information has to be communicated, 
multiple levels of headings may be needed. All main section headings covered 
by Article 59 (1) of Directive 2001/83/EC has to be included within the leaflet: 
  the name of the medicinal product and pharmaco-therapeutic group; 
  therapeutic indications; 
  the  information  which  is  necessary  before  the  use  of  the  medicinal 
product (contraindications; precautions for use; interactions with other 
medicinal products; special warnings); 
  the instructions for proper use (the dosage; the method, the route and 
the frequency of administration; etc.); 72 
 
   a description of adverse reactions which may occur under normal use 
of the medicinal; 
  a reference to the expiry date with special storage precautions, the full 
qualitative  and  quantitative  composition  (active  substance  and 
excipients), the pharmaceutical form and content in weight, volume or 
units of dosage; 
  the name and address of the marketing authorization holder and of the 
manufacturer; 
  The date on which the package leaflet was last revised. 
Sub-headings and associated text should only be included if these are relevant 
for the particular medicine. For example, in the patient information leaflet of 
Lempsip medication, in the section Before you take this medicine, there is a 
sub-heading  Important  information  about  some  of  the  ingredients  in  your 
medicine. This further section was added because some of the ingredients in 
Lempsip lozenges can be harmful for people affected by phenylketonuria (an 
inherited genetic disorder). 
4.  Syntax 
As some people may have poor reading skills and poor health literacy, simple 
words  of  few  syllables  should  be  used.  Long  sentences should  be  avoided 
because long paragraphs can confuse the readers, particularly where the list 
of side effects are included. The use of bullet points (preferably no more than 
6) for such lists is considered more appropriate. Particularly important is the 
order  in  which  side  effects  are  set  out;  generally,  they  should  be  listed 
progressively basing on their frequency of occurrence (starting with the most 
frequent side effect). For instance:  
-  Occasionally X can cause a temporary reddening of the skin; 
-  very rarely people report blood disorders. 
5.  Style 
An active style is recommended instead of the use of passive voice.  
Instructions should be followed by reasons, for example ‘do not take X if you 
have asthma- it may bring on an attack’. 73 
 
Abbreviations and acronyms should not be used unless these are appropriate. 
When first used in the text, the meaning should be spelled out in full. 
As scientific symbols (e.g. >) are not well understood, their use should be 
avoided. 
As regards the language used: 
Medical terms should be translated into language which patients can understand. 
Consistency should be assured in how translations are explained by giving the lay 
term with a description first and the detailed medical term immediately after. On a 
case by case basis the most appropriate term (lay or medical) may then be used 
thereafter throughout the package leaflet in order to achieve a readable text. Make 
sure that the language used alerts the reader to all the information relevant to 
him/her, and gives sufficient detail on how to recognize possible side effects and 
understand any action which may be necessary. (ENTR/F/2/SF/jr (2009) D/869:9-10) 
 
6.  Use of symbols and pictograms 
The use of images, pictograms and other graphics is permitted in order to aid 
the  comprehension  of  the  information,  but  any  element  of  a  promotional 
nature is excluded. Images and pictograms may be used as a supplement to 
the text and should not replace it. Some examples are shown below. 
 
                    A.                                        B.                      C. 
    
Figure 4.1. Examples of pictorials indicating to take one tablet in the morning and two at 
bedtime  (A);  not  to  drink  alcoholic  beverages  when  taking  the  medication  (B);  to  avoid 
excessive sun exposure (C). (Katz et al. 2006:2394) 
 
4.2 Patient Information Leaflets   
 
Language varies as its function varies. It differs in different situations. (Bhatia 1993:5) 
According  to  Bhatia’s  definition  (1993:13),  genre  is  a  recognizable 
communicative act primarily characterized by a set of communicative purposes that it 
is intended to fulfil. The set of communicative purposes shapes the genre and gives 
it an internal structure. Most often, it is a highly structured and conventionalized 74 
 
communicative event and it displays constraints in terms of its intent, positioning, 
form and functional value. 
Following this definition, patient information leaflets can be seen as a sub-genre 
which belongs to the more general genre of ‘instructions for use’ texts. Its main aim 
is to provide useful and clear information on the use of medicinal products in order to 
allow patients to use medicines in a way that is appropriate for their own health 
problems.  Therefore,  patient  information  leaflets  are  a  communication  medium 
between experts and non-experts, in particular between doctors and patients.  
As all specialized texts, patient information leaflets share some proprieties with 
highly  specialized  medical  texts  -  the  most  evident  shared  characteristic  is 
represented  by  the  use  of  technical  lexis.  However,  according  to  Cortellazzo 
(1994:21), when a specialized language is used in expert-layperson communication, 
it loses some of its characteristics and becomes ‘closer’ to natural language. This 
changing may be observed when technical terms are substituted by words which 
belong to the general lexis; when technical terms appears together with glosses or 
periphrases  written  in  general  language;  or  when  technical  terms  are  explained 
through definitions, metaphors, analogies or examples (Cortellazzo 1994:21). Some 
examples taken from the English corpus of patient information leaflets (Appendix 8) 
are quoted below: 
-  Medications  such  as  Moment  can  be  associated  to  a  slightly  risk  of  heart  attack 
(“myocardical infarction”) or stroke;  
-  Headache (or cefalea); 
-  Menstrual pain (or dysmenorrhea) 
-  Antiplatelet drugs like aspirin; 
-  Moment is included in the analgesic anti-inflammatory group, that is inflammation 
and pain relieving medications;  
-  Hemicrania, so called because the pulsating pain only affects one side of the head; 
-  Glaucoma (increased pressure in the eye) 
-  Oral contraceptives (“the pill”) 
-  Anti-coagulants (to thin the blood e.g. warfarin) 
-  Lesions without wounds (contusions) characterized by pain in the area of the trauma 
-  Small superficial haemorrhages (bruises) 
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-  Jaundice (yellowing of the skin or whites of the eyes) 
-  Rarely, agranulocytosis, a disease of the blood, may occur... 
Despite  this  ‘simplification/explanation’  of  specialized  terms,  patient  information 
leaflets have often been criticized for being difficult to understand. The question of 
comprehensibility of patient information leaflets started to be discussed long time 
ago  and  concerns  patient  information  leaflets  as  a  particular  text-genre  in  itself 
independently from the language in which they are written (Puato 2012:89).  
However, by considering two different languages (Italian and English), we can 
see  whether some  differences  in  terms  of readability  and  comprehensibility  exist. 
Italian patient information leaflets generally have a lower degree of accessibility for 
laypeople  compared  with  their  English  equivalents.  This  difference  is  primarily 
determined by the fact that Italian language is more inclined than English to use a 
formal  and  ‘bureaucratic’  register  in  written  texts.  Moreover,  in  Italy,  patient 
information  leaflets  are  used  by  doctors  too.  In  fact,  Summaries  of  Product 
Characteristics (SmPC), which are prepared by pharmaceutical companies and are 
intended for health professionals, are often difficult to find and they are less practical 
to use. Therefore, doctors often look for information in the Prontuario farmaceutico 
wherein they can find the same information as those described in patient information 
leaflets. 
As a consequence, poor comprehensibility of Italian patient information leaflets 
may be explained by the same nature of these texts. On the one hand, they are 
supposed to be informative tools for patients (laypeople/non-experts) and, at the 
same time, for doctors (experts); while, on the other hand, they are pharmaceutical 
documents which have to adapt to precise national and international legal norms. 
Hence, patient information leaflet writers have to find a sort of compromise between 
information completeness and information clarity.  
As far as non-expert addressees of patient information leaflets are concerned, 
another  relevant  aspect  needs  to  be  considered.  These  informative  texts  are 
intended for a highly heterogeneous public of non-experts, which differs in terms of 
sex,  age,  and  cultural-educational  background  knowledge.  Therefore,  the  texts’ 
degree of comprehensibility also varies according to the patient who makes use of it.  76 
 
Furthermore, differently from oral consultations, if patients cannot understand 
the information written in the leaflet and have some doubts, they have to ask for 
explanation to a third interlocutor, who generally is the pharmacist or the physician. 
This is emphasized through many phrases within patient information leaflets, like the 
following examples: 
 “if any….ask the doctor or pharmacist”; 
 “ask your doctor or pharmacist for further information” . 
 
4.3 Quantitative investigation into the complexity of patient information 
leaflets. 
 
The aim of this study is to investigate texts’ readability and the phenomena of 
lexical density, lexical variation, and keyness in patient information leaflets in order 
to understand how these leaflets are written and to highlight possible differences 
between Italian and English texts. 
Consequently,  fourteen  patient  information  leaflets  were  collected  in  two 
different corpora. One consists of Italian texts (Appendix 7) and the other collects 
English texts (Appendix 8). Each corpus contains seven patient information leaflets of 
self-treatment drugs which relieve the symptoms associated with colds and flu. The 
considered leaflets were chosen in relation to their active ingredients and excipients 
in  order  to  compare  English  and  Italian  texts  which  provide  information  about 
equivalent drugs. 
4.3.1 The type/token ratio 
 
The type/token ratio is the ratio of the number of different words (types) to the 
number of running words (tokens) in a given text or corpus. According to McEnery 
and Wilson (1996:158), this index indicates, on average, the frequency of new word-
forms in a text. Therefore, it can be seen as a method of measuring vocabulary and 
lexical diversity in a given text or corpus. 
However, three important factors need to be taken into account. Firstly, the 
index  varies  widely  according  to  the  length  of  the  text  (Biber  et  al.  1999:53). 77 
 
Secondly, this index does not distinguish between lexical and grammatical words.  
Therefore,  function/grammatical  words  contribute  to  lexical  diversity  to  the  same 
extent as lexical words (Castello 2008:42). Thirdly, this index does not consider word 
families. Therefore, words which belong to the same family are counted as different 
words (e.g. medicine, medicines, medicinal). In Sinclair’s words, this index is based 
on the occurrence of “any unique string of characters bounded by spaces” (Sinclair 
1991:176). 
The  texts  of  the  English  corpus  (Appendix  8)  under  investigation  vary 
considerably in terms of length: as can be seen from Table 4.1, their lengths range 
between 355 tokens (text 03) and 1226 tokens (text 04). As far as the size of patient 
information leaflets is concerned, we need to take into account that these texts are 
usually  written  basing  on  pre-defined  templates  indicating  all  the  necessary 
information which needs to be included in the texts. However, additional information 
may be added at the discretion of pharmaceutical companies. 
In Table 4.1, the number of words (tokens), of different words (types) and the 
value of the type/token ratio (TTR) are listed. 
English texts  Tokens  Types  TTR 
Text 01 (Anadin)  813  408  50.18 
Text02 (Vicks)  449  252  56.12 
Text 03 (Sinex)  355  205  57.74 
Text 04 (Lempsip)  1226  540  44.04 
Text 05 (Benylin)  1039  418  40.23 
Text 06 (Actifed)  666  313  46.99 
Text 07 (Strepsils)  900  379  42.11 
Table 4.1. Data comprising the number of tokens, types and the value of TTR in the English texts 
under investigation. 
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Furthermore, in Figure 4.2, the number of tokens, of types and the values of TTR are 
plotted on the diagram for comparison. 
 
Figure 4.2. The number of tokens and types in the texts and the value of the TTR. 
As  can  be  noticed  from  the  graph  in  Figure  4.2,  as  the  number  of  tokens 
increases from Text 03 to Text 04, the value of the TTR tends to decrease. In other 
words, the longer the text, the smaller the index tends to become
22.  
At this regard, Biber at al. (1999:53) state that in longer texts, there is a 
greater probability that words will be repeated. This seems to be true both for the 
most frequent words which recur in all kind of texts (i.e. function words: the, and, of, 
etc.) and of the words which are connected with the topic of a particular text (i.e., in 
patient information leaflets: doctor, medicine, pharmacist, product, effects, etc.) 
The  same  investigation  has  been  carried  out  considering  Italian  patient 
information leaflets. As their English equivalents, Italian texts under investigation 
                                                           
22 The same tendency was observed by Castello (2008:44) in the investigation of texts used for testing 
purposes.   
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(Appendix 7) vary considerably in terms of length: as can be seen from Table 4.3, 
their lengths range between 860 tokens (text 07) and 1666 tokens (text 01). 
 
Italian texts  Tokens  Types  TTR 
Text 01 (Cibalgina)  1666  714  42.85 
Text02 (Vicks)  1038  515  49.61 
Text 03 (Sinex)  985  573  58.17 
Text 04 (Tachifludec)  1295  616  47.56 
Text 05 (Actidue)  1340  667  49.77 
Text 06 (Actifed)  1281  661  51.60 
Text 07 (Benagol)  860  407  47.32 
 Table 4.3. Data comprising the number of tokens, types and the value of TTR in the English texts      
under investigation. 
 
The number of tokens, of types and the value of TTR are showed in Figure 4.4 
below. 
 
Figure 4.4. The number of tokens and types in the texts and the value of the TTR. 
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As is apparent from both Figure 4.2 and Figure 4.4 above, the value of TTR tends to 
decrease in both languages as the number of running words increases. This could 
mean that longer texts are characterized by a higher degree of repetitions. However, 
as has been said before, this index accounts for grammatical words too, which are 
obviously the most repeated words within a text. If we consider the list of words of 
both  English  and  Italian  texts,  we  can see  that  grammatical  words  are  the  most 
repeated. 
        
Table 4.5. The most recurrent words in the English and Italian corpora. 
 
4.3.2 Lexical density 
 
As previously suggested in section 4.3.1, one of the limits of the type/token 
ratio  is  the  fact  that  it  does  not  discriminate  between  grammatical/function  and 
lexical  words.  Therefore,  this  index  cannot  provide  precise  information  about  the 
lexical  density  of  a  given  text.  In  addition,  because  this  index  does  not  consider 
word-families,  it  can  neither  provide  information  about  the  frequency  of  lexical 
repetition nor about the degree of lexical variation. In order to obtain these kinds of 
information, we will make use of two methods which have been used by a large 
number  of  scholars  to  measure  lexical  density  and  lexical  variation  for  different 
purposes. 81 
 
Lexical  density  can  be  measured  in  various  ways.  According  to  Halliday 
(1987:60): 
lexical density is the proportion of lexical items (content words) to the total discourse. It 
can be measured in various ways: the ratio of lexical items either to the total running 
words or to some higher grammatical unit, most obviously the clause; with or without 
waiting for relative frequency (in the language) of the lexical items themselves. 
As  Castello  (2008:49)  points  out,  in  text-  and  corpus-based  linguistics  both 
types of lexical density measurement have been used in studies of different kinds of 
corpora. In particular, in 1971, Ure measured the lexical density of a 42,000-word 
corpus, calculating the index as a proportion of running words.  
However, one of the main problems to carry out lexical density analysis consists 
on the distinction between grammatical and lexical words. The problem is that there 
is  not  a  definite  distinction  between  these  two  categories  (Castello  2008:53).  In 
Halliday’s words, “grammar and lexis form a unified lexicogrammar system” (Halliday 
1989:63). At this regard, Halliday (1989:63) suggests that prepositions and certain 
classes of adverbs are on the borderline, and defines grammatical/function words as 
the words which function in closed systems in the language. He states: 
In  English,  [function  words  are]  determiners  [including  articles],  pronouns,  most 
prepositions, conjunctions, some classes of adverbs, and finite verbs. 
On the other hand, lexical words are defined as  content words which function in 
lexical sets, which are open systems (Halliday 1999:63). Moreover, he specifies that, 
differently from words in the usual sense, lexical words are items because they may 
consist of more than one word (Halliday 1999:63) (i.e., in patient information leaflets 
the terms beta blockers, non-steroidal anti-inflammatory drugs (NSAIDs), etc.). 
For the present study, in order to calculate the number of lexical words, two 
lists of grammatical words, one for English and one for Italian, were used. These lists 
were used as stop-lists with the software AntConc. Later, the following formula was 
used to calculate lexical density values: 
    
                       
                     
       
 82 
 
English texts  Tokens  Lexical words  LD 
Text 01  813  478  58.79 
Text 02  449  256  57.01 
Text 03  355  211  59.43 
Text 04  1226  718  58.56 
Text 05  1039  611  58.80 
Text 06  666  357  53.60 
Text 07  900  471  52.33 
Table 4.6. The number of tokens, lexical words and the values of LD in the English texts of the 
corpus. 
 
Italian texts  Tokens  Lexical words  LD 
Text 01  1666  943  56.60 
Text 02  1038  576  55.49 
Text 03  985  608  61.17 
Text 04  1295  738  56.98 
Text 05  1340  793  59.17 
Text 06  1281  740  57.76 
Text 07  860  450  52.32 
Table 4.7. The number of tokens, lexical words and the values of LD in the Italian texts of the 
corpus. 
 
  LD (English texts)  LD (Italian texts) 
Text 01  58.79  56.60 
Text 02  57.01  55.49 
Text 03  59.43  61.17 
Text 04  58.56  56.98 
Text 05  58.80  59.17 
Text 06  53.60  57.76 
Text 07  52.33  52.32 
Table 4.8. The values of LD in both English and Italian texts of the 
two corpora. 83 
 
The lexical density values of Italian and English texts were plotted on the following 
diagram for comparison. 
 
   Figure 4.9. The values of LD in both English and Italian texts of the considered corpora. 
 
As is apparent from Figure 4.9, texts 03 clearly stand out as the densest ones in both 
corpora, while texts 07 as the sparest ones. Lexical density values of English texts 
vary  between  52.33  and  59.43,  while  lexical  density  scores  of  Italian  texts  vary 
between 52.32 and 61.17. In addition, while text length may be seen as a possible 
element  which  influences  lexical  density  values  in  the  English  texts  under 
consideration (Te 07: 900 tokens; Te 03: 355 tokens), it does not seem to be the 
case for Italian texts (Te 07: 860 tokens; Te 03: 985 tokens). 
A linguistic feature that is bound to contribute to the high lexical density of 
these texts is the frequent use of complex noun groups containing pre- and post- 
modifying elements - such elements convey information that necessarily need to be 
expressed  in  patient  information  leaflets.  Moreover,  according  to  Halliday 
(2004:654),  written  language  is  characterized  by  being  lexically  dense,  since  “it 
packs  a  large  number  of  lexical  items  into  each  clause”.  The  concentration  of 
information within a nominal group makes the latter longer and more informative 
(Ventola 1995:181). In specialized discourse, this information packaging is usually 
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realized through the phenomenon of nominalization, when verbs are changed into 
nouns. According to Scarpa (2008:41): 
la  trasformazione  di  un  sintagma  verbale  in  uno  nominale  è  un  meccanismo  molto 
produttivo,  che  avviene  per  ragioni  stilistiche,  ma  anche  funzionali  in  quanto  serve  a 
impostare il discorso all’insegna della concisione e permette sia una ricchezza concettuale 
sia una sintassi sintetica e compatta. 
As far as English is concerned, the great use of nominalization can also be explained 
by the fact that it allows authors introducing the new information at the beginning of 
the  sentence,  thus  providing  greater  objectivity.  As  regards  Italian,  Balboni 
(2000:42)  highlights  the  translators’  tendency  to  maintain  the  nominal  style  of 
English language. Some examples of nominal groups and nominalizations taken from 
the two corpora under investigation are quoted below: 
-  disturbi cronici o ricorrenti dello stomaco o dell’intestino 
-  insufficienza renale epatica 
(examples of post-modification of the head noun); 
-  La somministrazione di inibitori della sintesi di prostaglandine ha mostrato…  
(example  where  the  verb  somministrare  has  been  turned  into  the  noun 
somministrazione); 
-  …assunzione di altri farmaci attivi sul fegato (example of nominalization of the verb 
assumere); 
-  …a previous history of asthma (pre- and post-modification of the head noun); 
-  …a temporary reddening of the skin (pre- and post-modification of the head noun); 
-  reduction in white blood cells (example of nominalization of the verb to reduce); 
-  stimulation  of  the  nervous  system  (example  of  nominalization  of  the  verb  to 
stimulate). 
 
According  to  patient  information  leaflets’  need  to  provide  all  of  the  necessary 
information,  noun  phrases  seem  to  be  a  valid  space-saving  linguistic  tool. 
Nevertheless, detailed information packed within noun phrases are not always simple 
to decode for non-expert people. As Scarpa (2008:43) suggests: 
dal momento che al sintagma nominale viene delegata la responsabilità di trasmettere 
gran  parte  dei  contenuti,  una  conseguenza  negativa  alla  densità  lessicale  è  una 
complessità semantica che può nuoncere alla chiarezza e alla facilità di comprensione del 
testo. 
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4.3.3 Lexical variation  
 
Lexical  variation  measurement  aims  at  quantifying  the  amount  of  lexical 
repetition or lexical diversity in a given text (Castello 2008:64). In lexical variation, 
the count is limited to lexical words, thus leaving out grammatical words which tend 
to be more frequent in occurrence. 
As  far  as  lexical  items  are  concerned,  Halliday  (1989:64)  states  that  “their 
repetition reduce the effect of density – since even if a word is intrinsically rare, its 
occurrence sets up the expectation that it will occur again”.  
In the present study, the formula that was used to quantify lexical variation 
(LV) is the following: 
    
                                 
                            
       
According to the formula above, a low value of lexical variation means that the 
text is characterized by a high number of repeated lexical items. On the contrary, if a 
given text shows a high value of this index, it means that the same lexical words 
were not often repeated (Castello 2008:64). 
English texts  Lexical words  Types  LV 
Text 01  478  317  66.31 
Text 02  256  187  73.04 
Text 03  211  157  74.40 
Text 04  718  424  59.05 
Text 05  611  332  54.33 
Text 06  357  237  66.38 
Text 07  471  269  57.11 
Table 4.10. The number of lexical words, types and the value of LD in the English texts of the 
corpus. 
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Italian texts  Lexical words  Types  LV 
Text 01  943  582  61.71 
Text 02  576  380  65.97 
Text 03  608  448  73.68 
Text 04  738  466  63.14 
Text 05  793  499  62.92 
Text 06  740  508  68.64 
Text 07  450  231  51.33 
Table 4.11. The number of lexical words, types and the value of LD in the Italian texts of the 
corpus. 
Furthermore,  as  pointed  out  by  Linnarud  (1975:50)  and  Gibson  (1993:164),  the 
length of a text plays an important role in determining the value of lexical variation. 
High values of LV are more likely to characterize a short rather than a long text. In 
order  to  see  if  LV’s  values  change  according  to  the  length  of  the  texts  under 
investigation, below, Table 4.12 and Table 4.13 show the number of tokens and the 
values of LV for each text. 
English texts  Tokens  LV 
Text 01  813  66.31 
Text 02  449  73.04 
Text 03  355  74.40 
Text 04  1226  59.05 
Text 05  1039  54.33 
Text 06  666  66.38 
Text 07  900  57.11 
Table 4.12. The number of tokens and the values of LV of the English texts under investigation. 
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Italian texts  Tokens  LV 
Text 01  1666  61.71 
Text 02  1038  65.97 
Text 03  985  73.68 
Text 04  1295  63.14 
Text 05  1340  62.92 
Text 06  1281  68.64 
Text 07  860  51.33 
Table 4.13 The number of tokens and the values of LV of the Italian texts under investigation. 
Below, the values of LV are plotted on the following diagrams for comparison. 
 
Figure 4.14. The number of token and the values of LV of the English texts. 
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Figure 4.15. The number of token and the values of LV of the Italian texts. 
As can be seen from Figure 4.14  and Figure 4.15, in English patient information 
leaflets  the  values  of  lexical  variation  tend  to  decrease  as  the  number  of  tokens 
increases  (Te  03:  355  tokens,  74,40  LV;  Te  04:1226  tokens,  59,05  LV).  On  the 
contrary, in the Italian texts under investigation, the values of lexical variation do not 
seem to decrease as texts become longer (Te 07: 860 tokens, 51,33 LV; Te 01: 1666 
tokens, 61,71 LV). 
Nevertheless, the analysis shows that all patient information leaflets score quite 
high values of lexical variation. These values may be explained by the fact that the 
language  of  pharmacology  uses  different  specialized  terms  to  refer  to  diseases, 
cures, medications’ effects and ingredients. In effect, the lexis which is used in this 
kind  of  texts  consists  of  various  words,  which  belong  to  general  language,  other 
terms which belong to the language of pharmacology, and other terms which belong 
to different specialized languages, such as the language of chemistry, biochemistry, 
and medicine.  
As far as terms deriving from chemistry are concerned, we can see that, in 
patient  information  leaflets,  the  majority  of  these  terms  are  found  in  the  section 
What it is, wherein the medicinal product’s active ingredients and other substances 
are listed. As can be seen from the table below (Table 4.16), while enzymes are 
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named  in  the same way  in  both  bio-chemical  and  pharmaceutical  languages,  the 
name of substances differs according to the field of use. Table 4.16 shows that, in 
chemistry, the IUPAC nomenclature is usually used to refer to substances; while, in 
pharmaceutical language, the names of active ingredients are the international non-
proprietary names (INN) recommended by the World Health Organisation. 
 
Lexical items which derive from chemistry 
 
CHEMICAL LANGUAGE  PHARMACEUTICAL LANGUAGE 
-IUPAC nomenclature
23  -Active Pharmaceutical Ingredients’ generic, 
non-proprietary name
24. 
 
(R)-3-[-1hydroxy-2-
(methylamino)ethyl]phenol 
Phenylephrine 
2-acetoxybenzoic acid  Aspirin/Acetylsalicylic acid 
N-(4-hydroxyphenyl)acetamine  Paracetamol 
(S,S)-2-methylamino-1-phenylpropan-1-ol  Pseudoephedrine 
2-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-yl-
prop-1-enyl]pyridine 
Triprolidine 
2-(diphenylmethoxy)-N,N-
dimethylethanamine 
Diphenhydramine 
Biochemical terminology: 
Glucose-6-phosphate dehydrogenase 
L-Monoamine oxidases 
Prostaglandin-endoperoxide synthase/Cyclooxygenease (COX) 
Fructose-bisphosphate aldolase 
Table 4.16. Non-proprietary names of active ingredients found in the corpora, their chemical 
denomination,  and  other  terms  found  in  the  corpora  which  belong  to  the  language  of 
biochemistry.  
                                                           
23 The most used chemical nomenclature is the one created by the International Union of Pure and 
Applied Chemistry (IUPAC). The primary function of chemical nomenclature is to ensure that a spoken 
or  written  chemical  name  leaves  no  ambiguity  concerning  to  what  chemical  compound  the  name 
refers. Each chemical name should refer to a single substance and its structure. 
24  For  the  past  fifty  years,  it  has  been  the  task  of  the  World  Health  Organization  to  assign 
International Non-proprietary Names (INN) to pharmaceutical substances. Over this period, various 
policies have been adopted by the INN Programme. According to the European Medicines Agency 
(EMeA), the name of the medicinal product “may be either an invented name not liable to confusion 
with the common name, or a common name or scientific name accompanied by a trade mark or the 
name of the marketing authorisation holder” (Article 1(20) of Directive 2001/83/EC). A common name 
is “the international non-proprietary name (INN) recommended by the World Health Organisation” 
(Article 1(21) of Directive 2001/83/EC). 
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As said above, the lexis of patient information leaflets also consists of medical 
terms which refer to diseases or illnesses. In this respect, an important aspect has to 
be taken into account. While some terms - those underlined in Table 4.17 below - 
can be easily understood  by most of  patients (though  people may not know  the 
terms’  exact  meaning),  other  terms  sound  awkward  to  most  of  people  (even  to 
highly educated people which are not experts in the field of medicine). According to 
Serianni  (2005:122),  this  fact  can  be  explained  by  the  terms’  frequency  of 
occurrence. For example, terms such as hypersensitivity, diabetes, sinusitis, asthma, 
diarrhea,  lumbago  are  usually  known  by  a  greater  number  of  ordinary  people 
because  these  terms  are  also  used  by  general  practioners  while  talking  to  their 
patients  about  diagnoses,  symptoms,  etc.  Similarly,  ordinary  people  may  also 
understand specialized terms which designate diagnostic tests, such as CAT, even 
though they may know neither the acronym’s expansion (in this case computerized 
axial tomography) nor the proper definition of the specialized term. Table 4.17 shows 
some examples of medical terms found in the corpus used for this study. 
Lexical terms which belong to the language of medicine 
      MEDICAL LANGUAGE                  PHARMACEUTICAL LANGUAGE 
Haemofilia; peptic ulcer; diarrhoea; Reye’s syndrome; history of asthma; agranulocytosis; 
sinusitis; hypertension; Raynaud’s syndrome; diabetes mellitus; history of pre-eclampsia; 
glaucoma; phenylketonuria; thrombocytopenia; hypersensitivity/hypersensitive; lumbago; 
neuralgia; epilepsy. 
Table 4.17 Medical terms found in the English corpus. 
 
Considering  now  the  ‘language  of  pharmacy’,  in  the  corpora,  we  find  terms 
which  belong  to  pharmacology  -  that  is  the  study  of  the  preparation,  properties, 
uses, and actions of drugs - and terms which belong to pharmacokinetics - that is a 
branch of pharmacology that describes how the body affects a specific drug after 
administration and the chemical changes of the substance in the body).   
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Pharmacological terms 
 
-Pharmaceutical terms which classify medicinal products according to their 
therapeutic effects (in both corpora): 
 
Analgesics; Antidepressants (anti-MAO); Anti-coagulants; Anti-inflammatory drugs (i.e. 
NSAIDs); Antipyretics; Antistamines; Appetite suppressants; Barbiturates; Contraceptives; 
Corticosteroids; Decongestants; Sedatives; Stimulants. 
 
-Other terms which belong to pharmacology (in both corpora): 
 
Excipients, active ingredients, decongestionants, vasodilators, vasoconstrictors, 
sympathomimetics, inhibitors (i.e. monoamine oxidase inhibitor (MAOI), beta-blockers. 
 
-One term which belong to pharmacokinetics (in the Italian corpus): 
 
Emivita (half-life): The period of time required for the concentration or amount of drug in 
the body to be reduced to exactly one-half of a given concentration or amount. 
 
     Table 4.18. Terms which belong to the language of pharmacology and pharmacokinetics.  
 
 4.3.4 Specialized terms and LSP collocations 
 
According to Serianni (2005:127), specialized languages do not only consist of 
specialized  terms  (what  he  calls  tecnicismi  specifici),  but  also  of  other  particular 
words (names, adjectives, verbs and phrases) which are used to maintain a high 
register. 
 The language of medicine, he says (2005:128), cannot only use specialized 
terms such as deltoid or granuloma. In order to connect the various parts of medical 
discourse, other words are needed. Although these particular words have a lower 
rate of technicalness in comparison with specialized terms, they characterize medical 
language to the same extent as specialized terms do. In addition, they generally 
sound unusual to ordinary people. These words are called by Serianni (2005:128) 
tecnicismi collaterali.  
An important aspect of these ‘specialized words’ (LSP collocations) is that they 
can  be  substituted  by  other  words  which  belong  to  general  language  without 
affecting  the  exactitude  of  the  scientific  information  that  is  being  conveyed.  For 
instance, a doctor can convey the same message by saying the disease began with a 92 
 
rise in body temperature, or, by using general language, the disease began with high 
body temperature. Similarly, when a patient says that he feels a bad headache, the 
doctor may translate it into the patient complained of acute headache. 
Furthermore, Serianni (2005:129) suggests that, while specialized terms may 
also be known or used by laypeople, the use of LSP collocations is limited to experts 
in  the  field.  In  addition,  differently  from  specialized  terms  which  refer  to  one 
determined specialized language, these tecnicismi collaterali can be used in different 
specialist fields. For instance, in Italian, the prepositional phrase ‘a carico di’ can be 
found  in  both  medical  and  judicial  languages  (i.e.  danni  a  carico  dell’apparato 
respiratorio; processo a carico di qualcuno). According to Serianni (2005:128): 
Una lingua speciale è fatta anche di vocaboli altrettanto caratteristici di un certo ambito 
settoriale,  che  però  sono  legati  non  a  effettive  necessità  comunicative  bensì 
all’opportunità di adoperare un registro elevato, distinto dal linguaggio comune. 
In the corpora under investigation, several occurrences of LSP collocations have 
been found: 
- in the Italian corpus, it is frequent to find the noun assunzione or the verb 
assumere  followed  by  medicinal  product/medicine  instead  of  the  verb  prendere, 
while, in English, we always find the verb to take (appendix 9-concordance results 
1); 
- in the English corpus, we find the verb to treat followed by symptoms and 
diseases,  while,  in  Italian,  we  find  the  nominalized  form  trattamento  followed  by 
symptoms (appendix 9-concordance results 2); 
- in the Italian corpus, we find the noun  insufficienza followed by relational 
adjectives like renale or epatica. No occurrences of the noun insufficiency have been 
found in the English corpus (appendix 9-concordance results 3); 
-  in Italian we find the nominalized form of the verb comparire (comparsa) 
followed  by  side  effects  or  symptoms;  while,  in  English,  we  find  the  verb  to 
experience followed by symptoms or side effects (appendix 9-concordance results 4); 93 
 
- in English, we find some occurrences of the noun inhibitor, while, in Italian, 
we  find  both  the  noun  inibitore  and  the  nominalized  form  of  the  verb  inibire 
(inibizione) (appendix 9-concordance results 5); 
-  in  English,  we  find  the  verb  to  develop  followed  by  symptoms,  while,  in 
Italian, we have just one occurrence of the verb evolvere followed by the symptom 
(appendix 9-concordance results 6). 
The comparison between English and Italian texts also shows that the language 
used in English patient information leaflets under investigation is much more direct 
and simpler to understand than Italian language. This fact can firstly be explained by 
the tendency of Italian language to recur to medical terms, while English uses more 
familiar terms which belong to general language, for example: 
-  You are allergic to paracetamol; 
-   Ipersensibilità verso i componenti; 
-  You have high blood pressure; 
-  In caso di ipertensione; 
-  Irregular or fast heartbeats; 
-  Tachicardia. 
Secondly, English tends to use more common hypernyms to refer to diseases, 
like  the  words  problem,  constraint,  disorder,  while  Italian  uses  more  specific 
hyponyms, as in the examples below: 
-  Kidney disorders/problems (all types of problem which may affect kidneys); 
-  Insufficienza  renale  (renal  failure:  a  medical  condition  in  which  the  kidneys fail  to 
adequately remove waste products and fluids from the blood). 
Thirdly,  Italian  texts  show  a  higher  degree  of  nominalization,  as  is 
demonstrated by the following examples: 
-  If you have taken more tablets than you should; 
 In caso di ingestione/assunzione; 
-  Vicks  VapoRub  is  used  to  relieve  nasal  catarrh  and  congestion,  sore  throat  and 
coughs due to colds; 
Vicks  VapRub  si  usa  per  il  trattamento  balsamico  nelle  affezioni  delle  prime  vie 
respiratorie; 
-  I you experience any hypersensitivity to this product stop taking this medicine; 94 
 
In caso di comparsa di fenomeni di sensibilizzazione o irritativi occorre interrompere 
l’assunzione del farmaco. 
 
Beyond  the  lexical  level,  some  differences  can  also  be  found  by  looking  at 
syntactic structures. Italian texts tend to use a number of prepositional phrases that 
do not occur in the English texts under investigation. Some examples are provided 
below: 
 
-  ‘A carico di/del’ followed by the name of the affected anatomic zone  
(i.e. malattie a carico dello stomaco); 
-   ‘A livello di’ followed by the name of the affected anatomic zone or by 
an equivalent relational adjective (i.e. a livello dello stomaco, a livello 
oculare); 
-  ‘In  presenza  di’  meaning  ‘with’  (i.e.  in  presenza  di  terapie 
concomitanti); 
-  ‘In  assenza  di’  meaning  ‘without’  (i.e.  in  assenza  di  risposta 
terapeutica). 
As can be seen from the examples above, Italian language often recurs to specialized 
terms, nominalizations and prepositional phrases. Therefore, Italian language tends 
to use a more formal register than English, using lexical and syntactic devices which 
increase sentences’ length and texts’ degree of complexity. 
This  tendency  collides  with  the  need  for  simplicity  and  concision  of  patient 
information leaflets. Specialized medical terms are difficult to understand, and if they 
are not followed by an explanation written in general language, they may lead to 
misunderstandings.  However,  the  presence  of  both  the  specialized  term  and  its 
explanation will result in an increase of sentence length. This problem may be solved 
with the use of more general words as is done in English texts. Moreover, since 
simple prepositions can convey the same meaning as prepositional phrases, the latter 
could be avoided for the sake of concision.  
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4.3.5 Readability of patient information leaflets 
 
Readability is what makes some texts easier to read than others. (DuBay 2004:2) 
The problem of readability is under investigation since 1920s, when educators 
discovered  a  way  to  use  vocabulary  difficulty  and  sentence  length  to  predict  the 
difficulty level of a text. They embedded this method in several readability formulas, 
and  they  deeply  investigate  the  concept  of  readability.  Writers  like  Rudolf  Flesh, 
George Klare, Edgar Dale, and Jeanne Chall brought the formulas and the research 
supporting them to the marketplace (DuBay 2004:2). The formulas were widely used 
in journalism, research, health care and other fields. By the 1980s, there were 200 
formulas and over a thousand studies published on the readability formulas attesting 
to their strong theoretical and statistical validity (DuBay 2004:2).  
The primary aim of such formulae is to measure the grade level a person must 
have to read and comprehend a given text. Readability formulas work by measuring 
certain features of a text based on mathematical calculations.  
For the present study, three readability indexes were made used of: the Flesh 
Reading  Ease  (FRE)  and  the  Flesch-Kinkaid  Grade  Level  (FKGL)  were  used  to 
measure  readability  of  the  English  texts  under  investigation,  while  the  Gulpease 
index was used to measure readability of the Italian texts considered for this study. 
The Flesch Reading Ease (FRE) index was devised by Rudolf Flesch and is the 
most widely used formula outside of educational circles. It measures reading from 
100 (extremely easy) to 0 (very difficult to read). Flesch has identified 60 as the 
minimum score for Plain English. The formula for the Flesch Reading Ease (FRE) test 
is: 
               
           
               
       
              
           
  
 
The Flesch-kinkaid Grade Level (FKGL) formula converts the 0-100 score into a 
U.S. grade level. The grade level is calculated with the following formula: 
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For  the  present  study,  the  Flesch  Reading  Ease  readability  scores  and  the 
Flesch-kinkaid  Grade  Level  for  each  text  of  the  English  corpus  were  obtained 
automatically from Microsoft Word. Below, Table 4.19 shows the results: 
English texts  FRE  FKGL  School levels 
Text 01  44.8  10.2  13
th and 14
th grade 
Text 02  55.6  8.4  10
th and 12
th grade 
Text 03  53.7  8.6  10
th and 12
th grade 
Text 04  49.1  9.5  13
th and 14
th grade 
Text 05  43.2  10.6  13
th and 14
th grade 
Text 06  45.4  10.5  13
th and 14
th grade 
Text 07  48.2  9.8  13
th and 14
th grade 
All texts  47.5  9.9  13
th and 14
th grade 
 Table 4.19 FRE scores, FKGLs and U.S. grade levels (as specified by Flesh 1948:149). 
 
As can be seen, the Flesch Reading Ease readability scores gave an average score of 
48.45 (minimum value = 43.2; maximum value = 53.7). The Flesch-kinkaid Grade 
Levels reveal an average score of 9.5 (minimum value = 8.4; maximum value = 
10.6).  According  to  these  data,  the  English  patient  information  leaflets  under 
investigation are expected to be understandable by high school students (13
th and 
14
th  grade,  which  correspond  to  4
th-year-students  in  European  high  schools). 
Therefore, as specified by Flesch (1948:149), they style is fairly difficult. 
In  order  to  measure  readability  of  the  Italian  texts  under  investigation,  the 
Gulpease index was used.  
The Gulpease index was devised by the GULP (Gruppo Universitario Linguistico 
Pedagogico) of the University of Rome. It is a widely used readability formula for the 
Italian  language.  Differently  from  the  FRE  index,  that  calculates  word  length  in 
number of syllables, the Gulpease index measures word length in number of letters. 
The Gulpease index is calculated with the following formula: 97 
 
    
                                                       
               
 
The value of such index may vary from 0 (hardest to read) to 100 (easiest to 
read). The score may be translated into school grades: a minimum value of 80, for 
example,  indicates  that  the  text  proves  to  be  comprehensible  for  users  with  an 
elementary school level of education, 60 for Italian secondary school students (aged 
from 10 to 13), and 40 for Italian high school students (Lucisano and Piemontese 
1988:110-124). 
For the present study, the Gulpease readability index scores for each text of the 
Italian corpus were obtained automatically from Microsoft Word. Below, Table 4.20 
shows the results: 
Italian texts  Gulpease scores 
Text 01  48 
Text 02  57 
Text 03  49 
Text 04  49 
Text 05  47 
Text 06  49 
Text 07  53 
All texts  50 
Table 4.20. Gulpease scores for each text. 
As  can  be  seen,  the  Gulpease  readability  scores  gave  an  average  score  of  52 
(minimum value = 47; maximum value = 57). Therefore, Italian patient information 
leaflets have a medium difficulty level. 
In order to compare English and Italian texts’ readability values, another corpus 
was  created.  The  latter  consists  of  the  mostly  read  sections  of  the  texts  under 
investigation.  These  sections  are:  what  the  medicine  is  for;  before  taking  the 
medicine; how to take the medicine; possible side effects. The Flesch Reading Ease 
and the Gulpease readability scores (respectively 50.6 and 49) indicate that both 98 
 
Italian and English texts are expected to be comprehensible for users with a high 
school educational level. 
These data reveal a problem. Patient information leaflets should be informative texts 
intended for all types of patients. Instead, they are not accessible to patients with 
poor literary skills and with low educational level. This can be a relevant problem, for 
example, for elderly people. Usually, they do not have a high educational level, and 
they are not able to use technological tools. Therefore, their only available sources to 
gain information about treatments and drugs are: doctors, pharmacists and patient 
information leaflets. 
4.3.6 Keyness 
 
Lexical items enjoy equal status in the lexicon of a given language, but their importance 
varies from the point of view of text (Bondi 2010:1). 
Each particular word form contributes to the construction of meaning in text. 
However, only some words, the so-called keywords, play a relevant role in identifying 
important elements of the texts. Thus, keywords are often defined as markers of the 
‘aboutness’ and style of a text (Scott and Tribble 2006:59-60). 
The  study  of  keywords  has  become  central  in  corpus  linguistics,  especially 
through the development of techniques for the analysis of the meaning of words in 
context (Bondi 2010:3). In a quantitative perspective, according to Scott and Tribble 
(2006:62): 
keywords are those whose frequency in a text is statistically significant, when compared 
to the standards set by a reference corpus. 
In order to measure keyness of words in a given text or corpus, the absolute 
frequency of words (tokens) and their relative frequency in the source text(s) are 
calculated and, then, compared with those of a reference corpus by means of log 
likelihood  statistics  using  AntConc  software.  These  tests  allow  us  to  compare  the 
frequencies we found with those of a reference corpus considered as standard in the 
domain, i.e. sources of health-related information. 
Words  that  are  more  frequent  than  in  the  reference  corpus  have  positive 
keyness values, while words that are less frequent have negative keyness values. 99 
 
According to Musacchio and Palumbo (2009:225), the words that usually turn out to 
be  key  are  proper  nouns,  words  suggesting  what  the  text  is  about,  and  high 
frequency words that are more indicative of style. 
For the present study, two reference corpora were created, one consisting of 
English  newspaper  articles  (articles  taken  from  The  Guardian),  and  the  other 
consisting  of  Italian  newspaper  articles  (articles  taken  from  La  Stampa).  All  the 
articles taken from the two newspapers talk about illnesses, treatments and drugs. 
Consequently, the analysis of keyness was carried out by using AntConc software.  
Firstly, a wordlist of lexical words - for both Italian and English texts - was made by 
using two stop-lists of Italian and English function words. 
 
Table 4.21. The Italian and English lexical word lists in the patient information leaflets corpora under 
investigation. 
Then, the keyword lists of lexical words were obtained by means of log likelihood 
statistics for Italian: 100 
 
 
                         Table 4.22. List of keywords in the Italian corpus. 
and then for English. As shown by the data in Table 4.22 above and Table 4.23 
below, most keywords are also the most frequent lexical words in the corpora. We 
can  see  that  words  such  us,  medicinale,  effetti  indesiderati,  pastiglie,  foglio 
illustrativo, uso, usare, prodotto, dosi, trattamento, suggest the topic of the texts. 
Similarly, in English, words such as tablets, medicine, product, leaflets, side effects, 
symptoms, use, ingredients, give an idea of what the texts are about. Among these 
keywords, we can see that, in Italian, the adjective indesiderati has a higher value of 
keyness in comparison with the keyness value of its noun head effetti. The opposite 
case is shown in English, where the head noun effects has a higher value of keyness 
in comparison with its pre-modifier adjective side. 
Moreover,  in  both  corpora,  words  like  doctor,  pharmacist,  ask/consultare 
appear to be keywords. This is probably due to the fact that all patient information 
leaflets  contain  numerous  phrases  which  invite  patients  to  see  a  doctor  or  a 
pharmacist in case of doubt or of side effects. In this respect, we also find in the 101 
 
English  corpus  the  keyword  please,  which  generally  precedes  these 
recommendations. 
 
                        Table 4.23. List of keywords in the English corpus. 
Another element which is worth highlighting is the presence of the ingredient 
paracetamol in both keyword lists. This word is certainly a keyword in these texts 
because almost all of the drugs under investigation contain paracetamol as active 
ingredient, which acts by relieving from the symptoms of flu and colds. Therefore, it 
gives an idea about the kind of drugs we are talking about. 
Furthermore, we can see that, in the Italian texts, the unit of weight mg is a 
keyword,  while  in  English  it  does  not  appear  in  the  keyword  list.  This  can  be 
explained by the fact that in English patient information leaflets different units of 
weight are used. We find mg, w/w, ml and w/v according to the kind of drugs we are 
referring to: mg unit is used with tablets; weight/ weight unit is used with creams 
and  weight/volume  or  ml  units  are  used  with  sprays.  In  Italian,  the  quantity  of 
ingredients is generally measured in mg (at least in the patient information leaflets 
considered for the present study). 102 
 
As  has  been  shown  above,  an  analysis  of  keyword  lists  can  provide  useful 
insights to understand to what extent and why some words function as keywords 
within a carefully selected group of texts. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 103 
 
Conclusions 
 
This study has investigated communication between experts and non-experts in 
medical  settings.  In  Chapter  three,  doctor-patient  interactions  were  taken  into 
account in order to see the difficulties patients may encounter while talking with 
general practioners about their health conditions. Despite the asymmetry - in terms 
of different educational background knowledge - which characterizes doctor-patient 
relationships, their interactions can be defined as successful communicative events. 
Since spoken discourse takes place in real time, both patients and doctors can have a 
direct feedback from their interlocutors. Therefore, in case of misunderstanding or 
doubt, patients always have the chance to interrupt their doctors to ask for further 
explanations.  Conversely,  doctors  can  always  adjust  their  talk  according  to  their 
patients’ answers. Nevertheless, physicians need to keep in mind that patients may 
not comprehend all the medical terms they use, thus they should always check their 
patients’ understanding. On the other hand, patients should not feel embarrassed to 
ask questions or explanations to their physicians – after all, they are talking about 
their own health.  
The advantages of real-time interactions help me to raise another important 
point concerning the use of the Internet. Beyond providing broader, speedier access 
to information, the Web is profoundly changing communication between doctors and 
patients.  However,  though  many  patients  -  especially  young  people  -  use  the 
Internet to find health-related information, they generally are not equipped to access 
and understand high-quality medical information without the mediation of an expert 
in the field. Moreover, since most e-patients start their search with a general search 
engine and they do not usually verify the validity of the sources, the use of online 
information  may  reveal  itself  dangerous  and  may  be  the  cause  of  additional 
misunderstandings. In addition, as far as Internet-based services - such as Ask the 
Doctor Services - are concerned, we can state that exchanging e-mails with patients 
is quite different from speaking with a patient face-to-face: replies may be delayed, 
sentences  may  be  more  stilted  and  the  tone  of  voice  is  absent.  Therefore,  both 
doctors and patients must consider carefully what they say, how they say it and how 
to interpret information. Furthermore, it is impossible to judge the effect on patients 104 
 
of information transmitted through cyberspace: doctors who do not have a direct 
feedback from their patients cannot check their patients’ understanding and cannot 
adjust their talk according to their patients’ non-verbal expressions. As a result, in 
my opinion, the Internet has to be used in a careful manner and patients should see 
their  general  practioners  as  consultants  even  in  case  of  online  health-related 
information.  Physicians  are  in  the  best  position  to  weight  information  and  advise 
patients,  drawing  on  their  understanding  of  available  evidence  as  well  as  their 
training and experience. On the other hand, since the Web is not going to disappear, 
physicians should figure out the best use of this technology in the interests of their 
patients  and  themselves,  for  example,  by  proving  useful  online  references  in 
accordance with their patients’ needs. 
As far as written discourse is concerned, this study has investigated the text-
inherent complexity and the receiver-oriented difficulty of two corpora of fourteen 
patient information leaflets of over-the-counter drugs. To this end, quantitative and 
qualitative  research  was  carried  out  on  the  texts.  In  Chapter  4,  seven  formulas 
allowed for an objective measurement of various aspects of the complexity of the 
texts under investigation. Although each measurement captured a specific aspect of 
the texts’ complexity, all scores – namely, the number of lexical words in the texts, 
the high values of lexical variation and the readability scores - demonstrate that the 
language used in patient information leaflets is quite difficult to understand. These 
results collide with the purpose of these texts which are thought to be informative 
texts for all types of patients. The language used in these texts seems not to be 
accessible  for  patients  with  poor  literacy  skills  and  low  educational  levels,  thus 
increasing the need to recur to a third interlocutor such as a doctor or a pharmacist. 
In this respect, even though in the websites of many pharmaceutical companies it is 
possible to find a section where the language used in patient information leaflets is 
explained, we should remember that not all patients can access online information, 
and that for some patients, especially the elderly, patient information leaflets remain 
the primary available source of information. 
For  what  concerns  differences  between  Italian  and  English  texts,  I  tried  to 
demonstrate that the Italian texts are less accessible than their English equivalents. 105 
 
 The  Italian  tendency  to  use  a  formal  register  results  in  a  higher  use  of 
specialized  terms,  nominalizations  and  prepositional  phrases  which  increase  the 
difficulty of the texts under investigation. Probably, the use of a more direct and 
simpler  language  could  facilitate  patients’  understanding.  Therefore,  patient 
information leaflets can be defined as informative texts for all types of readers. 
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APPENDIX 1: Articles for Italian general practioners 
Allergia all'uovo non impedisce vaccino antinfluenzale 
Il vaccino trivalente contro l'influenza stagionale può essere somministrato con sicurezza anche nei 
bambini con una grave allergia alle proteine dell'uovo 
Il vaccino trivalente contro l'influenza stagionale può essere somministrato con sicurezza anche nei 
bambini con una grave allergia alle proteine dell'uovo. Ogni anno l'influenza stagionale è causa, negli 
Stati Uniti, di circa 300mila ricoveri di cui 21mila riguardano bambini sotto i 5 anni. La vaccinazione 
potrebbe  azzerare  il  ricorso  all'ospedale  per  complicanze,  la  maggior  parte  delle  quali  interessa 
bambini con asma, patologia che frequentemente si associa all'allergia grave all'uovo (diffusa a sua 
volta nell'1,5% della popolazione infantile). Lo studio multicentrico pubblicato da Annals of allergy, 
asthma and immunology, è stato condotto daMatthew Greenhawt, dell'Università del  Michigan, e si 
è svolto in due fasi tra ottobre 2010 e marzo 2012. Sono statu inclusi i bambini che avevano avuto 
una grave reazione allergica, comprese le crisi anafilattiche, a seguito dell'ingestione di uova,  con 
test cutaneo positivo o ancora con titolo anticorpale IgE specifico per l'uovo elevato. La prima fase è 
consistita in uno studio randomizzato, prospettico, in doppio cieco, in cui a un gruppo di bambini 
(gruppo A) è stata somministrata una prima dose di 0,1 mL di vaccino antinfluenzale, seguito 30 
minuti dopo, in assenza di reazione, dal resto della dose.  Il secondo gruppo di bambini (gruppo B) ha 
ricevuto una prima dose iniziale di salina e 30 minuti dopo il 100% della dose stabilita in base all'età. 
A questo protocollo si sommava uno studio retrospettivo su bambini eleggibili che avevano ricevuto 
una  dose  intera  o  frazionata  di  vaccino  ma  che  avevano  rifiutato  di  partecipare  allo  studio 
randomizzato e controllato. Su 31 partecipanti allo studio controllato della fase 1 (14 appartenenti al 
gruppo A e 17 al gruppo B), e i 112 della fase 2, valutati retrospettivamente (87 con la dose singola e 
25 con la dose split), nessuno ha sviluppato una reazione allergica in seguito alla somministrazione 
del vaccino trivalente, sebbene il 45,1% dei bambini arruolati nella fase 1, e il 77,6% dei bambini della 
fase 2, avessero avuto una storia di anafilassi dopo ingestione di uova. «Questo studio dimostra che il 
vaccino  è  ben  tollerato  anche  nei  bambini  con  grave  allergia  all'uovo  e  precedenti  reazioni 
anafilattiche» spiegano gli autori. «Inoltre è ben tollerata anche la somministrazione con singola. Non 
è quindi necessaria né la somministrazione in due step né il test curaneo». La sola precauzione 
necessaria, conclude lo studio, è che i bambini con questo tipo di allergia vengano monitorati per 30 
minuti da un medico, dopo aver ricevuto la dose, in modo da poter intervenire tempestivamente nel 
caso si manifestasse una reazione allergica, una pratica che in Italia viene attuata di prassi in tutti i 
bambini. 
Rianimare per più di 20 minuti può salvare un bambino 
L’inutilit￠ della rianimazione cardiopolmonare (Rcp) protratta per più di venti minuti nei pazienti 
pediatrici ￨ stata recentemente confutata da uno studio condotto da Renee I. Matos dell’Universit￠ 
di Pittsburgh. La ricerca, pubblicata su Circulation, ha stabilito la relazione tra durata delle manovre 
di Rcp in caso di arresto verificatosi in ospedale e gli effetti sia sulla sopravvivenza dei pazienti sia 
sugli eventuali esiti neurologici. Lo studio ha preso in considerazione i casi di arresto cardiaco in 
ambiente  ospedaliero  censiti  dal  registro  multicentrico  Get  With  The  Guidelines—Resuscitation, 
l'unico database esistente che segnala tutti gli arresti cardiaci e gli esiti delle rianimazioni. Nell’analisi 
sono  stati  inclusi  3.419  bambini  con  arresto  cardiaco  avvenuto  in  ospedale  tra  gennaio  2000  e 118 
 
dicembre 2009, selezionati da 328 strutture ospedaliere di Stati Uniti e Canada. I pazienti sono stati 
suddivisi  per  reparto  di  ricovero:  chirurgia  cardiaca,  cardiologia,  medicina  generale,  chirurgia 
generale e traumatologia. Le comorbidità più frequenti sono state insufficienza respiratoria per il 
59,1%  dei  pazienti  e  ipotensione  per  il  39,9%. Tra  i  pazienti  ricoverati  in  cardiologia e chirurgia 
cardiaca, il 29,6% ha avuto un'aritmia. Gli arresti si sono verificati per il 66,8% nelle unità di terapia 
intensiva, seguite dal pronto soccorso per il 14,4%, dal reparto ospedaliero (10%) e infine dalla sala 
operatoria (6,2%). In 2.178 pazienti, pari al 64% del campione, si è avuto un ritorno spontaneo del 
circolo dopo più di 20 minuti di massaggio cardiaco. Erano vivi a 24 ore dall'evento 1.373 pazienti 
(40%); 954 (27,9%) sono sopravvissuti fino alle dimissioni e infine 651, pari al 68,2 per cento dei 
sopravvissuti (19% rispetto al totale), hanno dimostrato una buona ripresa neurologica. In caso di Rcp 
praticata per un tempo compreso tra 1 e 15 minuti, la sopravvivenza diminuisce linearmente del 
2,1%  ogni  minuto,  e  il  tasso  di  esiti  neurologici  favorevoli  diminuisce  dell’1,2%  al  minuto.  La 
probabilità di sopravvivenza in caso di Rcp da 1 a 15 minuti è pari al 41%, mentre per tempi superiori 
ai 35 minuti si attesta sul 12%. Tra i sopravvissuti, l’esito neurologico favorevole ￨ presente nel 70% 
dei pazienti che hanno subìto una Rcp inferiore a 15 minuti, e nel 60% in caso di Rcp superiore ai 35 
minuti. La durata della rianimazione cardiopolmonare è quindi indipendentemente associata alla 
probabilit￠ di sopravvivenza e all’esito neurologico favorevole. Protrarre le manovre di rianimazione 
per un periodo superiore ai 20 minuti non è quindi inutile nei bambini. Non va dimenticato che 
durate più brevi, pari a 10 minuti, sono comunque associate a migliori tassi di sopravvivenza globali: 
le probabilità di sopravvivenza e i recuperi neurologici diminuiscono con il trascorrere del tempo, e 
per  questo  rimane  salda  la  necessità  di  intervenire  tempestivamente.  «Questo  studio  sfata  i 
preconcetti  secondo  i  quali  la  Rcp  è  inutile  oltre  i  20  minuti.  Il  tasso  di  danni  neurologici  è 
sufficientemente contenuto da permettere di prendere in considerazione anche una manovra  di 
durata prolungata» afferma lo studio. «Gli operatori sanitari dovranno prendere in considerazione 
questi dati in caso di arresto nei bambini, al fine di salvare più vite». 
Gli antidepressivi hanno un effetto modesto sul Qt 
Alcuni antidepressivi appartenenti alla classe degli inibitori selettivi del reuptake della serotonina 
(Ssri) possono dare luogo a un modesto prolungamento all'Ecg dell’intervallo Qt 
Alcuni antidepressivi appartenenti alla classe degli inibitori selettivi del reuptake della serotonina 
(Ssri) possono dare luogo a un modesto prolungamento all'Ecg dell’intervallo Qt, fattore di rischio per 
l’aritmia ventricolare, secondo quanto ￨ emerso da uno studio americano teso a esplorare questo 
legame. In particolare l’analisi riguarda il citalopram e altri antidepressivi dal profilo farmacologico 
simile. Lo studio osservazionale trasversale, condotto da Victor M Castro e pubblicato su British 
medical  journal,  ha  utilizzato  i  dati  registrati  nelle  cartelle  cliniche  elettroniche,  le  prescrizioni 
mediche e i risultati dell’elettrocardiogramma, per analizzare la relazione tra uso di antidepressivi, la 
loro dose e l'intervallo QT. Il metadone, noto per la sua capacità di aumentare il Qt, è stato utilizzato 
come controllo per dimostrare la sensibilità della valutazione. I 38.397 partecipanti sono stati seguiti 
con elettrocardiogrammi effettuati dopo la prescrizione di antidepressivi o metadone, in un periodo 
compreso  tra  febbraio  1990  e  agosto  2011.  Sono  state  prese  in  considerazione  anche  le 
caratteristiche cliniche e sociodemografiche note per influenzare l'intervallo Qt, come età, sesso, 
etnia, storia clinica della depressione, eventuali episodi pregressi di infarto del miocardio o di aritmia 
ventricolare, ipertensione, iperlipidemia e comorbidit￠. L’associazione tra un prolungamento del Qt e 
l’assunzione di antidepressivi in funzione della dose ￨ stata osservata per citalopram, escitalopram e 
amitriptilina, ma non per altri antidepressivi esaminati. Un’associazione tra farmaco e riduzione del 119 
 
QT è stata identificata con l’assunzione di bupropione. Questo studio conferma quindi un modesto 
prolungamento  dell’intervallo  Qt.  ﾫTuttaviaﾻ  sottolineano  i  ricercatori  ﾫper  la  maggior  parte  dei 
pazienti  i  benefici  ottenuti  dal  trattamento  di  ansia  e  depressione  superano  i  rischi  incorsi  con 
l'aumento modesto del QT, che può essere tenuto sotto controllo grazie agli esami e alle cartelle 
cliniche  elettroniche».  Studi  di  farmacovigilanza  che  sfruttino  le  cartelle  cliniche  elettroniche 
potrebbero  fornire,  infatti,  un  valido  strumento  per  identificare  potenziali  rischi  associati  a 
trattamenti con antidepressivi. 
Una checklist migliora l'efficacia in sala operatoria 
Le equipe mediche che lavorano con una checklist a portata di mano aderiscono in modo più fedele 
ai protocolli di emergenza in caso di eventi avversi, come arresto cardiaco ed emorragie, durante un 
intervento 
Le equipe mediche che lavorano con una checklist a portata di mano aderiscono in modo più fedele 
ai protocolli di emergenza in caso di eventi avversi, come arresto cardiaco ed emorragie, durante un 
intervento. A dimostrarlo uno studio, pubblicato sul New England journal of medicine da Alexander 
Arriaga  dell’Harvard  school  of  public  health,  che  ha  analizzato  il  comportamento  di  17  equipe 
mediche  durante  l’esecuzione  di  106  scenari  di  crisi.  I  partecipanti  sono  stati  reclutati  da  tre 
istituzioni ospedaliere, un centro medico accademico e due ospedali nella zona di Boston, per un 
periodo di 17 mesi (da agosto 2010 fino a dicembre 2011). Le equipe comprendevano medici e 
infermieri specializzati, tecnici di sala operatoria e un chirurgo (un attore, a eccezione di pochi casi 
nei quali alcuni chirurghi volontari si sono prestati allo scenario). Ciascun team ha trascorso sei ore in 
una sala operatoria ricostruita in modo fedele dove i partecipanti sono stati sottoposti a scenari di 
crisi, e il loro comportamento analizzato in relazione all’aderenza ai protocolli di emergenza. In met￠ 
di questi scenari, scelti in modo casuale, il team ha avuto accesso a una checklist di passaggi chiave 
da eseguire in caso di evento avverso, nell’altra met￠ invece la memoria era l’unico strumento a 
disposizione dell’equipe, come avviene nella pratica clinica abituale. Oltre a valutare l’adesione ai 
protocolli  con  e  senza  checklist,  i  ricercatori  hanno  chiesto  ai  partecipanti  di  esternare  le  loro 
percezioni sull’utilit￠ clinica dell’uso di un promemoria. L’utilizzo della checklist ha ridotto del 75% i 
casi di mancata adesione a uno o più passaggi descritti dalle linee-guida. In particolare con l'uso della 
checklist la percentuale di gestioni approssimative è scesa dal 23% ad appena il 6%. Quanto alla 
percezione soggettiva, ben il 97% dei professionisti ha espresso il desiderio di avere a disposizione 
una  checklist  per  gestire  le  situazioni  di  emergenza  durante  la  pratica  chirurgica  quotidiana.  «I 
risultati  ottenuti  nelle  simulazioni  dimostrano  che  l’utilizzo  di  una  checklist  ￨  associato  a  un 
significativo  miglioramento  della  gestione  degli  eventi  avversi  che  si  sono  presentati  in  sala 
operatoriaﾻ conclude Arriaga. ﾫLa chirurgia pu￲ essere quindi migliorata grazie all’utilizzo di questo 
strumento». 
Colesterolo: raccomandazioni in attesa di nuove linee guida 
Le ultime linee guida Atp III del Necp per il trattamento e la prevenzione dell'ipercolesterolemia 
risalgono  a  10  anni  fa.  In  attesa  delle  Atp  IV,  un  gruppo  di  clinici  del  Johns  Hopkins  Center  di 
Baltimora suggerisce alcune importanti raccomandazioni 
Le  ultime  linee  guida  Atp  III  (Adult  treatment  panel)  del  Necp  (National  cholesterol  education 
program) per il trattamento e la prevenzione dell'ipercolesterolemia risalgono a 10 anni fa, con un 120 
 
solo breve update nel 2004. Con lo scopo dichiarato di aiutare nel difficile compito gli estensori delle 
Atp IV, un gruppo di clinici -  guidati da Seth S. Martindel Johns Hopkins Ciccarone center for the 
prevention of heart disease di Baltimora (Usa) – ha fornito 9 raccomandazioni attraverso le quali si 
possono  traslare  tutte  le  evidenze  disponibili  in  nuove  linee  guida  ampliate  di  prevenzione 
cardiovascolare,  ma  redatte  in  modo  semplice,  e  quindi  con  maggiori  probabilità  di  essere 
implementate nella pratica clinica.  
Dalla semplificazione degli algoritmi all'elasticità dei follow-up  
La prima raccomandazione ￨ quella di “definire in modo pi￹ accurato il  rischio”: non si pu￲ pi￹ 
ricorrere solo al Framingham risk score, perché tale metodo limita gli input ai soli fattori di rischio 
tradizionali, mentre occorre  incorporare  altri  dati, come  i  livelli  di  proteina C-reattiva,  il  Bmi,  lo 
spessore  intima-media  carotideo,  lo  score  Cac:  tutti  valori  più  correlati  all'attività  delle  statine. 
“Semplificare  l'algoritmo  iniziale”  ￨  la  raccomandazione  n.2:  vanno  abolite  le  attuali  complesse 
procedure per stabilire il valore target, e va legato direttamente il grado di rischio alla terapia. In 
pratica  se  il  soggetto, sulla  base  dei  parametri citati,  è  a  basso  rischio,  ci  si  deve  limitare  a  un 
counselling cardiovascolare generale, mentre se il rischio è elevato si deve incidere sugli stili di vita e 
valutare il ricorso alle statine. Il terzo punto, “dare priorit￠ alla terapia con statine”, ￨ in linea con 
l'attuale visione e non con quella dell'Atp III che mette al primo posto acido nicotinico e sequestranti 
degli acidi biliari. La quarta raccomandazione ￨: “essere elastici sulla durata del follow-up per la 
ripetizione degli esami di laboratorio”; dunque non applicare meccanicamente la regola della visita 6 
settimane dopo l'inizio della farmacoterapia per controllarne gli esiti, ma personalizzare l'arco di 
tempo e gli interventi svolti in esso.  
Criteri innovativi per la definizione del valore target  
Al  5°  punto  c'￨:  “stabilire  <70  mg/dl  come  target  ideale  di  colesterolemia-Ldl”;  tale  valore  ￨ 
considerato adatto per i soggetti ad alto rischio i quali in realtà, essendo riportato nell'Atp III come 
valore  normale  <100  mg/dL,  potrebbero  essere  disincentivati  al  trattamento  ipolipemizzante. 
“Approvare ulteriori obiettivi al di l￠ della colesterolemia-Ldl” ￨ la raccomandazione n.6:  nessuno si 
focalizza più solo sulle Ldl, ed è ormai chiara l'importanza di altri parametri, quali la colesterolemia 
totale, i trigliceridi, il colesterolo-Hdl, l'apolipoproteina A-I, l'apolipoproteina B, e il colesterolo non-
Hdl. Segue la settima norma: “definire i livelli terapeutici target sulla base del percentile equivalente 
di popolazione”; “soddisfacente” e “ideale” corrispondono nell'ordine al 40° e al 10° percentile. Gli 
ultimi due punti, di taglio pi￹ pratico che clinico, sono: “eliminare l'uso di descrittori fuorvianti, del 
tipoborderline alto” e “rendere pi￹ semplici i messaggi sullo stile di vita”. 
Aiutare il cuore dei bambini: un sms solidale per contribuire 
 
Ogni anno nel mondo nascono circa 1 milione di bambini affetti da cardiopatie e malformazioni 
cardiache congenite e i dati dicono che circa l'80% non ha la possibilità di essere curato ed operato 
nel proprio Paese, a causa dell'assenza di strutture ospedaliere o professionalità mediche adeguate e 
per l'alto costo delle operazioni. Questo significa che nel mondo quasi 800.000 bambini cardiopatici 
ogni anno rischiano la vita e in mancanza di cure mediche e chirurgiche tempestive, la metà di loro è 
destinata a non raggiungere il primo anno di vita. Gli altri vanno incontro a gravi problemi di crescita 
e di sviluppo psicosomatico, perché affetti da handicap respiratori e/o circolatori.  
 121 
 
In questo contesto si inserisce l'attività di organizzazioni come la Fondazione "Aiutare i bambini" che 
dal 2005, attraverso la campagna "Cuore di bimbi", raccoglie fondi per salvare i bambini cardiopatici 
che nascono nei Paesi più poveri, attraverso tre differenti modalità: operare i bambini in Italia presso 
alcune strutture convenzionate, nei casi in cui non sia possibile operarli nei loro Paesi di origine, 
operarli nel loro Paese grazie a missioni periodiche di équipe mediche costituite da volontari italiani, 
oppure operarli direttamente nel loro Paese, sostenendo le strutture locali dove esistono medici e 
ospedali in grado di realizzare le operazioni ai bambini, ma mancano attrezzature, macchinari o la 
copertura dei costi degli interventi. Per il 2013 l'obiettivo è operare nel complesso 310 bambini, e 
verranno realizzate 10 missioni di medici italiani volontari nei seguenti Paesi: Kazakistan (con il team 
degli  Ospedali  Riuniti  di  Bergamo),  Cambogia  (con  il  team  dell'Ospedale  Niguarda  di  Milano), 
Uzbekistan (con un team misto degli Ospedali Riuniti e dell'Ospedale Niguarda), Eritrea (con il team 
dell'Ospedale  G.  Pasquinucci  di  Massa)  e  Kurdistan  (con  il  team  del  Policlinico  di  San  Donato 
Milanese). Cambogia e Cameroun sono invece i due Paesi nei quali la Fondazione sosterrà i costi delle 
operazioni per le famiglie dei bambini più poveri. Infine, altri bambini arriveranno in Italia da Albania, 
Kosovo e Zimbabwe per essere sottoposti a intervento qui da noi, perché nei loro Paesi mancano 
oltre che i medici anche le strutture ospedaliere adeguate. 
Tutti possono contribuire a sostenere la campagna con un sms o una telefonata da rete fissa al 
numero 45501: il valore della donazione è di 2 euro oppure 5 euro a seconda della modalità scelta e 
dell'operatore telefonico. L'iniziativa è valida dal 4 al 24 febbraio 2013. 
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APPENDIX 2: Articles taken from Scientific American and Le 
Scienze. 
A Change of Heart.  
Authors:Jabr, Ferris. Source: Scientific American; Apr2013, Vol. 308 Issue 4, p50-52, 3p. 
Stem cells may transform the way doctors treat heart failure . 
IN EARLY 2009 Mike Jones bought a newspaper at a convenience store in Louisville, Ky., and read 
about  a  local  doctor  who  wanted  to  try  something  unprecedented:  healing  an  ailing  heart  by 
harvesting and multiplying its native stem cells -- immature cells with regenerative powers. Jones, 
then  65,  had  congestive  heart  failure:  his  heart  was  no  longer  pumping  blood  efficiently.  He 
contacted the doctor, Roberto Bolli of the University of Louisville, and in July of that year Jones 
became the first person in the world to receive an infusion of his own cardiac stem cells. 
Before  treatment,  Jones  could  barely climb stairs. Today  he  feels well  enough  to  chop  his own 
firewood and clear fallen tree limbs from his nine-acre property. His "ejection fraction," a measure of 
how much blood the heart pumps from one chamber to another, increased from 20 to 40 percent in 
the two years following the experimental treatment -- lower than a typical level (in the 55 to 70 
percent range) but still a dramatic improvement. 
Since then, hundreds of other patients with heart damage have similarly improved after doctors 
injected them with stem cells extracted from their own heart or bone marrow, as well as stem cells 
from unrelated donors. Researchers think the stem cells turn into new tissue and stimulate other 
cells to divide. Many important questions remain unanswered, however. Scientists still do not know 
which of the different kinds of stem cells work best and how exactly to prepare the cells before 
treatment -- but they are quickly gaining insights. "I think we are at the dawn of one of the biggest 
revolutions in medicine in our lifetime," Bolli says. "We still need to learn how to use these cells 
properly -- but this is real. In the future, we will collect our own stem cells, grow them and keep them 
in freezers until we need them." 
PRIMING THE PUMP  
FOR THE PAST FOUR DECADES scientists thought of the human heart as a powerful but vulnerable 
living pump. Because the adult heart appeared incapable of regenerating its cells, any cell death 
would irrevocably weaken the organ, researchers reasoned. Now and then, however, a scientist 
glimpsed adult heart cells dividing under the microscope. Carbon dating of preserved heart tissue has 
since  confirmed that  the adult  heart  replaces  its  cells  throughout  life,  although  this  turnover  is 
modest compared with that in the gut and skin. Biologists now estimate that the heart replaces 1 
percent or more of its four to five billion muscle cells each year. Researchers have also learned that 
the new cells arise from duplication of mature heart cells as well as from stem cells embedded in the 
heart. 
These  native  stem  cells  allow  the  heart  to  repair  itself  in  small  ways.  After  a  heart  attack,  for 
example, resident stem cells mature into new heart cells and encourage existing cells to divide. This 
self-repair lasts only a week or two, however, which is not nearly enough time to replace the more 
than one billion cells lost in a typical heart attack. The result is a large area of inflexible scar tissue. 
Just as a car tire bulges where it has been damaged, the human heart swells where it has been 
scarred; the once efficient football-shaped organ becomes a flabby, ineffectual pump. 
Stem cell therapy works by giving the heart a mega dose of its own repair cells. Animal studies 
indicate that some injected stem cells mature into adult cells, but most die within a few days. Before 
the cells expire, however, they secrete a cocktail of proteins that encourage healthy heart cells to 123 
 
proliferate, as well as enzymes that break down the collagen fibers in scar tissue, making way for 
new heart muscle. 
So far researchers have completed only a few small trials with patients. Bolli and his colleagues 
harvested  a  small  piece of  heart  tissue  from each of  23  patients  with  heart  damage or  failure, 
including Jones. The researchers nurtured tiny gardens of the heart cells in petri dishes, Altering out 
stem cells by searching for a stem cell-specific protein marker known as c-kit. They then allowed the 
stem cells to make millions of copies of themselves. 
Sixteen patients received one million cardiac stem cells each via a catheter fed into the coronary 
artery, and seven patients received standard care (which consisted mainly of beta blockers and 
diuretics). Four months later the ejection fraction had increased from a starting average of 30.3 
percent to an average of 38.5 percent in patients who received stem cells, but it had barely budged 
in standard care patients (inching from 30.1 to 30.2 percent). One year after treatment the average 
weight of scar tissue in stem cell patients had decreased by 30 percent. 
In a similar trial, Eduardo Marbán of the Cedars-Sinai Heart Institute in Los Angeles and his colleagues 
treated 17 patients with their own stem cells and another eight patients with standard care. Marbán 
and his team used remotely controlled forceps to pinch off peppercorn-size specks of heart tissue to 
grow in the lab. Whereas Bolli had extracted mainly "true" stem cells displaying c-kit from his lab 
cultures, Marbán extracted a more diverse mixture of cells -- some of which may have a more limited 
repertoire. Patients who received standard care showed no statistically significant change in scar 
mass or healthy heart tissue. Stem cell patients showed a 42 percent decrease in scar mass and a 13-
gram increase in healthy tissue over one year, although their ejection fraction hardly improved. 
Other  researchers  have  attempted  to  treat  heart  failure  with  so-called  mesenchymal  stem  cells 
derived from bone marrow, which are appealing because they are less likely to become cancerous 
compared with other stem cells. Mesenchymal stem cells secrete growth factors that prompt nearby 
cells to multiply and can turn into heart muscle in the right environment. Trial results have been 
inconsistent  so  far  --  some  patients  clearly  improve,  whereas  others  show  few  or  no  positive 
changes. 
Joshua Hare of the University of Miami wondered if heart patients would tolerate bone marrow stem 
cells donated by a stranger or reject them as foreign. Hare gave 15 patients injections of their own 
bone marrow stem cells, and another 15 people donated cells. Thirteen months later none of the 
patients in either group had rejected the stem cells, and scar tissue had diminished by more than one 
third in both groups. Elderly patients may benefit more from the stem cells of young donors than 
from their own because younger cells have not endured as much wear and tear. 
"Up until now, we had no way to remove the scar that follows a heart attack," Hare says. "Showing 
you can reduce scarring and replace it with new tissue is the home run we have been looking for. I 
think we will transform the treatment of heart failure." 
HEART REPAIR  
Harvesting semispecialized stem cells from an ailing heart, helping them to make millions of copies of 
themselves and injecting those cells into the heart enable the organ to break down scar tissue and 
grow new muscle. 
The Myth of Antioxidants.  
Authors:Moyer, Melinda Wenner. Source:Scientific American; Feb2013, Vol. 308 Issue 2, p62-67, 6p. 
The hallowed notion that oxidative damage causes aging and that vitamins might preserve our youth 
is now in doubt. 124 
 
DAVID GEMS'S LIFE WAS TURNED UPSIDE DOWN IN 2006 BY A GROUP OF WORMS THAT kept on 
living when they were supposed to die. As assistant director of the Institute of Healthy Aging at 
University  College  London,  Gems  regularly  runs  experiments  on  Caenorhabditis  elegans,  a 
roundworm that is often used to study the biology of aging. In this case, he was testing the idea that 
a buildup of cellular damage caused by oxidation-technically, the chemical removal of electrons from 
a molecule by highly reactive compounds, such as free radicals-is the main mechanism behind aging. 
According to this theory, rampant oxidation mangles more and more lipids, proteins, snippets of DNA 
and other key components of cells over time, eventually compromising tissues and organs and thus 
the functioning of the body as a whole. 
Gems genetically engineered the roundworms so they no longer produced certain enzymes that act 
as naturally occurring antioxidants by deactivating free radicals. Sure enough, in the absence of the 
antioxidants, levels of free radicals in the worms skyrocketed and triggered potentially damaging 
oxidative reactions throughout the worms' bodies. 
Contrary to Gems's expectations, however, the mutant worms did not die prematurely. Instead they 
lived just as long as normal worms did. The researcher was mystified. "I said, 'Come on, this can't be 
right,' " he recalls. " 'Obviously something's gone wrong here.' " He asked another investigator in his 
laboratory to check the results and do the experiment again. Nothing changed. The experimental 
worms did not produce these particular antioxidants; they accumulated free radicals as predicted, 
and yet they did not die young-despite suffering extreme oxidative damage. 
Other scientists were finding similarly confounding results in different lab animals. In the U.S., Arlan 
Richardson, director of the Barshop Institute for Longevity and Aging Studies at the University of 
Texas Health Science Center in San Antonio, genetically engineered 18 different strains of mice, some 
of which produced more of certain antioxidant enzymes than normal and some of which produced 
fewer  of  them  than  normal.  If  the  damage  caused  by  free  radical  production  and  subsequent 
oxidation was responsible for aging, then the mice with extra antioxidants in their bodies should 
have lived longer than the mice missing their antioxidant enzymes. Yet "I watched those goddamn 
life  span  curves,  and  there  was  not  an  inch  of  difference  between  them,"  Richardson  says.  He 
published his increasingly bewildering results in a series of papers between 2001 and 2009. 
Meanwhile, a few doors down the hall from Richardson, physiologist Rochelle Buffenstein has spent 
the past 11 years trying to understand why the longest-living rodent, the naked mole rat, is able to 
survive up to 25 to 30 years-around eight times longer than a similarly sized mouse. Buffenstein's 
experiments have shown that naked mole rats possess lower levels of natural antioxidants than mice 
and accumulate more oxidative damage to their tissues at an earlier age than other rodents. Yet 
paradoxically, they live virtually disease-free until they die at a very old age. 
To proponents of the long-standing oxidative damage theory of aging, these findings are nothing 
short of heretical. They are, however, becoming less the exception and more the rule. Over the 
course of the past decade, many experiments designed to further support the idea that free radicals 
and other reactive molecules drive aging have instead directly challenged it. What is more, it seems 
that in certain amounts and situations, these high-energy molecules may not be dangerous but 
useful and healthy, igniting intrinsic defense mechanisms that keep our bodies in tip-top shape. 
These ideas not only have drastic implications for future antiaging interventions, but they also raise 
questions about the common wisdom of popping high doses of antioxidant vitamins. If the oxidative-
damage theory is wrong, then aging is even more complicated than researchers thought-and they 
may ultimately need to revise their understanding of what healthy aging looks like on the molecular 
level. 
"The field of aging has been gliding along on this set of paradigms, ideas about what aging is, that to 
some extent were kind of plucked out of the air," Gems says. "We should probably be looking at 125 
 
other  theories  as  well  and  considering,  fundamentally,  that  we  might  have  to  look  completely 
differently at biology." 
THE BIRTH OF A RADICAL THEORY  
THE OXIDATIVE DAMAGE, or free radical, theory of aging can be traced back to Den- ham Harman, 
who found his true calling in December 1945, thanks to the Ladies' Home Journal. His wife, Helen, 
brought a copy of the magazine home and pointed out an article on the potential causes of aging, 
which he read. It fascinated him. 
Back then, the 29-year-old chemist was working at Shell Development, the research arm of Shell Oil, 
and he did not have much time to ponder the issue. Yet nine years later, after graduating from 
medical school and completing his training, he took a job as a research associate at the University of 
California, Berkeley, and began contemplating the science of aging more seriously. One morning 
while sitting in his office, he had an epiphany-"you know just 'out the blue,' " he recalled in a 2003 
interview: aging must be driven by free radicals. 
Although free radicals had never before been linked to aging, it made sense to Harman that they 
might be the culprit. For one thing, he knew that ionizing radiation from x-rays and radioactive 
bombs, which can be deadly, sparks the production of free radicals in the body. Studies at the time 
suggested  that  diets  rich  in  food-based  antioxidants  muted  radiation's  ill  effects,  suggesting-
correctly, as it turned out-that the radicals were a cause of those effects. Moreover, free radicals 
were normal by-products of breathing and metabolism and built up in the body over time. Because 
both cellular damage and free radical levels increased with age, free radicals probably caused the 
damage that was responsible for aging, Harman thought-and antioxidants probably slowed it. 
Harman started testing his hypothesis. In one of his first experiments, he fed mice antioxidants and 
showed that they lived longer. (At high concentrations, however, the antioxidants had deleterious 
effects.)  Other  scientists  soon  began  testing  it,  too.  In  1969  researchers  at  Duke  University 
discovered  the  first  antioxidant  enzyme  produced  inside  the  body-superoxide  dismutase-and 
speculated that it evolved to counter the deleterious effects of free radical accumulation. With these 
new data, most biologists began accepting the idea. "If you work in aging, it's like the air you breathe 
is the free radical theory," Gems says. "It's ubiquitous, it's in every textbook. Every paper seems to 
refer to it either indirectly or directly." 
Still, over time scientists had trouble replicating some of Harman's experimental findings. By the 
1970s "there wasn't a robust demonstration that feeding animals antioxidants really had an effect on 
life span," Richardson says. He assumed that the conflicting experiments-which had been done by 
other scientists-simply had not been controlled very well. Perhaps the animals could not absorb the 
antioxidants that they had been fed, and thus the overall level of free radicals in their blood had not 
changed.  By  the  1990s,  however,  genetic  advances  allowed  scientists  to  test  the  effects  of 
antioxidants  in  a  more  precise  way-by  directly  manipulating  genomes to  change  the  amount  of 
antioxidant enzymes animals were capable of producing. Time and again, Richardson's experiments 
with genetically modified mice showed that the levels of free radical molecules circulating in the 
animals' bodies-and subsequently the amount of oxidative damage they endured-had no bearing on 
how long they lived. 
More  recently,  Siegfried  Hekimi,  a  biologist  at  McGill  University,  has  bred  roundworms  that 
overproduce a specific free radical known as superoxide. "I thought they were going to help us prove 
the theory that oxidative stress causes aging," says Hekimi, who had predicted that the worms would 
die young. Instead he reported in a 2010 paper in FLOS Biology that the engineered worms did not 
develop high levels of oxidative damage and that they lived, on average, 32 percent longer than 
normal worms. Indeed, treating these genetically modified worms with the antioxidant vitamin C 
prevented this increase in life span. Hekimi speculates that superoxide acts not as a destructive 126 
 
molecule but as a protective signal in the worms' bodies, turning up the expression of genes that 
help to repair cellular damage. 
In a follow-up experiment, Hekimi exposed normal worms, from birth, to low levels of a common 
weed-controlling herbicide that initiates free radical production in animals as well as plants. In the 
same 2010 paper he reported the counterintuitive result: the toxin-bathed worms lived 58 percent 
longer than untreated worms. Again, feeding the worms antioxidants quenched the toxin's beneficial 
effects. Finally, in April 2012, he and his colleagues showed that knocking out, or deactivating, all five 
of the genes that code for superoxide dismutase enzymes in worms has virtually no effect on worm 
life span. 
Do these discoveries mean that the free radical theory is flat-out wrong? Simon Melov, a biochemist 
at the Buck Institute for Research on Aging in Novato, Calif., believes that the issue is unlikely to be 
so simple; free radicals may be beneficial in some contexts and dangerous in others. Large amounts 
of oxidative damage have indisputably been shown to cause cancer and organ damage, and plenty of 
evidence  indicates  that  oxidative  damage  plays  a  role  in  the  development  of  some  chronic 
conditions, such as heart disease. In addition, researchers at the University of Washington have 
demonstrated that mice live longer when they are genetically engineered to produce high levels of 
an antioxidant known as catalase. Saying that something, like oxidative damage, contributes to aging 
in certain instances, however, is "a very different thing than saying that it drives the pathology," 
Melov notes. Aging probably is not a monolithic entity with a single cause and a single cure, he 
argues, and it was wishful thinking to ever suppose it was one. 
SHIFTING PERSPECTIVE  
ASSUMING FREE RADICALS accumulate during aging but do not necessarily cause it, what effects do 
they have? So far that question has led to more speculation than definitive data. 
"They're actually part of the defense mechanism," Hekimi asserts. Free radicals might, in some cases, 
be produced in response to cellular damage-as a way to signal the body's own repair mechanisms, 
for example. In this scenario, free radicals are a consequence of age-related damage, not a cause of 
it. In large amounts, however, Hekimi says, free radicals may create damage as well. 
The general idea that minor insults might help the body withstand bigger ones is not new. Indeed, 
that is how muscles grow stronger in response to a steady increase in the amount of strain that is 
placed on them. Many occasional athletes, on the other hand, have learned from painful firsthand 
experience that an abrupt increase in the physical demands they place on their body after a long 
week of sitting at an office desk is instead almost guaranteed to lead to pulled calves and hamstrings, 
among other significant injuries. 
In 2002 researchers at the University of Colorado at Boulder briefly exposed worms to heat or to 
chemicals that induced the production of free radicals, showing that the environmental stressors 
each boosted the worms' ability to survive larger insults later. The interventions also increased the 
worms' life expectancy by 20 percent. It is unclear how these interventions affected overall levels of 
oxidative  damage,  however,  because  the  investigators  did  not  assess  these  changes.  In  2010 
researchers  at  the  University of  California,  San  Francisco,  and  Pohang  University of  Science  and 
Technology in South Korea reported in Current Biology that some free radicals turn on a gene called 
HIF-1 that is itself responsible for activating a number of genes involved in cellular repair, including 
one that helps to repair mutated DNA. 
Free radicals may also explain in part why exercise is beneficial. For years researchers assumed that 
exercise was good in spite of the fact that it produces free radicals, not because of it. Yet in a 2009 
study published in the Proceedings of the National Academy of Sciences USA, Michael Ristow, a 
nutrition  professor  at  the  Friedrich  Schiller  University  of  Jena  in  Germany,  and  his  colleagues 127 
 
compared the physiological profiles of exercisers who took antioxidants with exercisers who did not. 
Echoing Richardson's results in mice, Ristow found that the exercisers who did not pop vitamins were 
healthier than those who did; among other things, the unsupplemented athletes showed fewer signs 
that they might develop type 2 diabetes. Research by Beth Levine, a microbiologist at the University 
of Texas Southwestern Medical Center, has shown that exercise also ramps up a biological process 
called autophagy, in which cells recycle worn-out bits of proteins and other subcellular pieces. The 
tool used to digest and disassemble the old molecules: free radicals. Just to complicate matters a bit, 
however, Levine's research indicates that autophagy also reduces the overall level of free radicals, 
suggesting that the types and amounts of free radicals in different parts of the cell may play various 
roles, depending on the circumstances. 
THE ANTIOXIDANT MYTH  
IF FREE RADICALS are not always bad, then their antidotes, antioxidants, may not always be good-a 
worrisome possibility given that 52 percent of Americans take considerable doses of antioxidants 
daily, such as vitamin E and beta-carotene, in the form of multivitamin supplements. In 2007 the 
Journal of the American Medical Association published a systematic review of 68 clinical trials, which 
concluded that antioxidant supplements do not reduce risk of death. When the authors limited their 
review  to  the  trials  that  were  least  likely  to  be  affected  by  bias-those  in  which  assignment  of 
participants to their research arms was clearly random and neither investigators nor participants 
knew who was getting what pill, for instance-they found that certain antioxidants were linked to an 
increased risk of death, in some cases by up to 16 percent. 
Several  U.S.  organizations,  including  the  American Heart  Association  and the  American  Diabetes 
Association,  now  advise  that  people  should  not  take  antioxidant  supplements  except  to  treat  a 
diagnosed vitamin deficiency. "The literature is providing growing evidence that these supplements-
in particular, at high doses-do not necessarily have the beneficial effects that they have been thought 
to," says Demetrius Albanes, a senior investigator at the Nutritional Epidemiology Branch of the 
National Cancer Institute. Instead, he says, "we've become acutely aware of potential downsides." 
It is hard to imagine, however, that antioxidants will ever fall out of favor completely-or that most 
researchers who study aging will become truly comfortable with the idea of beneficial free radicals 
without a lot more proof. Yet slowly, it seems, the evidence is beginning to suggest that aging is far 
more intricate and complex than Harman imagined it to be nearly 60 years ago. Gems, for one, 
believes the evidence points to a new theory in which aging stems from the overactivity of certain 
biological  processes  involved  in  growth  and  reproduction.  But  no  matter  what  idea  (or  ideas) 
scientists settle on, moving forward, "the constant drilling away of scientists at the facts is shifting 
the field into a slightly stranger, but a bit more real, place," Gems says. "It's an amazing breath of 
fresh air." 
New threat from poxviruses. 
Authors:Shah, Sonia. Source:Scientific American; Mar2013, Vol. 308 Issue 3, p66-71, 6p. 
Smallpox may be gone, but its viral cousins -- monkeypox and cowpox -- are staging a comeback  
TEN THOUSAND YEARS AGO, WHEN SMALLPOX FIRST EMERGED, HUMANKIND COULD do little more 
than pray to the gods for succor. Later known as variola, the virus that caused the disease first 
attacked the linings of the nose or throat, spreading throughout the body until a characteristic rash 
followed by virus-filled blisters developed on the skin. Over the course of recorded history, the 
"speckled monster" killed up to a third of the people it infected. During the 20th century alone, it 
felled more than 300 million men, women and children. 128 
 
By the late 1970s, however, the deadly scourge had been eliminated from the face of the earth 
thanks to mass vaccination campaigns that protected millions and left them with a small scar on their 
upper arm. With nowhere to hide in the natural world -- humans are the virus's only host -- variola 
was  beaten  into  extinction.  Today  the  only  known  viral  samples  are  locked  in  two  specialized 
government laboratories, one in the U.S. and the other in Russia. Absent a catastrophic lab accident, 
deliberate release or the genetic re-engineering of the virus, smallpox will never again spread death 
and misery across the globe. 
The World Health Organization, which had organized the eradication campaign, sounded the official 
all clear in 1979, two years after the last sporadic case was recorded, in a Somali hospital worker. 
Since then, no country has routinely vaccinated its citizens against smallpox, although the U.S. began 
inoculating  certain  health  personnel  and  selected  members  of  its  armed  forces  after  the  terror 
attacks  on  September  11,2001.  Thus,  an  entire  generation  has  reached  adulthood  without  any 
exposure to either the disease or the vaccine, which sometimes caused serious side effects. 
And therein lies the rub. The smallpox vaccine did not protect just against the variola virus. Anyone 
who  was  vaccinated  against  smallpox  also  developed  immunity  to  infection  with  variola's  viral 
cousins -- including monkeypox and cowpox. Given the much larger scale of smallpox infections at 
the time, this secondary protection was seen as a minor benefit. 
Now that the smallpox vaccine is no longer widely given, the question becomes: Could these obscure 
pathogens, which, like smallpox, belong to the Orthopoxvirus genus, pose a new danger to humans? 
There are reasons to worry. Unlike smallpox, cowpox and monkeypox naturally lurk in rodents and 
other creatures, so they can never be fully eliminated. The number of cases of monkeypox and cow-
pox in humans has steadily risen in recent years. And both viruses have begun to infect different 
creatures beyond their normal hosts, raising the possibility that they might spread through new 
paths around the planet. 
No one knows how monkeypox and cowpox will change over time, but virologists worry that if they 
mutate to jump more easily from one person to the next, they could devastate large parts of the 
globe. That grim possibility drives a small band of virologists to learn more about these -- or any 
other  --  potential  pox  plagues  in  the  making,  so  as  to  sound  the  alarm  if  they  show  signs  of 
developing into more threatening forms. 
VARYING SEVERITY  
THE HISTORY AND BIOLOGY of poxviruses offer some clues as to what to expect from smallpox's kin 
in  the  future.  Historically,  60  percent  of  the  pathogens  that  plague  humankind,  including  the 
orthopoxviruses, have originated in the bodies of other vertebrates. Variola's closest living relative, 
taterapox,  was  isolated  from  a  wild  gerbil  in  Africa  in  1968.  Molecular  analyses  suggest  that 
smallpox's evolutionary ancestor probably got its start in an African rodent species, possibly now 
extinct. Similarly, cowpox and monkeypox, despite their names, live in voles, squirrels or other wild 
rodents. 
When  variola's  ancestor  first  jumped  into  humans,  it  probably  was  not  very  contagious,  says 
microbiologist Mark Buller of Saint Louis University. Then, somewhere along the line, he and other 
researchers  surmise,  a  variant  emerged  that  was  much  more  transmissible.  The  critical  change 
allowed the virus to broadcast itself via the coughs, exhalations or sneezes of an infected person. 
Meanwhile human beings started living in much closer quarters, making it that much more likely for 
one person to pass the infection on to another. The combination of the biological change and the 
altered environment gave the emerging virus the edge it needed to become a global scourge. 
Just because a virus is easily transmitted, however, does not necessarily make it lethal. Indeed, 
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camelpox and raccoonpox infections trigger little more than a skin rash, with virus-filled pustules that 
harmlessly clear up on their own. Monkeypox infections, on the other hand, can be quite deadly in 
humans. Even at that, not all monkeypox viruses are equally dangerous. The worst subtype, found in 
the Congo Basin, kills about 10 percent of people who are infected, whereas another version, from 
West Africa, rarely if ever ends in death. As it happens, the West African strain in 2003 caused the 
first-ever recorded cases of monkeypox in the Western Hemisphere. The outbreak, which occurred in 
six  states  in  the  U.S.,  led  to  the  hospitalization  of  19  people,  including  a  child  who  suffered 
encephalitis and a woman who was blinded, necessitating a corneal transplant. Investigators traced 
the infection to rodents imported from Ghana that passed the virus to pet prairie dogs, which in turn 
infected their owners. Such intermediary animals allow a virus that normally lives in animals with 
little human contact to reach potentially large numbers of people. 
Subtle genetic differences may help explain the shifting severity of pox infections. For example, some 
poxviruses  possess  genes  for  proteins  that  interfere  with  the  ability  of  the  immune  system  to 
respond  effectively  to  the  infection.  When  researchers  compared  the  genes  from  different 
poxviruses, they zeroed in on one that was found in several different kinds of poxviruses. In the most 
deadly strains of variola, this gene triggered the production of a protein  that evidence suggests 
prevents some immune cells from efficiently coordinating their counterattack against the virus. But 
the equivalent gene in the Congo Basin strains of monkeypox (which are less deadly than smallpox) 
provided the hereditary instructions for a much shorter protein. When researchers looked at the 
milder West African version of monkeypox, the gene was missing altogether and the protein in 
question could not be manufactured. Thus, the evidence suggested that the shorter protein in the 
Congo Basin strains of monkeypox somehow made them less deadly than smallpox. 
Speculation among  researchers  about  how  different  species of  poxvirus  acquired  this  and other 
genes indicates why monkeypox and its cousins could potentially become more dangerous threats 
than they are now. The genes, which are not essential for poxvirus replication, appear to be faithful 
copies of genes the viruses acquired at some point in the evolutionary past from organisms they 
infected. Yet, curiously, the viruses do not in the normal course of an infective cycle come anywhere 
near the genetic material stored in the nucleus of the host cells. 
One  possible explanation,  popular  among  pox virologists,  posits  the  simultaneous  infection of  a 
human or other vertebrate host with a poxvirus and a retrovirus. Such co-infections are probably 
pretty common, researchers say. Retroviruses are known for incorporating their own genes into their 
host's DNA. (About 8 percent of the human genome consists of DNA that originated in retroviruses.) 
It is possible that the unusual biochemical activity of the retrovirus inside the cell could allow the 
poxvirus to capture its host's genes. 
If true, this hypothesis could prove portentous. Poxviruses are genetically stable and do not usually 
mutate quickly. If they can steal genes from their hosts that make them more virulent, then there is 
no predicting what a relatively harmless, not to mention an already deadly, poxvirus might do under 
the right circumstances. The change from mild to dangerous threat could occur more quickly and 
unpredictably than anyone might have previously suspected. 
MONKEYPOX IS BETTER poised than any of its viral cousins at present to emerge as a global threat. 
Virologists refer to it as smallpox's "little cousin," in part because it causes an illness that is clinically 
indistinguishable from smallpox. First reported in captive monkeys in 1957, the virus typically lives, 
evidence suggests, in African rodents, possibly rope squirrels. Outbreaks have so far occurred mostly 
in Central Africa, with the notable exceptions of the U.S. in 2003 and Sudan in 2006. 
University of California, Los Angeles, epidemiologist Anne W. Rimoin was in Kinshasa, Democratic 
Republic of the Congo, in 2002, when she first heard about local residents who had fallen ill with 
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or whether the virus could spread to others. But she knew the disease was life-threatening and 
wanted to learn more. 
With her blond hair and buff pedicure, Rimoin could hardly be mistaken for a local in the remote 
Congolese jungles. Yet she had studied the country's politics as an undergraduate in African history 
and was fluent in French, which is still spoken in the former Belgian colony, as well as Lingala and 
other local languages. She started asking around. "I just clicked with the right people and asked the 
right questions," she says. And "it became clear to me that there were probably a lot more cases 
than were being reported." 
But how to find them? Unsurprisingly, given the dearth of health care facilities in rural Congo, few 
people  who  were  sick  sought  out  clinicians.  And  those  who  had  recovered  could  not  easily  be 
identified with blood tests because there was no way of telling whether the presence of antibodies 
against poxvirus was the result of an earlier smallpox vaccination or another poxvirus infection. 
Assessing the incidence of monkeypox required finding people who were in the throes of an acute 
monkeypox infection, when it would be possible to test for the virus itself from the pustules on the 
skin. 
Rimoin began her quest by establishing a research site deep in the forest. There were no roads, no 
cell-phone signals and no radio transmission. She chartered planes to get in and out and spent days 
walking  and  traveling  by  canoe  and  by  motorcycle  to  track  down  monkeypox  cases  among  the 
Lingala-speaking villagers of interior Congo. 
The results were alarming. Compared with similar data collected by the World Health Organization in 
1981-1986, Rimoin had found a 20-fold increase in the number of human monkeypox cases. Even so, 
she believes that her findings, which were published in 2010, are an underestimate. "It's the tip of 
the iceberg," she asserts. After all, the WHO had a much bigger and much better financed operation 
looking for monkeypox 30 years ago. Rimoin's team undoubtedly missed many more cases, relatively 
speaking, than that earlier, larger effort. 
RISE OF MONKEYPOX  
ALTHOUGH  THE  SPIKE  in  monkeypox  cases  was  larger  than  anyone  had  anticipated,  it  was  not 
unexpected.  After  all, most of  the  country's  population  is  unvaccinated against  poxviruses.  (The 
Democratic Republic of the Congo stopped vaccinating against smallpox in 1980.) 
Further research suggested that something else was going on as well. Ecologist James Lloyd-Smith, 
one of Rimoin's colleagues at U.C.L.A., uses computer models to study how diseases jump from 
animals  to  humans.  According  to  his  analyses of  Rimoin's  data, the  withdrawal  of  the  smallpox 
vaccine and subsequent loss of immunity to related poxviruses could not fully account for the spike 
in cases. There must have also been at least a fivefold increase in "spillover" events, he says, in which 
the virus jumped from infected rodents into humans. 
Why monkeypox might be jumping into humans more frequently is a matter of conjecture. It could 
be that continued clearing of land for agricultural use and for burning wood has put more and more 
people in contact with infected squirrels, mice and other rodents. In addition, more local people may 
have been reduced to eating potentially infected animals as a result of the Congolese civil war. A 
2009 survey, published in October 2011, found that a third of people in rural Congo eat rodents 
found dead in the forest and that, suggestively, 35 percent of monkeypox cases occur during hunting 
and farming season. (Most people contract monkeypox from close contact with infected animals, 
such as handling or eating them.) 
Rimoin and other virologists worry that with expanded opportunities to infect people, monkeypox 
might better adapt to the human body. Buller studies the ways in which orthopoxviruses cause 
diseases in both humans and animals. Monkeypox "can already kill people," he says, and it can 131 
 
spread  between  individuals,  too  --  just  not  that  well.  All  that  may  be  needed  to  transform 
monkeypox into a much more contagious human pathogen might be a few minor tweaks to a current 
viral trait. 
SPREAD OF COWPOX Cowpox infections are mild in most people. After the virus enters cells and 
disarms the host's initial immune response, a fusillade of virus-hunting antibodies made by the victim 
prevents the pathogen from spreading to tissues throughout the body. Not so in people whose 
immune  systems  have  been  weakened,  such  as  by  HIV,  cancer  chemotherapy  or  treatment  to 
prevent the rejection of transplanted organs. "They can get a smallpoxlike disease, and they can die," 
says Malcolm Bennett of the University of Liverpool in England. Since 1972, public health experts 
estimate, the number of immunocompromised people in the U.S. who are now susceptible to serious 
disease from cowpox and other poxviruses has grown 100-fold. 
Bennett, a veterinary pathologist, studies the ecology and evolution of cowpox in wildlife. In the U.K., 
he says, cowpox normally resides harmlessly in bank voles, field voles and wood mice. Domestic cats 
pick up the virus from the rodents they hunt. They then expose the people who care for them (often 
at close range) to cow-pox, a chain of events that accounts for half of all human cowpox cases in the 
U.K. 
Like monkeypox, cowpox has started making forays into creatures outside its normal reservoir hosts. 
With bank vole populations booming thanks to mild winters and other favorable climatic conditions, 
rats may have started playing an intermediary role in cowpox transmission similar to the one played 
by  prairie  dogs  in  the  2003  American  outbreak  of  monkeypox.  "There's  been  a  proliferation  of 
reports,  either  zoo-related  or  pet-related,  associated  with  rats,"  says  Mary  Reynolds,  an 
epidemiologist at the U.S. Centers for Disease Control and Prevention. That trend "is potentially quite 
concerning because black and brown rats sure make their way around the globe pretty efficiently," 
she notes. If cowpox becomes established in rats, as opposed to just voles and wood mice, millions 
more people could be readily infected by, for example, being bitten or coming into contact with their 
droppings. 
Indeed,  orthopoxviruses  are  notoriously  adept  at  colonizing  new  species.  The  vaccinia  virus,  for 
example, which was used to create modern smallpox vaccines, now freely propagates in dairy cattle 
in Brazil, as well as in buffalo in India. And there are "a range of orthopoxviruses out there that have 
never been isolated or fully characterized," Reynolds points out. Given the right opportunities, those 
less  familiar  pox  strains  could  extend  their  ranges into  new  regions  and  species.  "Some  will  be 
pathogenic to people," Bennett adds. "They just haven't managed to make the species jump yet." 
ARMED AND VIGILANT  
AS THE CROWD of people who have never received a smallpox vaccination grows, pox virologists 
expect the incidence of human cases of monkeypox, cowpox and other poxviruses to continue to 
rise. 
Should any of these poxviruses become adept at plaguing humans, new drugs and vaccines -- and the 
resources necessary to use them -- will be needed to contain the threat. Because of post-9/11 fears 
of intentional releases of smallpox, a spate of new vaccines and drugs are being developed to fight 
smallpox. These medications will likely provide protection against naturally emerging poxviruses as 
well.  But  producing  and  distributing  them,  as  well  as  safeguarding  against  their  inevitable  side 
effects, will be a complex and costly undertaking. New smallpox vaccines, such as Bavarian-Nordic's 
Imvamune, have been designed to be safely administered even to immunocompromised people, but 
they must be given in higher doses and over the course of two shots instead of one, making them 
more expensive than traditional smallpox vaccines. A new drug, manufactured by Siga Technologies 
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Despite not yet being approved by the U.S. Food and Drug Administration, the federal government 
has already purchased a large amount of ST 246 and added it to the national biodefense stockpile. 
In places such as the rural Congo River basin, where health financing for cutting-edge new vaccines 
and drugs is limited, the best hope for now seems to be enhanced surveillance, combined with 
community education programs. For example, a monkeypox education program run by the CDC, in 
conjunction  with  local  health  officials  and  voluntary  nongovernmental  organizations  in  the 
Democratic  Republic  of  the  Congo,  increased  the  proportion  of  local  people  able  to  recognize 
monkeypox cases from 23 to 61 percent. Rimoin's arduous surveillance of monkeypox continues as 
well, with new studies aimed at sequencing the genes in variants infecting animals and people today 
to see how the virus may be changing. Better detection means more opportunity to care for and 
isolate infected individuals, squelching chances for the virus to mutate into new forms that spread 
more efficiently between people. 
The ancient war between poxviruses and humans may not have ended when that 21-year-old Somali 
hospital worker cleared his smallpox infection back in 1977. With new tools and better surveillance, 
scientists are better armed and more vigilant than ever before. But to prevent another pox from 
falling on humankind, society will need to maintain those defenses for some time to come. 
Foam That Restores Breathing 
Authors: Harmon, Katherin Source:Scientific American, Dec2012, Vol. 307 Issue 6, p36-37. 
Injectable oxygen microbubbles could give asthma and choking victims precious minutes. 
Only a few minutes after someone stops breathing -- whether it is from a piece of meat stuck in the 
throat, a severe asthma attack or a lung injury -- the brain starts to shut down. Cardiac arrest and 
death are imminent. Emergency responders and hospital workers have one primary recourse: insert 
a breathing tube through a patient's mouth. That procedure can be risky and time-consuming. 
A new injectable solution could keep such people alive for 15 minutes or more, buying crucial time to 
get  victims  to  a  hospital or  to  do  some  surgical  gymnastics  in  an  operating  room.  The solution 
contains oxygen microbubbles, which the blood can absorb within seconds. The bubbles are too 
small to cause an air embolism -- a gas pocket that stops blood flow, thus causing a stroke or heart 
attack. 
To  create  this  lifesaving  foam,  John  Kheir,  a  cardiologist  at  Boston  Children's  Hospital,  and  his 
colleagues adapted existing medical nanotechnology. Microparticles with lipid membranes already 
deliver drugs, as well as dyes for ultrasound imaging. Kheir's team propelled phospholipids through 
an  oxygenated  chamber  and  used  sound  waves  to  spur  the  ingredients  to  self-assemble  into 
microparticles. The researchers then used a centrifuge to superconcentrate them into solution. Each 
four-micron-wide microbubble contains pure oxygen, surrounded by a lipid film that is just a few 
nanometers thick. 
Because the bubbles contain oxygen at a pressure that is higher than in the bloodstream, the gas 
diffuses into red blood cells on contact. Once a bubble is depleted, the shell collapses to a disk that is 
less than a micron wide, easily passing through the circulatory system. 
In a test, researchers blocked the airways of anesthetized rabbits for 15 minutes. Those injected with 
the solution were much less likely to go into cardiac arrest or have other organ damage than those 
who got saline solution -- despite not taking a single breath. 
The approach is "a fairly innovative idea compared to what we have now," says Raymond Koehler of 
Johns  Hopkins  University,  who  is  not  involved  in  the  work,  because  most  emergency  oxygen 
procedures require the pulmonary system to function at least at a minimal level. 133 
 
One  drawback  is  that  because  the  blood  absorbs  the  oxygen  so  quickly,  a  constant  infusion  is 
necessary, which involves a lot of saline to help the foam move smoothly into the bloodstream. The 
amount  of  solution  that a  patient  would  receive  after 15  minutes  could  lead  to  edema, a  fluid 
overload that can cause heart failure. Kheir's team is trying to improve the formulation so that it 
requires less saline. 
Another concern is that without normal respiration, carbon dioxide builds up in the body, which can 
be toxic As Koehler notes, however, the body can handle a little excess carbon dioxide better than it 
can  handle  a  total  lack  of  oxygen.  If  the  microbubbles  prove  successful  in  further  animal  (and 
subsequent human) trials, the solution could help emergency crews or operating room technicians 
buy  crucial  minutes  before  they  can  implement  other  lifesaving  treatments.  In  those  situations, 
Koehler says, "you want to have a backup plan." 
Early Treatment for Alzheimer's 
Authors:Laber-Warren, Emily; Source:Scientific American, Dec2012, Vol. 307 Issue 6, p38-39. 
A drug trial of 300 Colombians could reveal a way to prevent the disease from ever starting. 
Alzheimer's disease remains virtually untreatable. More than 100 experimental drugs have failed to 
halt  the  condition  that  robs  people  of  their  memories,  their  relationships  and,  ultimately,  their 
identity. Now scientists will be testing a new strategy for preventing this horrific condition from 
starting in the first place. Just as healthy people take statins to lower their cholesterol and avoid 
heart disease, people at risk for Alzheimer's could conceivably pop pills to keep the disease at bay. 
Researchers  will  be  investigating  a  drug  that  flushes  away  an  intrusive  protein  called  amyloid, 
suspected as a primary contributor to Alzheimer's. Until recently, amyloid clumps could only be seen 
by  dissecting  the  brain  after  death.  Yet  advanced  positron-emission  tomography  scans  of  living 
people's brains, a recent innovation, show that by the time symptoms appear, amyloid has been 
silently accumulating for up to 20 years. Perhaps by then the brain is irreversibly damaged, making 
any drug useless. No one knows for sure, however, whether amyloid causes Alzheimer's or is merely 
a by-product of the disease. The new study may provide an answer to this mystery. 
Set to start early in 2013 if all approvals are granted, the investigation will involve 300 members of 
distantly related families in Colombia whose rare and particularly devastating form of Alzheimer's 
strikes in the prime of life By their 50s and 60s, many are as helpless as infants. Normally it is 
impossible to predict who will develop Alzheimer's, but in this extended family, a single genetic 
mutation, detectable by a blood test, spells doom. 
Eric Reiman, executive director of the Banner Alzheimer's Institute in Phoenix, his colleague Pierre 
Tariot and their Colombian collaborator Francisco Lopera realized that the family provided a unique 
opportunity  to  test  the  benefits  of  early  intervention.  They  plan  to  give  an  experimental  drug, 
crenezumab, to 100 family members who are on the cusp of developing Alzheimer's symptoms and a 
placebo to 100 others. A third group not destined to get the disease will also receive the placebo. 
Participants  will  receive  biweekly  injections  for  at  least  five  years.  Every  few  months  they  will 
undergo  extensive  testing:  magnetic  resonance  imaging  to  track  brain  shrinkage;  spinal  taps  to 
measure  tau  protein,  which  is  associated  with  brain  cell  death;  and  memory  and  thinking  tests 
designed to pick up subtle cognitive lapses, such as forgetting a list of words that were memorized 
only minutes or hours earlier, a marker of emerging Alzheimer's. 
The study will also enlist up to three dozen patients in the U.S. The Americans, who will receive the 
same treatment, will be a less homogeneous bunch, possessing various mutations in any of three 
genes  linked  to  early-onset  Alzheimer's.  Investigators  hope  to  learn  whether  it  is  possible  to 134 
 
extrapolate from the Colombian family to others who are destined to develop dementia in middle 
age. 
The $100-million study is funded by the drug's maker, Genentech, as well as by philanthropists and 
the National Institutes of Health. Even if the drug succeeds, there is no guarantee that the results will 
translate to the much more common form of Alzheimer's that afflicts the elderly. Yet the researchers 
hope  this  trial  will  establish  for  Alzheimer's  what  cholesterol  and  high  blood  pressure  are  for 
cardiovascular disease -- intermediate signposts that aid research, diagnosis and treatment 
The  data  they  collect  could  mean  that  instead  of  having  to  wait  years  to  see  whether  an 
experimental  drug  helps  patients,  researchers  could  quickly  gauge  results  from  subtle  biological 
shifts such as smaller brain size or changes in tau or amyloid deposits. "We need to develop faster 
ways to test the range of promising therapies and find ones that work as soon as possible," Reiman 
says.  
Sugar-Powered Pacemakers. (cover history)  
Authors: Fessenden, Marissa; Source: Scientific American, Dec2012, Vol. 307 Issue 6, p42-43. 
The glucose in our blood could drive medical implants 
PACEMAKERS, insulin pumps and other medical devices of the future may run without batteries, 
powered  instead  by  the  same  energy  that  fuels  the  body:  sugar.  Researchers  first  dreamed  of 
glucose-powered implants in the 1960s, but the advent of lithium-ion batteries in the late 1970s 
provided a simpler, more powerful fix. Batteries have always had a major drawback, however: they 
must  be  surgically  replaced  --  every  five  to  15  years  for  pacemakers.  Rechargeables  connect  to 
electronics outside the body with wires that pierce the skin and leave a person open to infection. 
Several advances have prompted researchers to look again at glucose, which is plentiful in blood and 
the  interstitial  fluid  that  bathes  our  cells.  More  efficient  circuitry  in  implants,  for  example,  has 
reduced power requirements. And glucose biofuel cells are becoming much more efficient and body-
friendly. 
In most biofuel cells, enzymes at the anode strip electrons from glucose molecules. The electrons 
provide current as they flow to the cathode, where they react with oxygen, forming only small 
amounts of water. Unlike batteries, however, fuel cells need to be immersed in a constant supply of 
fuel -- which blood or interstitial fluid can readily provide. 
Excitement started to build in 2003, when researchers at the University of Texas at Austin built a tiny 
biofuel cell that generated power from a grape. Since then, a handful of groups have demonstrated 
practical devices. Past models demanded acidic conditions not found in the body, but researchers at 
Joseph Fourier University in Grenoble, France, packed biocompatible enzymes on a graphite base, 
which produced a milder chemistry. Their diskshaped cell is half the diameter of a dime and slightly 
thinner. It is wrapped in material used for dialysis bags, which allows small molecules of glucose in 
but keeps enzymes from getting out. In a 2010 lab rat experiment, the device drew glucose from 
interstitial fluid and produced a stable power output of 1.8 microwatts for 11 days. 
This  year  researchers  at  the  Massachusetts  Institute  of  Technology  took  another  step  toward 
commercialization. Engineer Rahul Sarpeshkar built a fuel cell as an integrated circuit on a silicon 
chip, using "the same easy-to-manufacture process as semiconductors," he says. His team wants to 
use cerebrospinal fluid to power brainmachine interfaces. The fluid, which cushions the brain and 
spinal cord, contains plenty of glucose yet few immune system cells that could work to reject the 
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Sarpeshkar  has  crafted  platinum  electrodes, which do  not  irritate tissue or  corrode,  notes  Sven 
Kerzenmacher, a chemical engineer at the University of Freiburg in Germany, who is also using the 
material in his designs. Still, the body can mount opposition to such an incursion; Kerzenmacher says 
biocompatibility is the biggest hurdle. His prototype fuel cell works well in buffer solutions in the lab, 
he says, but in body-fluid tests, amino acids in blood or serum caused the device to lose power. 
While a Clarkson University group has implanted a biofuel cell in a snail, the Grenoble group is still 
the only one to successfully operate a glucose fuel cell inside a vertebrate. The M.I.T. design has not 
been  tested  in  cerebrospinal  fluid  but  in  a  buffer  that  approximates  body-fluid  chemistry.  Yet 
Sarpeshkar  is  optimistic that  biofuel  cells  could  enter  the market  in  10 years.  His  silicon  device 
produces a reliable power output of 3.4 microwatts per square centimeter. Current pacemakers need 
eight to 10 microwatts, a feasible goal. Cochlear implants require a few milliwatts, and artificial 
organs would require even more. 
As sugar-powered implants advance, they are opening up the possibility of tiny medical devices. 
Perhaps nanoscale robots that run on glucose and dispense targeted drugs will one day swim from 
science fiction to reality. 
A cure for what ails you. 
Authors: Lewis, Ricki; Source: Scientific American, Jan2013, Vol. 308 Issue 1, p32-32. 
Gene therapy, once off to a rocky start, transforms medicine by getting at the root cause of many 
diseases. 
50 IT IS 2063. YOU WALK INTO THE DOCTOR'S OFFICE, AND A nurse takes a sample of saliva, blood or 
a prenatal cell and applies it to a microchip the size of a letter on this page on a handheld device. 
Minutes later the device reads the test results. The multicolored fluorescence pattern on its display 
reveals  the  presence  of  DNA  sequences  that  cause  or  influence  any  of  1,200-plus  single-gene 
disorders. Fortunately, regulatory authorities have approved a cure for each one of these diseases: 
gene therapy. 
Gene therapy works by using the innate biological machinery of a virus to carry healthy versions of 
genes into the nucleus of a cell to replace a mutation that leads to illness. It was conceived shortly 
after the discovery of DNA's structure in 1953, but its path to a bona fide treatment was fitful. Early 
attempts worked sporadically at best. In 1999 an 18-year-old died when a type of gene-carrying virus 
used  to  treat  a metabolic  disorder  triggered  a  deadly  immune  response;  the molecular  payload 
ignited a reaction in immune cells in the patient's liver. Also that year, two infants with an inherited 
immune deficiency received genes, onboard retroviruses, that veered into cancer-causing genes as 
well as their targets -- leukemia resulted. 
These setbacks mired the development of gene therapy in a debate about which viruses could be 
used safely as a vector, the gene-bearing invader of a cell. 
After a difficult start, gene therapy began to rack up milestones. In 2012 the European Commission 
approved the first gene therapy for lipoprotein lipase deficiency, which impairs fat digestion. 
Then, in 2014, the U.S. Food and Drug Administration approved treatments for a form of inherited 
blindness  (Leber's  congenital  amaurosis),  an  immune  deficiency  (adenosine  deaminase,  or  ADA, 
deficiency)  and  a  genetic  disorder  affecting  the  brain  (adrenoleukodystrophy).  Though  rare,  the 
conditions were relatively easy to target. 
These  endorsements  affirmed  adeno-associated  virus  (AAV)  as  the  vector of  choice. Most  of  us 
already carry it in some of our cells, which means our immune systems ignore it. Retroviruses, in 
contrast,  were  retooled  to  self-destruct  but  could  still  cause  cancer,  as  they  had  in  the 136 
 
immunodeficient  infants. And  lentivirus,  after winning  FDA  approval,  failed to  catch  on  because 
patients were reluctant to allow themselves to be injected with HIV, albeit in a form stripped of AIDS-
related genes. 
Arrival of gene therapy for hemophilia B, in 2016, proved the economic value of the technology: 
$30,000 for a one-time gene treatment trumped a lifetime of clotting factor injections -- a bill that 
could tally up to an expenditure of $20 million over the course of many years. 
The ability to control the immune response to the vector meant that the most imposing technical 
barrier  had  been  overcome:  the  chemical  package  delivered  to  patients  not  only  provided  a 
replacement gene, it also bolstered parts of the immune reaction against cancers and infections and 
dampened the aspects of the response that could lead to the rejection of viral vectors. 
The floodgates now opened. Because the retina is shielded from the immune system, gene therapies 
for about 100 forms of blindness came first. In 2019 a dozen children with the ultra-rare giant axonal 
neuropathy became pioneers by receiving gene therapy to the spinal cord. Next on the list were 
spinal cord injury, amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease) and spinal muscular 
atrophy. Intravenous, gene-laden AAV slipped across the blood-brain barrier, thereby preventing 
Parkinson's  and  other  brain  diseases.  No  longer  was  it  necessary  to  bore  holes  in  the  skull,  as 
happened in the early part of the century. 
Over time researchers came to recognize that some conditions are best treated without replacing a 
gene. For cystic fibrosis, drugs that could untangle a protein with a faulty structure were better 
because  gene-treated  cells  in  the  lungs  and  airway  do  not  persist.  And  for  Duchenne  muscular 
dystrophy, reactivating silenced genes was easier than delivering healing genes to all the muscle cells 
in a child's body. 
The successes only left room for more. By midcentury new therapies were targeted beyond rare, 
single-gene disorders to embrace common conditions that reflected genetic and environmental risk 
factors, such as mental illnesses, diabetes and most forms of heart disease. 
By 2060 the ability to use gene testing to predict a patient's future health -- coupled with genetic 
interventions -- had reached an unprecedented level of precision, with profound repercussions. With 
diseases stopped in their tracks, health care costs plunged as a longer-lived, physically fit population 
emerged. 
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Influenza, la caccia ai nuovi vaccini - Katherine Hobson 
http://www.nationalgeographic.it/scienza/medicina/2013/01/18/news/influenza_verso_un_vaccino
_migliore_-1467156/ 
Immunizzarsi è sempre consigliabile, ma l'efficacia dei vaccini attualmente disponibili è limitata. Gli scienziati 
studiano nuovi prodotti in grado di proteggere l'organismo anche per diversi anni 
Secondo uno studio condotto negli Stati Uniti, il vaccino anti-influenzale di quest'anno si è dimostrato efficace 
nel 62 per cento dei casi.  
Come ogni anno, l'epidemia invernale di influenza si avvicina al suo picco, che in Italia dovrebbe arrivare tra la 
fine di gennaio e l'inizio di febbraio. Si calcola che dall'inizio di novembre la malattia abbia colpito circa 13 
milioni di italiani. Anche se siamo alla "stretta finale", è ancora possibile vaccinarsi: il Ministero della Salute 
raccomanda di farlo soprattutto agli anziani e a persone che soffrono di particolari patologie. 
Secondo uno studio del Centro studi della Federazione dei medici di famiglia, quest'anno la quota degli italiani 
che si sono sottoposti alla vaccinazione sarebbe scesa di circa il 25 per cento, soprattutto a causa dei timori 
suscitati dal ritiro, lo scorso ottobre, di alcuni lotti del vaccino che presentavano anomalie.  
Ma perché contro l'influenza è necessario vaccinarsi ogni anno? Non sarebbe possibile farlo una volta per tutte, 
come avviene per altre malattie? La  risposta sta nella natura "sfuggente" del virus dell'influenza.  
Esistono virus che mutano molto poco nel tempo. Quello del morbillo, ad esempio, è "stabile come la roccia", 
sostiene  William  Schaffner,  capo  del  dipartimento  di  medicina  preventiva  della  Vanderbilt  University  di 
Nashville, negli Stati Uniti. 
Anche la varicella subisce pochi cambiamenti da un anno all'altro.  
Il  virus  dell'influenza,  invece,  è  "geneticamente  flessibile",  spiega  Shaffner.  Muta  continuamente,  e  può 
combinarsi con ceppi diversi dando vita a varianti sempre nuove. Può accadere così che il nostro sistema 
immunitario non riconosca la "versione" dell'influenza di quest'anno anche se l'anno scorso abbiamo contratto 
la malattia o ci siamo vaccinati.  
"È come dover mettere un cappotto nuovo ogni inverno", spiega Shaffner, che ha anche presieduto la National 
Foundation for Infectious Diseases.  
Occorre dunque aggiornare il vaccino per tener conto delle mutazioni del virus. Non sempre è facile. Ogni anno 
le autorità sanitarie tentano di prevedere come sono mutati i tre ceppi del virus - due dell'influenza A e uno 
dell'influenza B - che saranno più comuni nell'inverno seguente. L'operazione viene svolta con mesi d'anticipo, 
per dare il tempo di fabbricare, distribuire e somministrare i vaccini. "È marzo, ma devi cercare di capire che 
cosa circolerà nel febbraio seguente", spiega Shaffner.  
Nei mesi seguenti, i ceppi circolanti del virus possono mutare abbastanza da ridurre l'efficacia del vaccino. E 
anche quando i vaccini distribuiti si rivelano efficaci, è sempre possibile essere infettati da un ceppo meno 
comune per il quale non è stata messa a punto una protezione. C'è inoltre una parte della popolazione  - 
soprattutto tra gli anziani, i bambini e persone afflitte da particolari patologie - che anche dopo la vaccinazione 
non riesce a sviluppare una risposta immunitaria abbastanza forte da reprimere la malattia. E c'è chi contrae 
l'influenza prima che il vaccino possa fare effetto.  
I  Centers  for  Disease  Control  and  Prevention,  l'agenzia  USA  che  si  occupa  di  studiare  e  prevenire  le 
patologie,hanno calcolato che il vaccino di quest'anno è stato efficace nel 62 per cento dei casi. La stima è stata 
effettuata monitorando per un mese lo stato di salute di un migliaio di adulti e bambini americani. Si tratta di 
una percentuale in linea con i risultati degli anni precedenti: analizzando i dati delle ricerche effettuate in 
passato, la rivista  Lancet Infectious Diseases ha calcolato nel 2011 che sugli adulti sani di età pari o inferiore a 
65 anni l'efficacia combinata dei vaccini è stata del 59 per cento: un risultato non proprio eccezionale.  
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Naturalmente i ricercatori sono al lavoro per mettere a punto metodi migliori per  sconfiggere l'epidemia. 
"Quando mi chiedono se il vaccino attuale sia lo strumento più efficace che abbiamo a disposizione oggi, 
rispondo di sì. Bisogna usarlo», dice Michael Osterholm, principale autore della ricerca di Lancet e direttore del 
Center for Infectious Disease Research and Policy dell'Università del Minnesota. «Ma lo è anche per il futuro? 
No. Abbiamo bisogno di vaccini migliori».  
E  si  tratta  di  un  bisogno  urgente.  Secondo  l'Organizzazione  Mondiale  della  Sanità,  ogni  anno  l'influenza 
stagionale fa tra i 250 mila e i 500 mila morti nel mondo. I casi gravi sono tra i tre e i cinque milioni. In Italia le 
vittime della malattia e delle sue complicazioni sono intorno alle 8.000 l'anno, in grande maggioranza anziani. 
In un recente rapporto, Osterholm ha lanciato l'appello perché nella ricerca sui vaccini "si cambi strada".  
I tradizionali vaccini per l'influenza contengono pezzi della "testa" dell'emoagglutinina, una proteina che si 
trova sulla superficie del virus dell'influenza. Quando si imbattono in quei frammenti di proteina, dopo la 
vaccinazione, le cellule del sistema immunitario dette linfociti B imparano a produrre anticorpi contro di essi. 
Più tardi, se l'organismo viene a contatto con il virus, i linfociti sono già pronti a rispondere rapidamente per 
prevenire l'infezione.  
Il problema è che questa parte della proteina muta rapidamente: per questo i vecchi anticorpi non sono più 
efficaci contro la nuova versione del virus.  
Ricercatori  e  ditte  biotech  stanno  quindi  cercando  di  contrastare  le  proteine  del  virus  che  non  mutano  a 
seconda dei ceppi o degli anni. "Se troviamo un componente comune a tutti i virus dell'influenza che non muta 
col tempo, forse possiamo mettere a punto un vaccino che lo combatta", spiega Gregory Poland, direttore del 
gruppo di ricerca sui vaccini della Mayo Clinic, prestigioso centro di ricerca e di cura del Minnesota.  
La  speranza  è  che  con  questo  approccio  si  riesca  a  mettere  a  punto  un  vaccino  universale  che  protegga 
dall'influenza stagionale per diversi anni di fila e prepari l'organismo anche a combattere ceppi particolarmente 
aggressivi del virus, come quello della "spagnola", che a partire dal 1918 causò decine di milioni di morti in 
tutto il mondo, o quello della cosiddetta influenza suina, una variante del sottotipo H1N1 che provocò una 
pandemia globale nel 2009.  
Per raggiungere l'obiettivo però, i ricercatori seguono anche altre strade. Sarah Gilbert, docente di vaccinologia 
all'Università di Oxford, sta lavorando con la sua équipe a un vaccino che interagisca con i linfociti T, che sono 
in grado di uccidere le cellule infettate dai virus. "Riescono a riconoscere le cellule infette perché riconoscono i 
piccoli  segnali  dell'infezione  presenti  all'esterno  della  cellula",  spiega  Gilbert.  "È  come  se  queste  cellule 
mettessero fuori delle bandierine per dire che all'interno hanno qualcosa di non umano". Il vantaggio è che 
quelle "bandierine" sono più o meno le stesse per tutti i ceppi di virus influenzale.  
L'équipe di Oxford ha pubblicato i risultati di alcuni piccoli esperimenti preliminari condotti su esseri umani, 
ma, precisa la studiosa, saranno necessari studi molto più estesi per dimostrare l'efficacia di questo approccio.  
In ogni caso, anche se un vaccino più efficace fosse messo a punto, è molto improbabile che possa durare per la 
vita. L'efficacia dell'immunizzazione cala con il tempo, e quindi resterebbe la necessità di effettuare richiami.  
"Probabilmente metteremo a punto un vaccino da richiamare ogni cinque anni circa", prevede Gilbert. Sarebbe 
inoltre disponibile tutto l'anno, in modo da evitare le tradizionali code negli studi medici tra settembre e marzo.  
C'è ancora da aspettare 
Per ora però, l'attesa continua. "I possibili vaccini sono ancora nella fase dei primi test", precisa Poland. "Prima 
di diffonderne uno potrebbero passare dai quattro ai dieci anni".  
Il rapporto dello scorso ottobre del Center for Infectious Disease Research and Policy ha sottolineato come per 
mettere un nuovo vaccino sul mercato possono occorrere anche 15 anni e un investimento di un miliardo di 
dollari. Nel rapporto, si prevede anche che un vaccino fondato su un approccio completamente diverso da 
quelli tradizionali dovrà sottostare a un processo di approvazione più lungo, con rischi finanziari "notevolmente 
più alti".   
Nell'attesa, ci sono miglioramenti in vista anche per i vaccini tradizionali. A partire dal prossimo inverno sarà 
disponibile un vaccino quadrivalente, in grado di proteggere da due ceppi dell'influenza A e due della B. Entro 
un paio d'anni, assicura Poland, tutti i produttori di vaccini dovrebbero essere in grado di commercializzarlo. 
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How Far Off Is a Better Flu Shot?- Katherine Hobson 
http://news.nationalgeographic.com/news/2013/01/130116-flu-vaccine-immunity-virus-diseases-
health-science/ 
 
Someday you may only have to get a flu shot every five years. 
The Centers for Disease Control estimates this year’s flu vaccine to be 62 percent effective. 
As you waited in line for your flu shot last weekend, you may have been wondering: Why must I go through 
this every year? 
The answer is that the influenza virus is a slippery character. Some viruses barely change at all over time. The 
measles virus, for example, is "as stable as stone," said William Schaffner, chairman of the department of 
preventive medicine at Vanderbilt University. 
Chicken pox, too, is consistent from year to year. But influenza is "genetically plastic," said Schaffner. It mutates 
all the time, and it can combine with other flu strains to regularly make new variants. 
Those kinds of changes happen so frequently that the body's immune system won't necessarily recognize this 
year's iteration of the flu as a dangerous threat—even if you suffered from or were vaccinated against last 
year's version. 
"It's  like  putting  on  a  new  sport  coat  every  winter,"  said  Schaffner,  the  past  president  of  the National 
Foundation for Infectious Diseases. 
The vaccine has to be updated every year to account for the flu's changes. But forecasting what those changes 
will be is tough. 
Every year, public health officials try to predict the three flu strains—two of influenza A and one of influenza 
B—that will be common in the coming winter. They do this months in advance, giving manufacturers time to 
produce, distribute, and administer the vaccine. 
"Here you are in March, trying to figure out what will be circulating next February," said Schaffner. 
In  the  intervening  months,  circulating  strains  of  the  flu  virus  can  change  enough  to  reduce  the  vaccine's 
effectiveness. 
Even when the seasonal vaccine is a good match, it doesn't offer complete protection. People may be infected 
by a less common strain not included in the vaccine. 
Some,  especially  the  elderly,  very  young,  or  those  with  certain  health  conditions,  don't  develop  a  strong 
immune response to the flu even after vaccination. Others get exposed to the flu before the vaccine can take 
effect. 
The Centers for Disease Control and Prevention last week estimated the effectiveness of this year's vaccine to 
be 62 percent, based on a one-month survey of more than a thousand adults and kids. 
That's in line with the historical average. A 2011 review of previous research published in Lancet Infectious 
Diseases found that vaccines had a combined efficacy of 59 percent against flu in healthy adults aged 65 and 
younger. 
Trying to Change the Game 
That less than stellar record has scientists working to develop better tools to fight flu. 
"Is [the current vaccine] the answer for tomorrow? Yes, it's the best we have. Use it," said Michael Osterholm, 
lead author of the 2011 review and director of the Center for Infectious Disease Research and Policy at the 
University of Minnesota. 
"Is this the answer for the next few tomorrows?" he continues. "No. We need better flu vaccines." 
And that need is acute. The World Health Organization puts the global death toll from seasonal flu at 250,000 
to 500,000 per year, out of 3 million to 5 million severe cases. In the United States, an estimated 3,000 to 
49,000 people die each year from the flu, according to the CDC. 
Osterholm was the lead author of an October Center for Infectious Disease Research and Policy report that 
called for "game-changing" influenza vaccines. 
The traditional flu vaccine includes pieces of the "head" of the hemagglutinin protein, which is found on the 
surface of the flu virus. When immune cells called B cells run into those bits of protein after vaccination, the 
cells learn to make antibodies against them. Later, if the actual flu virus comes along, these prepared B cells 
can mount a speedy response and prevent infection. 
The problem is that this part of hem agglutinin mutates rapidly, and the older antibodies are of no use against 
the newer version of the virus. 
Researchers and some biotech companies are now trying to target proteins in the influenza virus that don't 
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"If this piece of the virus is the same among all influenza viruses and doesn't change over time, maybe we can 
make a vaccine against it," said Gregory Poland, director of the Mayo Clinic's Vaccine Research Group. 
The hope is that the approach yields a universal vaccine that protects against seasonal flu without annual 
shots. Such a vaccine could also keep the body poised to fend off a major new flu virus, like the 1918 strain that 
killed tens of millions of people and the 2009 pandemic of a strain of H1N1, aka swine flu. 
As they seek that silver bullet, researchers are taking a variety of approaches. 
Sarah Gilbert, a professor of vaccinology at the University of Oxford, is working with colleagues on a vaccine 
that interacts with the body's T cells, which kill other cells that have been infected by a virus. 
"T cells can recognize human cells infected with the virus because very small regions of the [infected cells'] 
contents are displayed on the outside," said Gilbert. "It's like putting little flags on the outside to say there is 
something nonhuman inside." 
The advantage is that those little flags on the outside of infected cells don't vary much from flu strain to flu 
strain. 
The Wait Continues 
The Oxford group has published the results from some small, early studies in humans but will need many more 
studies to prove T cell approach is effective, Gilbert said. 
Even if that or other new vaccines make it to market, the likelihood of a flu shot for life is low. Immunity 
declines over time, so people would probably need boosters. 
"I think we'll probably move to a shot every five years," said Gilbert. Such a shot could be offered year-round, 
cutting down on lines at drugstores and doctors' offices between September and March. 
For now, the wait continues. "Candidate vaccines are in early trials," said the Mayo Clinic's Poland. "It could be 
four to ten years before we see one." 
The Center for Infectious Disease Research and Policy report from October noted that it can take as long as 15 
years and as much as $1 billion to bring a new vaccine to market. 
It also predicted that flu vaccines taking an entirely new approach will face a longer approval process and 
"substantially higher" financial risk than more traditional vaccines. More studies will be needed, and regulators 
will need to figure out, for example, how to estimate the biological effectiveness of a vaccine that doesn't rely 
on the same mechanism as today's vaccines. 
The October report urged changes to the U.S. government's regulatory process for approving new flu vaccines 
and "coordinated partnerships involving national governments, the pharmaceutical industry, the investment 
community, and academia." And it called on the U.S. government to "assume a primary leadership role" in 
spurring the development of new vaccines. 
Can't wait for all that? There is an incremental improvement to the current flu vaccine coming soon. 
Starting in the 2013-14 flu season, there will be a "quadrivalent" vaccine available that will protect against two 
influenza A and two influenza B strains. In a couple of years, all vaccine manufacturers will be making them, 
said Poland. 
Avremo anche noi l'udito di Superman?- Ker Than 
http://www.nationalgeographic.it/scienza/2011/05/18/news/un_superudito_anche_per_gli_esseri_
umani_-338483/ 
Grazie a una nuova ricerca in futuro potremmo essere in grado di sentire suoni che oggi non percepiamo. 
Sott'acqua  l'udito  dei  subacquei  percepisce  una  gamma  di  suoni  che  gli  esseri  umani  non  sentono  fuori 
dall'acqua. Le ricerche su questo fenomeno potrebbero un giorno portare alla creazione di apparecchi che ci 
consentano di avere un superudito.  
Secondo una nuova ricerca, gli esseri umani potranno sentire  suoni che oggi non sono in grado di percepire. 
Nuovi esperimenti suggeriscono che facendo vibrare le ossa dell'orecchio si può creare una "scorciatoia" per far 
arrivare i suoni al cervello, potenziando l'udito. 
La maggior parte della gente sente suoni nella gamma tra 20 hertz (Hz) al minimo, fino a circa 20 kilohertz (kHz) 
al massimo. 
20 kHz, il suono più acuto, può suonare come il ronzio acuto di una zanzara mentre 20 Hz è ciò che sentiremmo 
“a un concerto rock se ci trovassimo vicino al bassista”, spiega Michael Qin, ricercatore del Naval Submarine 
Medical Research Laboratory in Connecticut. 
In  alcuni  casi,  l'uomo  può  anche  percepire  frequenze  al  di  fuori  di  questa  gamma.  Per  esempio,  chi  fa 
immersioni subacquee può sentire suoni fino a 100 kHz, come dimostrato dagli esperimenti di Qin. 141 
 
Non è chiaro perché l'udito dei subacquei migliori sott'acqua, ma ciò si può spiegare con il fatto che il suono 
viaggia direttamente attraverso le ossa al cervello, spiega Qin.  
Le vibrazioni delle ossa del cervello potenziano l'udito 
Nell'udito  normale,  le  onde  sonore  che  viaggiano  attraverso  l'aria  o  l'acqua  entrano  nel  canale  uditivo  e 
colpiscono il timpano, facendolo vibrare. Il timpano è connesso a tre  ossicini collegati tra loro: il martello, 
l'incudine e la staffa. 
La staffa, oscillando, spinge contro una struttura contenente fluido chiamata coclea nell'orecchio interno. A 
forma di chiocciola, la coclea contiene strutture simili a peli che convertono la pressione nel fluido in segnali 
nervosi che vengono inviati al cervello e interpretati come suoni. 
"Se consideriamo l'apparato uditivo come l'insieme di una lunga catena di eventi, ci sono molti punti in questa 
catena in cui la conduzione ossea o l'immersione subacquea possono scavalcare il normale avvicendamento 
nella catena di eventi”, dice Qin. 
Per esempio, la conduzione ossea avviene quando suoni ad alta frequenza stimolano direttamente le ossa 
dell'orecchio, inviando segnali al cervello senza attivare i timpani. È così che alcune specie di balene sentono 
sott'acqua. 
"Il nostro studio mira essenzialmente a comprendere come funziona l'udito sott'acqua e la conduzione ossea 
dell'udito, e a stabilire inoltre se condividono lo stesso meccanismo. 
In alternativa, alcune frequenze ultrasoniche potrebbero stimolare il fluido nella coclea. 
"Il fluido stesso potrebbe oscillare, come l'acqua di un serbatoio colpito da un oggetto metallico”, dice Qin. 
Potremo usare apparecchi per avere un udito super? 
Qin  e  il  suo  team  stanno  cercando  di  capire  quali  ossa  dell'orecchio  siano  più  sensibili  alle  vibrazioni 
ultrasoniche. 
La ricerca porterà alla creazione di apparecchi che diano a tutti la possibilità di sentire come Superman o di 
migliorare notevolmente un udito normale? Qin non si lascia scappare una parola sull'argomento. 
Alla fine di maggio Qin presenterà con il gruppo dei suoi ricercatori lo studio al congresso della Acoustical 
Society of America. 
(18 maggio 2011)© RIPRODUZIONE RISERVATA 
Superhuman Hearing Possible, Experiments Suggest- Ker Than 
http://news.nationalgeographic.com/news/2011/05/110516-people-hearing-aids-ears-science/ 
Vibrating ear bones could someday boost hearing. 
People may one day be able to hear what are now inaudible sounds, scientists say. 
New experiments suggest that just vibrating the ear bones could create shortcuts for sounds to enter 
the brain, thus boosting hearing. 
Most people can hear sounds in the range of about 20 hertz (Hz) at the low end to about 20 kilohertz 
(kHz) at the high end. 
Twenty kHz would sound like a very high-pitched mosquito buzz, and 20 Hz would be what you'd 
hear if "you were at an R&B concert and you just stood next to the bass," explained Michael Qin, a 
senior research scientist at the Naval Submarine Medical Research Laboratory in Connecticut. 
"It would be the thing that's moving your pants leg." 
Under certain circumstances, humans can also hear frequencies outside of this normal range. For 
instance, divers underwater can detect sounds of up to a hundred kHz, according to Qin's recent 
experiments. 
It's unclear why the divers have enhanced hearing underwater, but it may be because the sounds 
travel directly through the bones to the brain, he said. 
Vibrating Ear Bones Boost Hearing 
In normal hearing, sound waves traveling through the air or water enter our ear canals and strike our 
eardrums, causing them to vibrate. Our eardrums are connected to three tiny, connected bones 
called the malleus, incus, and stapes—popularly known as the hammer, anvil, and stirrup, due to 
their shapes. 142 
 
As the stapes bone rocks back and forth, it pushes against a fluid-filled structure called the cochlea in 
the inner ear. Resembling a tiny snail, the cochlea contains tiny hair-like structures that translate the 
pressure waves in the jostling fluid into nerve signals that are sent to the brain and interpreted as 
sounds. 
"If you think of the hearing system as one long chain of events, there are multiple places in which 
bone conduction or underwater hearing can bypass that chain," he said. 
For example, bone conduction occurs when very high-frequency sounds directly stimulate the ear 
bones, sending signals to the brain without activating the eardrums. This is how some species of 
whales hear underwater. 
"The core of our work is trying to understand underwater hearing and bone-conduction hearing, and 
to determine if they share the same underlying mechanism," he said. 
Alternatively, certain ultrasonic frequencies might stimulate the fluid in the cochlea. 
"It could be like hitting a wrench against a water tank," Qin explained. "The fluid itself could go into 
oscillation." 
Superhuman Hearing Devices on the Horizon? 
Qin and his team are now exploring which bones are most likely to be most sensitive to ultrasonic 
vibrations. 
Could such research lead to devices that give us superhuman hearing or improved hearing aids? Qin 
is mum for now. 
"That's the great thing about basic science, right? It lets you know how things work, and you can 
bend it to many applications." 
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APPENDIX 4: Doctor Shmerling’s answers 
- What are the main difficulties in explaining to a patient the illness? 
I think the main difficulty is that physicians spend so much time immersed in the language 
doctors use that they forget that patients cannot understand them.  And patients are often 
hesitant to ask for clarification.  Much like translating a foreign language, doctors have to 
remember  to  slow  down  and  communicate  in  terms  their  patients  will  understand.  
Conversely, patients need to understand that it’s okay to ask their doctors to explain things 
more clearly. 
-  Is  it  really  difficult  to  provide  an  explanation  using  a  "common/everyday  language"  to 
explain the diagnosis? 
I  don’t  think  it’s  difficult  –  after  all,  physicians  once  used  common,  everyday  language 
themselves!  But it does require a certain amount of attention and focus. 
-  Could  you  give  me  some  examples  of  "explanation  request"  so  that  I  can  see  how 
specialists try to explain to patients an illness? 
If  I  tell  a  patient  that  she  has  “renal  insufficiency  and  heart  failure”  she  may  have  little 
understanding of what is actually happening.  I would, instead, tell her that her kidneys are 
working at about 70% of normal and that her heart is not pumping as forcefully as it should.  I 
can then provide more details about how these problems may affect her and what treatments 
are recommended. 
-  To give you an example, how would you explain me what an hiatus hernia is?  
I would say:  “The esophagus connects the mouth to the stomach by traveling through a 
small opening in the diaphragm.  The stomach sits in the abdomen below the diaphragm.  
Sometimes, the stomach can slide up through this opening into the chest.  This is called a 
hiatus hernia.” 
  
All the best, 
 
Rob Shmerling  
Robert H. Shmerling, M.D. 
Harvard Medical School 
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APPENDIX 6: Questionnaire for general practioners 
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APPENDIX 7: Corpus of Italian patient information leaflets 
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APPENDIX 8: Corpus of English patient information leaflets 
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APPENDIX 9: Concordance results 
1. 
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